Processing 00000000.tx.1: Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease  Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease Marc Cruts1, Cornelia M. van Duijn2, Hubert Backhovens1, Marleen Van den Broeck1, Anita Wehnert1, Sally Serneels1, Robin Sherrington3, Michael Hutton4, John Hardy4, Peter H. 

Phrase: "Estimation of the genetic contribution of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0680844:estimation [Mental Process]
   744   C0681916:Estimation [Quantitative Concept]
   744   C0750572:Estimation [Quantitative Concept]

Phrase: "and -"

Phrase: "2 mutations in a population-based study of presenile Alzheimer disease  Estimation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   736   C0026882:Mutations [Genetic Function]
   703 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of the genetic contribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1880177:Contribution [Activity]

Phrase: "of presenilin-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418985:PRESENILIN 1 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and -"

Phrase: "2 mutations in a population-based study"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "of presenile Alzheimer disease Marc Cruts1,"

Phrase: "Cornelia M. van Duijn2,"

Phrase: "Hubert Backhovens1,"

Phrase: "Marleen Van den Broeck1,"

Phrase: "Anita Wehnert1,"

Phrase: "Sally Serneels1,"

Phrase: "Robin Sherrington3,"

Phrase: "Michael Hutton4,"

Phrase: "John Hardy4,"

Phrase: "Peter H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.2: St George-Hyslop3, Albert Hofman2 and Christine Van Broeckhoven1,* 1Laboratory of Neurogenetics, Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry, Antwerpen, Belgium, 2Department of Epidemiology and Biostatistics, Erasmus University, Rotterdam, The Netherlands, 3Centre for Research into Neurodegenerative Diseases, Department of Medicine and Medical Biophysics, University of Toronto, Toronto, Canada and 4Neurogenetics Laboratory, The Mayo Clinic, Jacksonville, FL, USA Received August 1, 1997; 

Phrase: "St George-Hyslop3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "Albert Hofman2"

Phrase: "and"

Phrase: "Christine Van Broeckhoven1,"

Phrase: "* 1Laboratory of Neurogenetics,"

Phrase: "Flanders Interuniversity Institute for Biotechnology"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "(VIB"

Phrase: ")"

Phrase: ","

Phrase: "Born-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004897:Bear [Mammal]

Phrase: "Bunge Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "(BBS"

Phrase: ")"

Phrase: ","

Phrase: "University of Antwerp (UIA),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Department of Biochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "Antwerpen,"

Phrase: "Belgium,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: "2Department of Epidemiology"

Phrase: "and"

Phrase: "Biostatistics,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005544:biostatistics [Research Activity]
  1000   C2717898:Biostatistics [Research Activity]
  1000   C2718322:Biostatistics [Occupation or Discipline]

Phrase: "Erasmus University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Rotterdam,"

Phrase: "The Netherlands,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "3Centre for Research"

Phrase: "into Neurodegenerative Diseases,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   861   C0012634:Diseases [Disease or Syndrome]
   789 E C1836721:MALS [Finding]
   789 E C3538764:MALS [Gene or Genome]
   789 E C3540595:MAL [Gene or Genome]

Phrase: "Department of Medicine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Medical Biophysics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005553:Biophysics [Biomedical Occupation or Discipline]

Phrase: "University of Toronto,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Toronto,"

Phrase: "Canada"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006823:Canada [Geographic Area]

Phrase: "and"

Phrase: "4Neurogenetics Laboratory,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0022877:Laboratory [Manufactured Object,Organization]
   861   C3244292:laboratory [Functional Concept]

Phrase: "The Mayo Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   861   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   789 E C0205210:Clinical [Qualitative Concept]

Phrase: "Jacksonville,"

Phrase: "FL,"

Phrase: "USA Received August 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0041703:USA [Geographic Area]
   812   C1514756:Received [Qualitative Concept]

Phrase: "1997"

Phrase: ";"
Processing 00000000.tx.3: Revised and Accepted October 2, 1997 Two closely related genes, the presenilins (PS), located at chromosomes 14q24.3 and 1q42.1, have been identified for autosomal dominant Alzheimer disease (AD) with onset age below 65 years (presenile AD). 

Phrase: "Revised"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1527075:Revised [Therapeutic or Preventive Procedure]
   966 E C3244319:revise [Functional Concept]

Phrase: "and"

Phrase: "Accepted October 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "1997 Two closely related genes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0017337:Genes [Gene or Genome]

Phrase: "the presenilins (PS),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "located at chromosomes 14q24.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1520594:14q24.3 [Cell Component]
   781   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosomes [Cell Component]
   760   C1520591:14q24 [Cell Component]

Phrase: "and"

Phrase: "1q42.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521016:1q42.1 [Cell Component]
   861   C1521014:1q42 [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "identified for autosomal dominant Alzheimer disease (AD)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0443147:Autosomal dominant [Intellectual Product]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205396:Identified [Qualitative Concept]
   753   C0596142:autosomal [Cell Component]
   753   C1527180:Dominant [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]

Phrase: "with onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206132:Onset Age [Quantitative Concept]
   861   C0001779:Age [Organism Attribute]

Phrase: "below 65 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(presenile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.4: We performed a systematic mutation analysis of all coding and 5'-non-coding exons of PS-1 and PS-2 in a population-based epidemiological series of 101 unrelated familial and sporadic presenile AD cases. 

Phrase: "We"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a systematic mutation analysis of all coding"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "5'-non-coding exons of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PS-2 in a population-based epidemiological series"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0017337:Gene [Gene or Genome]

Phrase: "of 101 unrelated familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic presenile AD cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.5: The familial cases included 10 patients of autosomal dominant AD families sampled for linkage analysis studies. 

Phrase: "The familial cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "10 patients of autosomal dominant AD families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0030705:Patients [Patient or Disabled Group]

Phrase: "sampled for linkage analysis studies."
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   806   C0796345:linkage analysis [Laboratory Procedure]
   781   C1303103:Sample analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023745:linkage [Molecular Function]
   760   C0441621:sampled [Diagnostic Procedure]
   760   C0870078:sampled [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1524024:analysis [Functional Concept]
   726 E C0370003:Sample [Substance]
   726 E C0557651:Study [Manufactured Object]
   726 E C2347026:Sample [Conceptual Entity]
   726 E C2603343:Study [Research Activity]
Processing 00000000.tx.6: In all patients mutations in the amyloid precursor protein gene (APP) had previously been excluded. 

Phrase: "In all patients mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(APP)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538722:APP [Laboratory Procedure]

Phrase: "had"

Phrase: "previously"

Phrase: "been"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.7: Four different PS-1 missense mutations were identified in six familial cases, two of which where autosomal dominant cases. 

Phrase: "Four different PS-1 missense mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   829   C0596611:gene mutations [Genetic Function]
   818   C0599155:Mutations, Missense [Genetic Function]
   795   C0026882:Mutations [Genetic Function]
   762 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified in six familial cases,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   760   C0015576:familial [Family Group]
   760   C0205396:Identified [Qualitative Concept]
   760   C0205452:Six [Quantitative Concept]
   760   C0241888:Familial [Functional Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "two of which where autosomal dominant cases."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205448:Two [Quantitative Concept]
Processing 00000000.tx.8: Three mutations resulted in onset ages above 55 years, with one segregating in an autosomal dominant family with mean onset age 64 years (range 50-78 years). 

Phrase: "Three mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "resulted in onset"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0332162:Onset [Qualitative Concept]
   756   C1274040:Result [Functional Concept]
   756   C1546471:Result [Idea or Concept]
   756   C2825142:Result [Finding]

Phrase: "ages above 55 years,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1510829:Age-Years [Temporal Concept]
   770   C0001779:Age [Organism Attribute]
   770   C0439234:years [Temporal Concept]
   770   C0450382:55 [Intellectual Product]
   737 E C0439508:/year [Temporal Concept]

Phrase: "with one segregating"

Phrase: "in an autosomal dominant family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "with mean onset age 64 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   853   C1510829:Age-Years [Temporal Concept]
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(range 50-78 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.9: One PS-2 mutation was identified in a sporadic case with onset age 62 years. 

Phrase: "One PS-2 mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0596611:Gene Mutation [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "identified in a sporadic case"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205396:Identified [Qualitative Concept]
   760   C0205422:Sporadic [Temporal Concept]
   760   C0868928:Case [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "with onset age 62 years."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   875   C1510829:Age-Years [Temporal Concept]
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.10: Our mutation data provided estimates for PS-1 and PS-2 mutation frequencies in presenile AD of 6 and 1% respectively. 

Phrase: "Our mutation data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "estimates for PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0750572:estimates [Quantitative Concept]

Phrase: "and"

Phrase: "PS-2 mutation frequencies in presenile AD of 6"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   756   C3178846:Mutation Frequencies [Qualitative Concept]
   754   C0017270:Gene Frequencies [Quantitative Concept]
   738   C0439603:Frequencies [Temporal Concept]
   704 E C0376249:frequency [Quantitative Concept]
   704 E C0871396:Frequency [Quantitative Concept]
   704 E C1561548:Frequency [Qualitative Concept]
   704 E C1705502:Frequency [Quantitative Concept]

Phrase: "and"

Phrase: "1% respectively."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]
Processing 00000000.tx.11: When family history was accounted for mutation frequencies for PS-1 were 9% in familial cases and 18% in autosomal dominant cases. 

Phrase: "When"

Phrase: "family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "was"

Phrase: "accounted for mutation frequencies"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   833   C3178846:Mutation Frequencies [Qualitative Concept]
   770   C0026882:Mutation [Genetic Function]
   770   C0439603:Frequencies [Temporal Concept]
   770   C1705285:Mutation [Cell or Molecular Dysfunction]
   737 E C0376249:frequency [Quantitative Concept]
   737 E C0871396:Frequency [Quantitative Concept]
   737   C1551359:account [Idea or Concept]
   737 E C1561548:Frequency [Qualitative Concept]
   737 E C1705502:Frequency [Quantitative Concept]
   737   C2741673:Account # [Clinical Attribute]
   737   C2981730:Account [Classification]

Phrase: "for PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "9% in familial cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "18% in autosomal dominant cases."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0596142:autosomal [Cell Component]
   760   C0868928:Cases [Functional Concept]
   760   C1527180:Dominant [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.12: Further, polymorphisms were detected in the promoter and the 5'-non-coding region of PS-1 and in intronic and exonic sequences of PS-2 that will be useful in genetic association studies. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "detected in the promoter"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "the 5'-non-coding region of PS-1"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   764   C0079941:Coding Region [Gene or Genome]
   742   C0009219:Coding [Occupational Activity]
   742   C0017446:Region [Geographic Area]
   742   C0205147:Region [Spatial Concept]
   742   C1518422:Non [Functional Concept]
   708 E C0805701:Code [Intellectual Product]

Phrase: "and in intronic"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1515981:And [Idea or Concept]

Phrase: "and"

Phrase: "exonic sequences of PS-2"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0162326:Sequences [Nucleotide Sequence]
   719 E C0004793:Sequence [Nucleotide Sequence]
   719 E C0162327:Sequence [Nucleotide Sequence]
   719 E C1519249:Sequence [Functional Concept]

Phrase: "that"

Phrase: "will"

Phrase: "be"

Phrase: "useful in genetic association studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0869040:Use studies [Research Activity]
Processing 00000000.tx.13: INTRODUCTION Alzheimer disease (AD) is the most common cause of senile dementia and the fourth leading cause of death in western societies. 

Phrase: "INTRODUCTION Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "(AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: "is"

Phrase: "the most common cause of senile dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015127:cause [Functional Concept]
   748   C1524003:Cause [Conceptual Entity]

Phrase: "and"

Phrase: "the fourth leading cause of death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007465:Cause of Death [Finding]
           Death Cause
   833   C0804771:Cause of death [Clinical Attribute]
   753   C0015127:cause [Functional Concept]
   753   C1524003:Cause [Conceptual Entity]

Phrase: "in western societies."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0680323:Western society [Population Group]
   861   C0037455:Societies [Organization]
Processing 00000000.tx.14: AD is a neurodegenerative disorder of the central nervous system characterized by progressive loss of memory and intellectual functioning due to the appearance in the brain of two major lesions: senile plaques and neurofibrillary tangles. 

Phrase: "AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "a neurodegenerative disorder of the central nervous system"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   909   C0007682:Disorder of the central nervous system [Disease or Syndrome]
           Disorder of Central Nervous System
           Central Nervous System Disorder
   848   C0270715:Central Nervous System Neurodegenerative Disorder [Disease or Syndrome]
   819   C0027765:Disorder of nervous system [Disease or Syndrome]
           DISORDER NERVOUS SYSTEM
   793   C1298233:Disorder of system [Functional Concept]
           disorder system
   770   C0524851:Neurodegenerative Disorder [Disease or Syndrome]
   767   C0851241:nervous disorder [Mental or Behavioral Dysfunction]
   744   C0012634:Disorder [Disease or Syndrome]
   731 E C0442893:Systemic Disorder [Disease or Syndrome]

Phrase: "characterized by progressive loss of memory"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0002622:Loss of memory [Mental or Behavioral Dysfunction]
           Memory loss
   833   C0751295:LOSS OF MEMORY [Sign or Symptom]
           Memory Loss
   753   C0025260:Memory [Mental Process]
   753   C0205329:Progressive [Functional Concept]
   753   C0700327:memory [Finding]
   753   C1517945:Loss [Quantitative Concept]
   753   C1706377:Memory [Manufactured Object]
   753   C1880022:Characterized [Activity]

Phrase: "and"

Phrase: "intellectual functioning due to the appearance"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0392334:intellectual functioning [Mental Process]
   753   C0542341:functioning [Functional Concept]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "of two major lesions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0221198:lesions [Finding]
   793 E C1546698:Lesion [Intellectual Product]

Phrase: ":"

Phrase: "senile plaques"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "neurofibrillary tangles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.15: The exact biochemical pathway leading to neurodegeneration is still unknown. 

Phrase: "The exact biochemical pathway"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1704259:Biochemical Pathway [Molecular Function]
           Pathway
   827   C0205474:Biochemical [Functional Concept]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to neurodegeneration"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "still unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.16: In most AD cases the first symptoms of memory dysfunction or behavior changes become apparent after age 65 years (late-onset or senile AD); 

Phrase: "In most AD cases"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "the first symptoms of memory dysfunction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0683368:symptoms [Functional Concept]
   753   C1457887:Symptoms [Sign or Symptom]

Phrase: "or"

Phrase: "behavior changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0542299:behavior changes [Individual Behavior]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "become"

Phrase: "apparent after age 65 years"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0521994:Apparent age [Organism Attribute]
   760   C0750489:apparent [Idea or Concept]

Phrase: "(late-onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205087:Late [Temporal Concept]
   861   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "senile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.17: however, in many cases the disease starts earlier in life (early-onset or presenile AD). 

Phrase: "however,"

Phrase: "in many cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "starts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439659:Start [Temporal Concept]

Phrase: "earlier in life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0376558:Life [Idea or Concept]
   743 E C0595998:lives [Finding]

Phrase: "(early-onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1833334:Early-onset [Finding]
   861   C0332162:Onset [Qualitative Concept]
   861   C1279919:Early [Temporal Concept]

Phrase: "or"

Phrase: "presenile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.18: There are no indications that the disease in presenile AD cases is different from that observed in senile AD cases, apart from a more severe pathology and more rapid clinical progression. 

Phrase: "There"

Phrase: "are"

Phrase: "no indications"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0392360:Indications [Idea or Concept]
   966 E C3146298:Indication [Functional Concept]

Phrase: "that"

Phrase: "the disease in presenile AD cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "is"

Phrase: "different from that"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1705242:Different [Qualitative Concept]
   718 E C1705241:*Difference [Quantitative Concept]

Phrase: "observed in senile AD cases,"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0392079:Senile [Finding]
   753   C0868928:Cases [Functional Concept]
   753   C1441672:Observed [Functional Concept]
   753   C1533148:Cases [Quantitative Concept]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "apart from a more severe pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0030664:Pathology [Biomedical Occupation or Discipline]
   827   C0205469:pathology [Functional Concept]
   827   C0677042:pathology [Pathologic Function]
   755 E C1521733:Pathologic [Functional Concept]

Phrase: "and"

Phrase: "more rapid clinical progression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C1838681:Rapid progression [Finding]
   812   C0242656:progression [Pathologic Function]
   812   C0449258:Progression [Functional Concept]
Processing 00000000.tx.19: Both senile and presenile AD have a genetic etiology; 

Phrase: "Both senile"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392079:Senile [Finding]
   944 E C0231337:Old age [Finding]
   944 E C1999167:Old age [Population Group]

Phrase: "and"

Phrase: "presenile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "have"

Phrase: "a genetic etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015127:aetiology [Functional Concept]
   861   C1314792:Aetiology [Functional Concept]
   861   C1524003:Etiology [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.20: however, genetic cases are more frequent among presenile AD cases (for a review see 1 ). 

Phrase: "however,"

Phrase: "genetic cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "are"

Phrase: "more frequent among presenile AD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332183:Frequent [Temporal Concept]

Phrase: "("

Phrase: "for a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.21: Also, several AD families have been documented that segregate presenile AD in an autosomal dominant manner. 

Phrase: "Also,"

Phrase: "several AD families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0344339:disease family [Finding]
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "documented"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1301725:Documented [Health Care Activity]
  1000   C1609436:documented [Idea or Concept]
   966 E C1301746:document [Intellectual Product]
   966 E C1547673:Document [Intellectual Product]

Phrase: "that"

Phrase: "segregate"

Phrase: "presenile AD in an autosomal dominant manner."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
Processing 00000000.tx.22: In these families a positional cloning approach has been employed to identify AD genes (for a review see 1 ). 

Phrase: "In these families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "a positional cloning approach"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0449445:Approach [Spatial Concept]
   734   C1656250:positional cloning [Research Activity]

Phrase: "has"

Phrase: "been"

Phrase: "employed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0557351:Employed [Finding]
   966 E C0457083:Employ [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "AD genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   856   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "("

Phrase: "for a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.23: To date, three AD genes are known that, when mutated, lead to presenile AD: the amyloid precursor protein gene (APP) on chromosome 21 at 21q21.1 (2 ); 

Phrase: "To date,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "three AD genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   816   C1416989:MAL gene [Gene or Genome]
   812   C0017337:Genes [Gene or Genome]

Phrase: "are"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "that,"

Phrase: "when"

Phrase: "mutated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705285:Mutated [Cell or Molecular Dysfunction]
   966 E C1513776:Mutate [Genetic Function]

Phrase: ","

Phrase: "lead to presenile AD"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "(APP) on chromosome 21"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3538722:APP [Laboratory Procedure]

Phrase: "at 21q21.1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2825752:21q21.1 [Cell Component]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.24: the presenilin-1 gene (PS-1) on chromosome 14 at 14q24.3(3 ); 

Phrase: "the presenilin-1 gene (PS-1) on chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C1418985:Presenilin 1 Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "at 14q24.3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1520594:14q24.3 [Cell Component]
   861   C1520591:14q24 [Cell Component]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.25: the presenilin-2 gene (PS-2) on chromosome 1 at 1q42.1 (4 ,5 ). 

Phrase: "the presenilin-2 gene (PS-2) on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C1418985:Presenilin 1 Gene [Gene or Genome]
   748   C0017337:Gene [Gene or Genome]

Phrase: "at 1q42.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521016:1q42.1 [Cell Component]
   861   C1521014:1q42 [Cell Component]

Phrase: "(4 ,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.26: Although the normal function of the amyloid precursor protein (app) is unknown, mutations have been demonstrated to alter endoproteolysis of app such that more of a 42 amino acid long form of amyloid [beta] (A[beta]42) is produced (6 ). 

Phrase: "Although"

Phrase: "the normal function of the amyloid precursor protein (app)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0815043:function protein [Amino Acid, Peptide, or Protein]
   767   C1527118:Protein Function [Molecular Function]
   744   C0031843:function [Physiologic Function]
   744   C0542341:Function [Functional Concept]
   744   C0700205:FUNCTION [Classification]
   744   C1705273:Function [Intellectual Product]

Phrase: "is"

Phrase: "unknown, mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "endoproteolysis of app"

Phrase: "such"

Phrase: "that more of a 42 amino acid long form of amyloid [beta"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   767   C2827504:Amyloid Beta 42 [Laboratory Procedure]
   753   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C2917660:Amino Acid [Pharmacologic Substance]
   753   C3484390:Amyloid beta [Amino Acid, Peptide, or Protein]
   751   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   751 E C2825879:Amyloid, Beta [Laboratory Procedure]
   736   C0001128:Acid [Chemical]
   736   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0011560:Amyloid [Pathologic Function]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0205166:Long [Qualitative Concept]
   736   C0330390:Beta [Plant]
   736   C0348078:Form [Qualitative Concept]
   736   C0376315:Form [Manufactured Object]
   736   C0439096:Beta [Intellectual Product]
   736   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C1522492:Form [Functional Concept]
   736   C1706317:Long [Qualitative Concept]
   736   C2004068:Beta [Qualitative Concept]

Phrase: "]"

Phrase: "(A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "]42"

Phrase: ")"

Phrase: "is"

Phrase: "produced"

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.27: Rapid deposition of A[beta]42 in AD brains is an early morphological event in AD pathology. 

Phrase: "Rapid deposition of A[beta"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0333562:Deposition [Functional Concept]

Phrase: "]42 in AD brains"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   781   C0006111:Brain Disease [Disease or Syndrome]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0012634:Disease [Disease or Syndrome]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "is"

Phrase: "an early morphological event in AD pathology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0441471:Event [Event]
Processing 00000000.tx.28: Also, the normal and pathological functions of the presenilin proteins (ps-1 and ps-2) are unknown (for a review see 7 ). 

Phrase: "Also,"

Phrase: "the normal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205307:Normal [Qualitative Concept]
  1000   C0439166:% normal [Quantitative Concept]
  1000   C2347086:% Normal [Quantitative Concept]

Phrase: "and"

Phrase: "pathological functions of the presenilin proteins"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   783   C0815043:functions proteins [Amino Acid, Peptide, or Protein]
   753   C0542341:Functions [Functional Concept]
   750 E C1527118:Protein Function [Molecular Function]
   719 E C0031843:function [Physiologic Function]
   719 E C0700205:FUNCTION [Classification]
   719 E C1705273:Function [Intellectual Product]

Phrase: "(ps-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ps-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: ")"

Phrase: "are"

Phrase: "unknown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]

Phrase: "("

Phrase: "for a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "7"

Phrase: ")."
Processing 00000000.tx.29: Since they both constitute integral membrane proteins with six to eight transmembrane domains (TM) and one large hydrophilic loop (HL) (8 ,9 ), similar functions of ps-1 and ps-2 were predicted. 

Phrase: "Since"

Phrase: "they both"

Phrase: "constitute"

Phrase: "integral membrane proteins with six"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C0021699:Integral Membrane Proteins [Amino Acid, Peptide, or Protein]
   806   C0025252:Membrane Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0025255:Membrane [Tissue]
   760   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0443238:Integral [Quantitative Concept]
   760   C0596901:Membrane [Cell Component]
   760   C1706182:Membrane [Manufactured Object]

Phrase: "to eight transmembrane domains (TM)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   867   C1519623:Transmembrane Domain [Amino Acid Sequence]
   827   C1167322:transmembrane [Cell Component]
   827   C2752508:transmembrane [Cell Component]
   793   C1880389:Domain [Functional Concept]
   793   C1883221:Domain [Conceptual Entity]
   793   C3541951:Domain [Intellectual Product]

Phrase: "and"

Phrase: "one large hydrophilic loop (HL)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0419518:Loop [Medical Device]
   812   C0445022:Loop [Spatial Concept]

Phrase: "(8 ,"

Phrase: "9"

Phrase: ")"

Phrase: ","

Phrase: "similar functions of ps-1"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0542341:Functions [Functional Concept]
   726 E C0031843:function [Physiologic Function]
   726 E C0700205:FUNCTION [Classification]
   726 E C1705273:Function [Intellectual Product]

Phrase: "and"

Phrase: "ps-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "predicted."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]
Processing 00000000.tx.30: Remarkably, mutations in PS-1 and PS-2 also produce more A[beta]42, suggesting that PS mutations and APP mutations lead to AD pathology through a common biochemical pathway. 

Phrase: "Remarkably,"

Phrase: "mutations in PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "PS-2 also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "produce"

Phrase: "more A[beta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "]42,"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that PS mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "APP mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "lead to AD pathology"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "through a common biochemical pathway."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1704259:Biochemical Pathway [Molecular Function]
           Pathway
   827   C0205474:Biochemical [Functional Concept]
   827   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.31: In APP seven different mutations have been identified in autosomal dominant families with presenile AD or AD-related phenotypes (6 ). 

Phrase: "In APP seven different mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "been"

Phrase: "identified in autosomal dominant families"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0015576:Families [Family Group]
   760   C0205396:Identified [Qualitative Concept]
   760   C0596142:autosomal [Cell Component]
   760   C1527180:Dominant [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1704727:Family [Conceptual Entity]

Phrase: "with presenile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "or"

Phrase: "AD-related phenotypes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0031437:Phenotypes [Organism Attribute]
   779 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.32: All mutations occur in exons 16 and 17, encoding the A[beta] proteolysis product of app. 

Phrase: "All mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occur in exons 16"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "17,"

Phrase: "encoding"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1547699:Encoding [Idea or Concept]
  1000   C2700640:Encoding [Activity]

Phrase: "the A[beta"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1420510:A-BETA [Gene or Genome]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "] proteolysis product of app."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1514468:product [Entity]
   753   C1704444:Product [Quantitative Concept]
Processing 00000000.tx.33: However, extensive mutation analyses have shown that mutations in APP are rare, since they segregate in only 5% of the presenile AD families (1 ). 

Phrase: "However,"

Phrase: "extensive mutation analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0796357:mutation analysis [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that mutations in APP"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0026882:Mutations [Genetic Function]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "rare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "since"

Phrase: "they"

Phrase: "segregate in only 5% of the presenile AD families"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   777   C1412178:Alzheimer disease 5 [Gene or Genome]
   777   C1865868:ALZHEIMER DISEASE 5 [Disease or Syndrome]
   760   C0002395:Alzheimer's Disease [Disease or Syndrome]
   760   C0344339:disease family [Finding]
   760   C1521724:Alzheimer's Disease [Pathologic Function]
   739   C0012634:Disease [Disease or Syndrome]
   739   C0015576:Families [Family Group]
   739   C0205171:Only [Quantitative Concept]
   739   C1704727:Family [Conceptual Entity]
   739   C1720467:Only [Intellectual Product]
   736   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   730   C0067430:MAL-5 [Organic Chemical]
   716 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")."
Processing 00000000.tx.34: Since the PS genes were identified more recently (for a review see 7 ), extensive mutation analyses have not yet been performed. 

Phrase: "Since"

Phrase: "the PS genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "were"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "more recently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "("

Phrase: "for a review"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0282443:Review [Intellectual Product]
  1000   C1552617:Review [Idea or Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "7"

Phrase: ")"

Phrase: ","

Phrase: "extensive mutation analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0796357:mutation analysis [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.35: However, initial estimates based on linkage analysis studies suggested that 70% of the presenile AD families were linked to chromosome 14 (10 ). 

Phrase: "However,"

Phrase: "initial estimates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750572:estimates [Quantitative Concept]

Phrase: "based on linkage analysis studies"
Meta Candidates (Total=13; Excluded=5; Pruned=0; Remaining=8)
   806   C0796345:linkage analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023745:linkage [Molecular Function]
   760   C0936012:Analysis [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1524024:analysis [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C0557651:Study [Manufactured Object]
   726 E C1880279:Base [Biomedical or Dental Material]
   726 E C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that 70% of the presenile AD families"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0344339:disease family [Finding]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   751   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]
   725 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "were"

Phrase: "linked to chromosome 14"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008656:Chromosome 14 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(10"

Phrase: ")."
Processing 00000000.tx.36: Later, a mutation in PS-1 was found in each chromosome 14-linked AD family (3 ,11 ,12 ). 

Phrase: "Later,"

Phrase: "a mutation in PS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0596611:Gene Mutation [Genetic Function]
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "found in each chromosome 14-linked AD family"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   784   C1970144:Alzheimer Disease 14 [Disease or Syndrome]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C0008656:Chromosome 14 [Cell Component]
   764   C0344339:disease family [Finding]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   742   C0008633:Chromosome [Cell Component]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:Family [Family Group]
   742   C0150312:Found [Quantitative Concept]
   742   C1704727:Family [Conceptual Entity]
   726   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
   726 E C0277558:Familial disease [Disease or Syndrome]
   708 E C0243095:Find [Finding]
   708   C1517892:Link [Intellectual Product]
   708   C1704666:Link [Intellectual Product]

Phrase: "(3 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "11 ,"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.37: To date 42 different missense mutations and one in-frame splice site mutation in PS-1 have been reported in 82 families world wide (13 ). 

Phrase: "To date 42 different missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   840   C0599155:Mutations, Missense [Genetic Function]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "one in-frame splice site mutation in PS-1"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   782   C1519478:Splice-Site Mutation [Genetic Function]
   777   C1881206:Inframe Mutation [Genetic Function]
   757   C0596611:Gene Mutation [Genetic Function]
   739   C0026882:Mutation [Genetic Function]
   739   C0205145:Site [Spatial Concept]
   739   C1515974:Site [Body Location or Region]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]
   739   C2825164:Site [Spatial Concept]

Phrase: "have"

Phrase: "been"

Phrase: "reported in 82 families"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0015576:Families [Family Group]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1704727:Family [Conceptual Entity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "world wide"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332464:Wide [Spatial Concept]
   861   C2700280:World [Population Group]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.38: Mutation screenings of PS-1 in presenile AD families not selected on the basis of linkage to chromosome 14 indicated that PS-1 mutations contribute less (30-50%) than initially estimated (14 ,15 ). 

Phrase: "Mutation screenings of PS-1"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   753   C0220908:Screenings [Health Care Activity]
   719 E C0220909:screening [Functional Concept]
   719 E C1698960:screening [Intellectual Product]
   719 E C1710031:Screening [Diagnostic Procedure]
   719 E C1710477:SCREENING [Research Activity]

Phrase: "in presenile AD families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0344339:disease family [Finding]
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "selected on the basis of linkage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0023745:linkage [Molecular Function]
   753   C1527178:Basis [Functional Concept]
   753   C1874451:Basis [Pharmacologic Substance]
   719   C1707391:Select [Activity]

Phrase: "to chromosome 14"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008656:Chromosome 14 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "contribute"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "(30-50%"

Phrase: ")"

Phrase: "than initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205265:Initially [Temporal Concept]

Phrase: "estimated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]

Phrase: "(14 ,"

Phrase: "15"

Phrase: ")."
Processing 00000000.tx.39: A possible explanation for the lower mutation frequency of PS-1 may be that the initial mutation data were biased towards finding PS-1 mutations, since most families analyzed had been included in a genome-wide search for AD genes and were known to be linked to chromosome 14. 

Phrase: "A possible explanation for the lower mutation frequency of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0681841:Explanation [Intellectual Product]

Phrase: "may"

Phrase: "be"

Phrase: "that"

Phrase: "the initial mutation data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "biased towards finding PS-1 mutations,"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   814   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0596611:gene mutations [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0026882:Mutations [Genetic Function]
   748   C0037088:Finding [Sign or Symptom]
   748   C0242568:Biased [Idea or Concept]
   748   C0243095:Finding [Finding]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C2825141:Finding [Finding]
   714 E C1504315:Bias [Bird]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "since"

Phrase: "most families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "had"

Phrase: "been"

Phrase: "included in a genome-wide search"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   753   C0017428:Genome [Gene or Genome]
   753   C0332257:included [Functional Concept]
   753   C0332464:Wide [Spatial Concept]
   753   C1552603:search [Intellectual Product]
   753   C1706202:Search [Activity]
   753   C2338314:Genome [Conceptual Entity]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C1552866:include [Idea or Concept]
   719 E C2700399:Include [Activity]

Phrase: "for AD genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   856   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "and"

Phrase: "were"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked to chromosome 14."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008656:Chromosome 14 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]
Processing 00000000.tx.40: Only one mutation has been reported in a proven non-familial AD case (16 ); 

Phrase: "Only one mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "been"

Phrase: "reported in a proven non-familial AD case"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   790   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   764   C0002395:Alzheimer's Disease [Disease or Syndrome]
   764   C1521724:Alzheimer's Disease [Pathologic Function]
   762   C0007320:case reported [Intellectual Product]
   762   C0277558:Familial disease [Disease or Syndrome]
   745 E C0085973:Case Report [Intellectual Product]
   742   C0012634:Disease [Disease or Syndrome]
   742   C0015576:familial [Family Group]
   742   C0241888:Familial [Functional Concept]
   742   C0456369:Proven [Qualitative Concept]
   742   C0684224:Reported [Intellectual Product]
   742   C0700287:Reported [Health Care Activity]
   742   C0868928:Case [Functional Concept]
   742   C1518422:Non [Functional Concept]
   742   C1706255:CASE [Medical Device]
   742   C1706256:Case [Conceptual Entity]
   742   C3496591:Reported [Clinical Attribute]
   726 E C0344339:disease family [Finding]
   708 E C3273238:Report [Intellectual Product]

Phrase: "(16"

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.41: however, only few mutation studies of sporadic AD cases have been performed. 

Phrase: "however,"

Phrase: "only few mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "studies of sporadic AD cases"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0085973:Case Studies [Intellectual Product]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0205422:Sporadic [Temporal Concept]
   753   C0557651:Study [Manufactured Object]
   753   C0868928:Cases [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1533148:Cases [Quantitative Concept]
   753   C2603343:Study [Research Activity]
   719 E C1706255:CASE [Medical Device]
   719 E C1706256:Case [Conceptual Entity]

Phrase: "have"

Phrase: "been"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.42: Initial linkage studies indicated that PS-2 mutations are far less frequent than PS-1 mutations (5 ). 

Phrase: "Initial linkage studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that PS-2 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "far less frequent than PS-1 mutations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0332183:Frequent [Temporal Concept]
   731   C0017270:Gene Frequencies [Quantitative Concept]
   714   C3178846:Mutation Frequencies [Qualitative Concept]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.43: Apart from the one PS-2 mutation identified in the chromosome 1-linked group of Volga German AD families, only one other PS-2 mutation has been identified to date (5 ,17 ). 

Phrase: "Apart from the one PS-2 mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0596611:Gene Mutation [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0026882:Mutation [Genetic Function]
   804   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "identified in the chromosome 1-linked group"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   778   C0008651:Chromosome 1 [Cell Component]
   774   C0230572:Chromosome group [Cell Component]
   774   C0441861:Group 1 [Intellectual Product]
   748   C0008633:Chromosome [Cell Component]
   748   C0205396:Identified [Qualitative Concept]
   748   C0441833:Group [Idea or Concept]
   748   C0687744:group [Population Group]
   748   C1257890:Group [Population Group]
   748   C1550043:Identified [Finding]
   748   C1551388:Identified [Functional Concept]
   748   C1552516:Group [Health Care Related Organization]
   748   C1705428:Group [Conceptual Entity]
   748   C1705429:Group [Population Group]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "of Volga German AD families,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "only one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205447:One [Quantitative Concept]

Phrase: "other PS-2 mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0596611:Gene Mutation [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "been"

Phrase: "identified to date"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0011008:Date [Temporal Concept]
   790   C0205396:Identified [Qualitative Concept]
   790   C1550043:Identified [Finding]
   790   C1551388:Identified [Functional Concept]
   790   C2348077:Date [Food]

Phrase: "(5 ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "17"

Phrase: ")."
Processing 00000000.tx.44: However, in contrast to PS-1 families onset ages in PS-2 families are highly variable and usually later in life (13 ). 

Phrase: "However,"

Phrase: "in contrast to PS-1 families onset"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332162:Onset [Qualitative Concept]
   717   C1418985:Presenilin 1 Gene [Gene or Genome]

Phrase: "ages in PS-2 families"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1418986:PRESENILIN 2 [Gene or Genome]
   790   C1517488:Gene Family [Gene or Genome]
   753   C0001779:Age [Organism Attribute]
   753   C0015576:Families [Family Group]
   753   C0017337:Gene [Gene or Genome]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C1704727:Family [Conceptual Entity]

Phrase: "are"

Phrase: "highly variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "usually later in life"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0376558:Life [Idea or Concept]
   729 E C0595998:lives [Finding]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.45: Therefore, it cannot be excluded that PS-2 families may have been missed, since presenile AD families with earlier onset ages are more likely to be ascertained for linkage analysis studies since they have more clear inheritance patterns. 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "that PS-2 families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C1517488:Gene Family [Gene or Genome]
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "missed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705492:Missed [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: ","

Phrase: "since"

Phrase: "presenile AD families with earlier onset ages"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0344339:disease family [Finding]
   751   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]
   725 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "are"

Phrase: "more likely to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205172:More [Functional Concept]
   827   C0332148:Likely [Qualitative Concept]
   827   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "ascertained for linkage analysis studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0796345:linkage analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0023745:linkage [Molecular Function]
   760   C0936012:Analysis [Research Activity]
   760   C0947630:studies [Laboratory Procedure]
   760   C1524024:analysis [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "since"

Phrase: "they"

Phrase: "have"

Phrase: "more"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205172:More [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "inheritance patterns."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136375:Inheritance Patterns [Genetic Function]
   861   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.46: To date no mutation reports of PS-2 in non-familial presenile AD cases have been published; 

Phrase: "To date"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011008:Date [Temporal Concept]
  1000   C2348077:Date [Food]

Phrase: "no mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reports of PS-2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418986:PRESENILIN 2 [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0684224:Report [Intellectual Product]
   760   C0700287:Report [Health Care Activity]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C3273238:Report [Intellectual Product]

Phrase: "in non-familial presenile AD cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]
   700   C0276496:Alzheimer disease, familial [Disease or Syndrome]

Phrase: "have"

Phrase: "been"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.47: however, PS-2 has been less intensively investigated for mutations than PS-1. 

Phrase: "however,"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "less intensively"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439092:less [Intellectual Product]
   861   C0547044:Less [Qualitative Concept]

Phrase: "investigated for mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026882:Mutations [Genetic Function]
   790   C1292732:investigated [Functional Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "than PS-1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.48: In this study we aimed at evaluating the genetic contributions of PS-1 and PS-2 mutations to presenile AD in autosomal dominant, familial and sporadic cases. 

Phrase: "In this study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "aimed at evaluating"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0220825:Evaluate [Functional Concept]
   756   C1947946:Aim [Idea or Concept]
   756   C2948600:Aim [Pharmacologic Substance]
   756   C3540471:AIM [Gene or Genome]
   756   C3540472:AIM [Functional Concept]

Phrase: "the genetic contributions of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1880177:Contribution [Activity]

Phrase: "and"

Phrase: "PS-2 mutations to presenile AD"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0596611:gene mutations [Genetic Function]
   744   C0017337:Gene [Gene or Genome]
   744   C0026882:Mutations [Genetic Function]
   739   C1416989:MAL gene [Gene or Genome]
   711 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in autosomal dominant, familial"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   755 E C1704727:Family [Conceptual Entity]
   734   C0443147:Autosomal dominant [Intellectual Product]

Phrase: "and"

Phrase: "sporadic cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.49: To overcome several of the biases mentioned above we used a unique sample of 101 unrelated familial and sporadic presenile AD cases ascertained in a population-based manner in The Netherlands (18 ,19 ). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "overcome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2983310:Overcome [Activity]

Phrase: "several of the biases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439064:Several [Quantitative Concept]
   770   C0443302:Several [Quantitative Concept]

Phrase: "mentioned above we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a unique sample of 101 unrelated familial"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0370003:Sample [Substance]
   748   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "sporadic presenile AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]

Phrase: "ascertained in a population-based manner"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1880279:Base [Biomedical or Dental Material]

Phrase: "in The Netherlands"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027778:The Netherlands [Geographic Area]
           Netherlands

Phrase: "(18 ,"

Phrase: "19"

Phrase: ")."
Processing 00000000.tx.50: The sample contained 11 autosomal dominant, 56 familial and 34 sporadic presenile AD cases. 

Phrase: "The sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "11 autosomal dominant, 56 familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   733 E C1704727:Family [Conceptual Entity]

Phrase: "and"

Phrase: "34 sporadic presenile AD cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.51: The mean onset age was 56.7  5.4 years (range 45-64 years), being lower than 60 years in 71 cases and lower than 50 years in 10 cases. 

Phrase: "The mean onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206132:Onset Age [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "56.7  5.4 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: "(range 45-64 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: ","

Phrase: "being"

Phrase: "lower than 60 years"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "in 71 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "and"

Phrase: "lower than 50 years"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0441994:Lower [Spatial Concept]
   770   C1548802:Lower [Body Location or Region]
   770   C2003888:Lower [Activity]

Phrase: "in 10 cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.52: In the autosomal dominant AD families all probands had an onset age before 65 years; 

Phrase: "In the autosomal dominant AD families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "all probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "had"

Phrase: "an onset age before 65 years"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0206132:Onset Age [Quantitative Concept]
   783   C1510829:Age-Years [Temporal Concept]
   753   C0001779:Age [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.53: however, in four families the mean onset age was above 65 years. 

Phrase: "however,"

Phrase: "in four families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "the mean onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206132:Onset Age [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "above 65 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0439234:years [Temporal Concept]
   793 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.54: In addition we analyzed the families of 10 autosomal dominant presenile AD cases included in this population-based study (20 ). 

Phrase: "In addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "we"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "the families of 10 autosomal dominant presenile AD cases"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C1864828:Alzheimer Disease, Familial, 10 [Disease or Syndrome]
   757   C0344339:disease family [Finding]
   739   C0015576:Families [Family Group]
   739   C1704727:Family [Conceptual Entity]
   736   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   716 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "included in this population-based study"
Meta Candidates (Total=16; Excluded=5; Pruned=0; Remaining=11)
   833   C1709599:Population Based Study [Research Activity]
   783   C0681876:Population Study [Research Activity]
   783   C2348561:Study Population [Population Group]
   753   C0032659:Population [Quantitative Concept]
   753   C0332257:included [Functional Concept]
   753   C0557651:Study [Manufactured Object]
   753   C1257890:Population [Population Group]
   753   C1527178:Based [Functional Concept]
   753   C1705938:Based [Idea or Concept]
   753   C2603343:Study [Research Activity]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C0002055:base [Inorganic Chemical]
   719 E C0178499:Base [Chemical Viewed Functionally]
   719 E C1552866:include [Idea or Concept]
   719 E C1880279:Base [Biomedical or Dental Material]
   719 E C2700399:Include [Activity]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.55: In all cases mutations in exons 16 and 17 of the APP gene were previously excluded (19 ,20 ) while one family was shown to be linked to chromosome 14 (20 ). 

Phrase: "In all cases mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in exons 16"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "17 of the APP gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1364818:APP gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C3538722:APP [Laboratory Procedure]

Phrase: "were"

Phrase: "previously"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "(19 ,"

Phrase: "20"

Phrase: ")"

Phrase: "while"

Phrase: "one family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "linked to chromosome 14"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008656:Chromosome 14 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.56: Table 1 . Intronic PCR primers flanking the coding and 5'-non-coding exons of PS-1 and PS-2 PS-1 PS-2 Exon Primer Sequence Size (bp) Exon Primer Sequence Size (bp) 1A S182ex1A-3 TTCTCCCCGCAATCGTTTCTCCAG 297 1 PS-2ex1-3 TGTTAGCAGCGGTGTTTG 248  S182ex1A-4 GCCCATGTCCGCGGTGCCTTCC   PS-2ex1-4 TCTGCTCGGAGGGATGGAC 1B S182ex1B-3 AGGAGGGGCGGCCCGTTTCTCG 523 2 PS-2ex2-1 CAGGGCCAGGGGGAGGAA 303  S182ex1B-4 AGCCTCTGCCACCACCGNAGGATC   PS-2ex2-2 AAAAGCAGGTTGGGAGTCAC 2 S182ex2-3 TGGATGACCTGGTGAAATCCTATT 223 3 PS-2ex3-1 GTCCTCCACTGCCTTTGTCTCAC 328  S182ex2-4 CAGAAAACAAAGCCTCTTGAGGTT   PS-2ex3-2 CTTCCCTTCTCCCTCCCGCATCAG 3 S182ex3-1 ACAAAGTTCTGTTTTTCTTTCCC 247 4 52PS-2x4 AAAAATCCGTGCATTACAT 395  S182ex3-2 CAGCATTTCTCAGAGGTGAGG   3PS-2x4 GCTGGTTGTGAGCTGCAGGTACAGTG 4 S182ex4-1 CGTTACCTTGATTCTGCTGA 371 5 PS-2-ex5-1 AGCCTCGAGGAGCAGTCAG 241  S182ex4-2 GACATGCTGTAAAGAAAAGCC   PS-2-ex5-2 GCAGACGGAGAGAAGCGT  5 S182ex5-3 GATTGGTGAGTTGGGGAAAAGTG 335 6 5PS-2x6 GGTATCAGTCTCAGGATCATGGG 265  S182ex5-4 ATACCCAACCATAAGAAGAACAGG   3PS-2x6 TGGGGAAGACTGGAGCTCGATG  6 S182ex6-3 GGTTGTGGGACCTGTTAATT 149 7 PS-2-ex7-1 GTAAAGAGGGCCAGGTTGGG 387  S182ex6-4 TTAATTCTGAAAGACAGACCC   PS-2-ex7-2 GTGCAGCACTGGGGACGATTT  7 S182ex7-1 GGAGCCATCACATTATTCTAAA 326 8 52PS-2x8 GGGCAGGCTCTTCTTCAGGG 251  S182ex7-2 AACAAATTATCAGTCTTGGGTTT   3PS-2x8 GAAAGCCACGGCCAGGAAG  8 S182ex8-1 TTACAAGTTTAGCCCATACATTTT 215 9 PS-2ex9-3 ACCGCCTGAGACGTGAACCTT 235  S182ex8-2 TCAAGTTCCCGATAAATTCTAC   PS-2ex9-4 TCCCTCTGCCCCTCCTGAACT  9 S182ex9-1 TGTGTGTCCAGTGCTTACCTG 188 10 5PS-2x10 CTCTGACCAGCTGTTGTTTC 249  S182ex9-2 TGTTAGCTTATAACAGTGACCCTG   3PS-2x10 AGCCTCCACCCTCTGTCT 10 S182ex10-1 CCAGCTAGTTACAATGACAGC 345 11 5PS-2x11 TTCCATTCTGTGCACGCCTC 244  S182ex10-2 TCAAAAAGGTTGATAATGTAGCT   3PS-2x11 ACCTGCCCCCACCACAATG  11 S182ex11-1 GGTTGAGTAGGGCAGTGATA 275 12 PS-2ex12-3 ACACCAGGGATCACCACGCTCAC 344  S182ex11-2 TTAAAGGGACTGTGTAATCAAAG   PS-2ex12-4 TGCCTCCTCCTCACCAAGTAAACA 12 S182ex12-1 GTCTTTCCCATCTTCTCCAC 199  S182ex12-2 GGGATTCTAACCGCAAATAT Table 2 . Missense mutations detected in PS-1 and PS-2 Gene Exon Location Mutation Family Onset age (years) Family historya Restriction site change PS-1 4 236C -> T Ala79Val 1005 53 AD AciI, BbeI, BanI, EheI, HaeII, HinP1I, HhaI, Hsp92I, KasI, NarI, NlaIV     1087 55 F      1061 58 F   5 344A -> G Tyr115Cys 1066 45 AD Csp6I, RsaI  7 692C -> T Ala231Val 1072 58 F BglI, Bsp1286I, MwoI  9 953A -> G Glu318Gly 1069 57 F PS-2 4 185G -> A Arg62His 1121 62 S AciI aAD, autosomal dominant; 

Phrase: "Table 1 . Intronic PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   762   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "the coding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0009219:Coding [Occupational Activity]

Phrase: "and"

Phrase: "5'-non-coding exons of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PS-2 PS-1 PS-2 Exon Primer Sequence Size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0456389:size [Spatial Concept]

Phrase: "(bp) Exon Primer Sequence Size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0456389:size [Spatial Concept]

Phrase: "(bp) 1A S182ex1A-3 TTCTCCCCGCAATCGTTTCTCCAG 297 1 PS-2ex1-3 TGTTAGCAGCGGTGTTTG 248  S182ex1A-4 GCCCATGTCCGCGGTGCCTTCC   PS-2ex1-4 TCTGCTCGGAGGGATGGAC 1B S182ex1B-3 AGGAGGGGCGGCCCGTTTCTCG 523 2 PS-2ex2-1 CAGGGCCAGGGGGAGGAA 303  S182ex1B-4 AGCCTCTGCCACCACCGNAGGATC   PS-2ex2-2 AAAAGCAGGTTGGGAGTCAC 2 S182ex2-3 TGGATGACCTGGTGAAATCCTATT 223 3 PS-2ex3-1 GTCCTCCACTGCCTTTGTCTCAC 328  S182ex2-4 CAGAAAACAAAGCCTCTTGAGGTT   PS-2ex3-2 CTTCCCTTCTCCCTCCCGCATCAG 3 S182ex3-1 ACAAAGTTCTGTTTTTCTTTCCC 247 4 52PS-2x4 AAAAATCCGTGCATTACAT 395  S182ex3-2 CAGCATTTCTCAGAGGTGAGG   3PS-2x4 GCTGGTTGTGAGCTGCAGGTACAGTG 4 S182ex4-1 CGTTACCTTGATTCTGCTGA 371 5 PS-2-ex5-1 AGCCTCGAGGAGCAGTCAG 241  S182ex4-2 GACATGCTGTAAAGAAAAGCC   PS-2-ex5-2 GCAGACGGAGAGAAGCGT  5 S182ex5-3 GATTGGTGAGTTGGGGAAAAGTG 335 6 5PS-2x6 GGTATCAGTCTCAGGATCATGGG 265  S182ex5-4 ATACCCAACCATAAGAAGAACAGG   3PS-2x6 TGGGGAAGACTGGAGCTCGATG  6 S182ex6-3 GGTTGTGGGACCTGTTAATT 149 7 PS-2-ex7-1 GTAAAGAGGGCCAGGTTGGG 387  S182ex6-4 TTAATTCTGAAAGACAGACCC   PS-2-ex7-2 GTGCAGCACTGGGGACGATTT  7 S182ex7-1 GGAGCCATCACATTATTCTAAA 326 8 52PS-2x8 GGGCAGGCTCTTCTTCAGGG 251  S182ex7-2 AACAAATTATCAGTCTTGGGTTT   3PS-2x8 GAAAGCCACGGCCAGGAAG  8 S182ex8-1 TTACAAGTTTAGCCCATACATTTT 215 9 PS-2ex9-3 ACCGCCTGAGACGTGAACCTT 235  S182ex8-2 TCAAGTTCCCGATAAATTCTAC   PS-2ex9-4 TCCCTCTGCCCCTCCTGAACT  9 S182ex9-1 TGTGTGTCCAGTGCTTACCTG 188 10 5PS-2x10 CTCTGACCAGCTGTTGTTTC 249  S182ex9-2 TGTTAGCTTATAACAGTGACCCTG   3PS-2x10 AGCCTCCACCCTCTGTCT 10 S182ex10-1 CCAGCTAGTTACAATGACAGC 345 11 5PS-2x11 TTCCATTCTGTGCACGCCTC 244  S182ex10-2 TCAAAAAGGTTGATAATGTAGCT   3PS-2x11 ACCTGCCCCCACCACAATG  11 S182ex11-1 GGTTGAGTAGGGCAGTGATA 275 12 PS-2ex12-3 ACACCAGGGATCACCACGCTCAC 344  S182ex11-2 TTAAAGGGACTGTGTAATCAAAG   PS-2ex12-4 TGCCTCCTCCTCACCAAGTAAACA 12 S182ex12-1 GTCTTTCCCATCTTCTCCAC 199  S182ex12-2 GGGATTCTAACCGCAAATAT Table 2 . Missense mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   850   C0596611:gene mutations [Genetic Function]
   778   C0026882:Mutations [Genetic Function]
   778   C0599155:Mutations, Missense [Genetic Function]
   744 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "detected in PS-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0442726:Detected [Finding]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PS-2 Gene Exon Location Mutation Family Onset age (years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   801   C1510829:Age-Years [Temporal Concept]
   788   C0439234:years [Temporal Concept]
   755 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "Family historya Restriction site change PS-1 4 236C -"

Phrase: "> T Ala79Val 1005 53 AD AciI,"

Phrase: "BbeI,"

Phrase: "BanI,"

Phrase: "EheI,"

Phrase: "HaeII,"

Phrase: "HinP1I,"

Phrase: "HhaI,"

Phrase: "Hsp92I,"

Phrase: "KasI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1151968:KASI [Molecular Function]

Phrase: "NarI,"

Phrase: "NlaIV     1087 55 F      1061 58 F   5 344A -"

Phrase: "> G Tyr115Cys 1066 45 AD Csp6I,"

Phrase: "RsaI  7 692C -"

Phrase: "> T Ala231Val 1072 58 F BglI,"

Phrase: "Bsp1286I,"

Phrase: "MwoI  9 953A -"

Phrase: "> G Glu318Gly 1069 57 F PS-2 4 185G -"

Phrase: ">"

Phrase: "A Arg62His 1121 62 S AciI aAD,"

Phrase: "autosomal dominant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443147:Autosomal dominant [Intellectual Product]
   861   C1527180:Dominant [Functional Concept]

Phrase: ";"
Processing 00000000.tx.57: F, familial; 

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:familial [Family Group]
  1000   C0241888:Familial [Functional Concept]
   928 E C1704727:Family [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.58: S, sporadic.

Phrase: "S,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]

Phrase: "sporadic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205422:Sporadic [Temporal Concept]
Processing 00000000.tx.59: Nucleotide positions are relative to the translation start site in the PS-1 or PS-2 cDNA. 

Phrase: "Nucleotide positions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0733755:positions [Spatial Concept]
   777 E C0240795:POSITIONAL [Finding]

Phrase: "are"

Phrase: "relative to the translation start site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in the PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "PS-2 cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.60: Restriction enzymes used in this study to test for the presence of the mutation are denoted in bold (Fig. 1A). 

Phrase: "Restriction enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   861   C0443288:Restriction [Functional Concept]

Phrase: "used in this study to"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   781   C0869040:study use [Research Activity]
   760   C0557651:Study [Manufactured Object]
   760   C1273517:used [Finding]
   760   C2603343:Study [Research Activity]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "test for the presence of the mutation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0022885:Test [Laboratory Procedure]
   748   C0026882:Mutation [Genetic Function]
   748   C0039593:Test [Functional Concept]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0392366:test [Intellectual Product]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "denoted in bold"

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")."
Processing 00000000.tx.61: The pedigrees of families with a PS-1 mutation are depicted in Figure 2. 

Phrase: "The pedigrees of families"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030761:pedigrees [Intellectual Product]

Phrase: "with a PS-1 mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:Gene Mutation [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "depicted in Figure 2."
Processing 00000000.tx.62: Table 3 . Polymorphisms detected in PS-1 and PS-2 Gene Exon Location Codon Allele frequencies Restriction site change PS-1 1A (-48)C -> T  0.88/0.12 HgaI, Hsp96I, SfaNI  1B -364C -> A  0.18/0.82 BstXI  8 (+16)A -> C  0.54/0.46 Alw26I PS-2 3 69C -> T Ala23 0.79/0.21 DdeI  3 129C -> T Asn43 n.d. 

Phrase: "Table 3 . Polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "detected in PS-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   862   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0442726:Detected [Finding]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "PS-2 Gene Exon Location Codon Allele frequencies Restriction site change PS-1 1A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   785   C0450344:1A [Intellectual Product]
   785   C1553633:1a [Medical Device]
   709   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   709   C1418985:PRESENILIN 1 [Gene or Genome]

Phrase: "(-48"

Phrase: ")"

Phrase: "C -> T  0.88/0.12 HgaI,"

Phrase: "Hsp96I,"

Phrase: "SfaNI  1B -364C -"

Phrase: ">"

Phrase: "A  0.18/0.82 BstXI  8"

Phrase: "(+16"

Phrase: ")"

Phrase: "A -> C  0.54/0.46 Alw26I PS-2 3 69C -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   705   C0079429:A Gene [Gene or Genome]

Phrase: "> T Ala23 0.79/0.21 DdeI  3 129C -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   712   C0041014:T-3 [Amino Acid, Peptide, or Protein,Hormone,Pharmacologic Substance]

Phrase: "> T Asn43 n.d."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C2986835:T/N [Quantitative Concept]
Processing 00000000.tx.63: TspRI  4 (-42)A -> G  0.54/0.46 NcoI, NlaIII, StyI  4 261C -> T His87 0.46/0.54 BbrPI, BsaAI, Eco72I, MaeII, NlaIII, NspI, TaiI  5 366G -> A Thr122 n.d.   

Phrase: "TspRI  4"

Phrase: "(-42"

Phrase: ")"

Phrase: "A -> G  0.54/0.46 NcoI,"

Phrase: "NlaIII,"

Phrase: "StyI  4 261C -"

Phrase: "> T His87 0.46/0.54 BbrPI,"

Phrase: "BsaAI,"

Phrase: "Eco72I,"

Phrase: "MaeII,"

Phrase: "NlaIII,"

Phrase: "NspI,"

Phrase: "TaiI  5 366G -"

Phrase: ">"

Phrase: "A Thr122 n.d."
Processing 00000000.tx.64: 7 708T -> C Ser236 n.d. 

Phrase: "7 708T -"

Phrase: "> C Ser236 n.d."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   902   C0012358:c d [Therapeutic or Preventive Procedure]
Processing 00000000.tx.65: BssHII, BstUI, Cag8I, HinPI, TspRI  11 (+24)A -> G  0.55/0.45 AluI, Bst71I, BstF5I, CviJI, MspA1I, PvuII The nucleotide position of exonic polymorphisms are relative to the translation start site in the PS-1 or PS-2 cDNA. 

Phrase: "BssHII,"

Phrase: "BstUI,"

Phrase: "Cag8I,"

Phrase: "HinPI,"

Phrase: "TspRI  11"

Phrase: "(+24"

Phrase: ")"

Phrase: "A -> G  0.55/0.45 AluI,"

Phrase: "Bst71I,"

Phrase: "BstF5I,"

Phrase: "CviJI,"

Phrase: "MspA1I,"

Phrase: "PvuII"

Phrase: "The nucleotide position of exonic polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0733755:Position [Spatial Concept]

Phrase: "are"

Phrase: "relative to the translation start site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0080103:Relative [Family Group]
   753   C0205345:Relative [Qualitative Concept]
   753   C1547039:*Relative [Quantitative Concept]

Phrase: "in the PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "PS-2 cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.66: The nucleotide positions of intronic polymorphisms are relative to the start (+) or end (-) of the intron. 

Phrase: "The nucleotide positions of intronic polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0733755:positions [Spatial Concept]

Phrase: "are"

Phrase: "relative to the start"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1547039:*Relative [Quantitative Concept]

Phrase: "(+"

Phrase: ")"

Phrase: "or"

Phrase: "end (-) of the intron."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0444930:End [Spatial Concept]
   770   C2746065:End [Temporal Concept]
   715 E C0205088:Terminal [Temporal Concept]
   715 E C1705314:Terminal [Manufactured Object]
   715 E C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.67: Allele frequencies were determined in the 118 control individuals using the restriction enzymes denoted in bold (Fig. 1B). 

Phrase: "Allele frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0017270:Frequencies, Allele [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "determined in the 118 control individuals"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0243148:control [Qualitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the restriction enzymes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0014442:Enzymes [Enzyme,Organic Chemical]
   861   C0014445:enzymes [Functional Concept]
   861   C0443288:Restriction [Functional Concept]

Phrase: "denoted in bold"

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.68: n.d., not determined. 

Phrase: "n."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "d."

Phrase: ","

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "determined."
Processing 00000000.tx.69: RESULTS Mutation analysis of PS-1 and PS-2 Previously, the complete genomic structure of PS-1 and PS-2 was determined identifying 10 coding exons in each gene (21 ,22 ). 

Phrase: "RESULTS Mutation analysis of PS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1294200:Gene mutation analysis [Laboratory Procedure]
   778   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "PS-2 Previously,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0017337:Gene [Gene or Genome]

Phrase: "the complete genomic structure of PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C1517495:Gene Structure [Gene or Genome]
   744   C0678594:Structure [Spatial Concept]
   731 E C0017366:Structural gene [Gene or Genome]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "was"

Phrase: "determined"

Phrase: "identifying"

Phrase: "10 coding exons in each gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(21 ,"

Phrase: "22"

Phrase: ")."
Processing 00000000.tx.70: In order to avoid confusion we used the exon numbering 3-12 for PS-1 in this study, as introduced by Clark et al. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "avoid"

Phrase: "confusion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009676:Confusion [Mental or Behavioral Dysfunction]
  1000   C1963086:Confusion [Finding]
   928 E C1547301:Confused [Intellectual Product]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the exon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "numbering"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449788:numbering [Quantitative Concept]
   966 E C0237753:*Number [Quantitative Concept]

Phrase: "3-12 for PS-1"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   820   C1424582:3.1 GENE [Gene or Genome]
   790   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0442761:3/12 [Finding]
   753   C0017337:Gene [Gene or Genome]
   753   C0439086:<3 [Quantitative Concept]
   753   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   753   C2827736:3+ [Quantitative Concept]
   753   C2981702:3+ [Classification]

Phrase: "in this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "as"

Phrase: "introduced by Clark et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1292748:introduce [Functional Concept]
Processing 00000000.tx.71: (11 ). 

Phrase: "(11"

Phrase: ")."
Processing 00000000.tx.72: Intronic primer pairs were designed allowing PCR amplification of the 10 coding exons of PS-1 and PS-2 (Table 1 ). 

Phrase: "Intronic primer pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709450:Pair [Qualitative Concept]

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "allowing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowing [Social Behavior]

Phrase: "PCR amplification of the 10 coding exons of PS-1"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   766   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   749   C0017256:Gene Amplification [Genetic Function]
   749   C1335440:Polymerase Gene [Gene or Genome]
   749   C1705759:Gene Amplification [Cell or Molecular Dysfunction]
           Amplification
   735   C0337112:Chain [Manufactured Object]
   735   C0443286:Reaction [Functional Concept]
   735   C1114821:Reaction [Clinical Attribute]
   735   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   735   C1517480:Amplification [Molecular Biology Research Technique]
   735   C1521871:Amplification [Phenomenon or Process]
   735   C1524075:Chain [Idea or Concept]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.73: All 101 AD patients were examined for mutations in PS-1 and PS-2 by SSCP analysis and PCR cycle sequencing. 

Phrase: "All 101 AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "were"

Phrase: "examined for mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0026882:Mutations [Genetic Function]
   790   C0332128:Examined [Finding]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PS-2 by SSCP analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "PCR cycle sequencing."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1553778:Sequencing [Intellectual Product]
   804   C1561491:Sequencing [Functional Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.74: In PS-1 we identified four missense mutations in exons 4, 5, 7 and 9 respectively and one intronic polymorphism in intron 8 (Tables 2 and 3 and Fig. 1 ). 

Phrase: "In PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "we"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "four missense mutations in exons 4,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0599155:Mutations, Missense [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: "and"

Phrase: "9 respectively"

Phrase: "and"

Phrase: "one intronic polymorphism in intron 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032529:Polymorphism [Genetic Function]
   753   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Tables 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.75: The Ala79Val mutation was identified in three patients (1005, 1061 and 1087) (Table 2 ). 

Phrase: "The Ala79Val mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "identified in three patients"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0030705:Patients [Patient or Disabled Group]
   770   C0205396:Identified [Qualitative Concept]
   770   C0205449:Three [Quantitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "(1005,"

Phrase: "1061"

Phrase: "and"

Phrase: "1087"

Phrase: ")"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: To test whether the mutation in the three patients has the same ancestral origin we genotyped three simple tandem repeat (STR) markers flanking PS-1 (23 ,24 ). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "the mutation in the three patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "has"

Phrase: "the same ancestral origin"
Meta Candidates (Total=16; Excluded=13; Pruned=0; Remaining=3)
   827   C0079946:origin [Classification]
   827   C0439659:Origin [Temporal Concept]
   827   C1550512:origin [Intellectual Product]
   771 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   771 E C0314603:Genetic [Functional Concept]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   743 E C0005615:Birth [Organism Function]
   743 E C0035150:Reproduction [Organism Function]
   743 E C1550722:birth [Idea or Concept]
   743 E C3245487:birth [Intellectual Product]
   727 E C0454729:Natal [Geographic Area]
   727 E C0559522:Genital [Body System]
   727 E C0598240:originality [Mental Process]
   727 E C1546649:Genital [Intellectual Product]
   727 E C1550642:Genital [Body Substance]

Phrase: "we"

Phrase: "genotyped"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0017431:Genotype [Organism Attribute]

Phrase: "three simple tandem repeat (STR) markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0005516:Marker [Clinical Attribute]

Phrase: "flanking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230171:flanking [Body Location or Region]

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(23 ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.77: For D14S1028, D14S77 and D14S1004 all patients shared one common allele with allele frequencies calculated among the cases of respectively 0.27, 0.05 and 0.12. 

Phrase: "For D14S1028,"

Phrase: "D14S77"

Phrase: "and"

Phrase: "D14S1004"

Phrase: "all patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "shared"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0237876:shared [Social Behavior]
  1000   C1522138:Shared [Functional Concept]

Phrase: "one common allele with allele frequencies"

Phrase: "calculated among the cases of respectively 0.27,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   744   C0444686:Calculated [Functional Concept]
   744   C0868928:Cases [Functional Concept]
   744   C1441506:Calculated [Activity]
   744   C1443182:Calculated [Laboratory Procedure]
   744   C1533148:Cases [Quantitative Concept]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "0.05"

Phrase: "and"

Phrase: "0.12."
Processing 00000000.tx.78: These data suggested that the three patients carrying the Ala79Val mutation might be related, although not closely, since genealogy studies had not indicated a familial relationship. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the three patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "the Ala79Val mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "might"

Phrase: "be"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: ","

Phrase: "although"

Phrase: "not closely,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "since"

Phrase: "genealogy studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "a familial relationship."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   964   C0015608:Family Relationship [Social Behavior]
   861   C0439849:Relationship [Qualitative Concept]
   861   C1705630:Relationship [Idea or Concept]
   861   C1706279:Relationship [Idea or Concept]
   861   C3540605:Relationship [Intellectual Product]
Processing 00000000.tx.79: The other three mutations occurred only once and none of the mutations were present in the 118 control individuals. 

Phrase: "The"

Phrase: "other three mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurred"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1709305:Occurred [Activity]
   966 E C2745955:OCCUR [Temporal Concept]

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "once"

Phrase: "and"

Phrase: "none of the mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0026882:Mutations [Genetic Function]
   770   C0456148:None [Quantitative Concept]
   770   C0549184:None [Quantitative Concept]
   737 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "present in the 118 control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.80: The polymorphism observed in intron 8 is identical to that reported by Wragg et al. 

Phrase: "The polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032529:Polymorphism [Genetic Function]
  1000   C1882417:Polymorphism [Qualitative Concept]

Phrase: "observed in intron 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441672:Observed [Functional Concept]

Phrase: "is"

Phrase: "identical to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205280:Identical [Qualitative Concept]

Phrase: "reported by Wragg et al."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C1709908:Reported By [Group]
   760   C0684224:Reported [Intellectual Product]
   760   C0700287:Reported [Health Care Activity]
   760   C3496591:Reported [Clinical Attribute]
   726 E C3273238:Report [Intellectual Product]
Processing 00000000.tx.81: (25 ) and allele frequencies were determined by the primer mismatch PCR assay described by those authors (Table 3 ). 

Phrase: "(25"

Phrase: ")"

Phrase: "and"

Phrase: "allele frequencies"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
  1000   C0017270:Frequencies, Allele [Quantitative Concept]
   861   C0439603:Frequencies [Temporal Concept]
   827 E C0376249:frequency [Quantitative Concept]
   827 E C0871396:Frequency [Quantitative Concept]
   827 E C1561548:Frequency [Qualitative Concept]
   827 E C1705502:Frequency [Quantitative Concept]
   777 E C0332183:Frequent [Temporal Concept]

Phrase: "were"

Phrase: "determined by the primer mismatch PCR assay"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0005507:Assay [Laboratory Procedure]
   742   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0243073:assay [Qualitative Concept]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1510438:Assay [Laboratory Procedure]
   742   C1524075:Chain [Idea or Concept]
   742   C1881865:Mismatch [Qualitative Concept]

Phrase: "described by those authors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0221193:Authors [Professional or Occupational Group]
   770   C1552738:described [Idea or Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.82: Since the SSCP pattern of the intron 8 polymorphism could have masked the presence of mutations, we sequenced exon 8 in all cases. 

Phrase: "Since"

Phrase: "the SSCP pattern of the intron 8 polymorphism"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0449774:Pattern [Spatial Concept]

Phrase: "could"

Phrase: "have"

Phrase: "masked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0150108:masked [Research Activity]
  1000   C0150112:MASKED [Functional Concept]
  1000   C1555580:masked [Idea or Concept]
   966 E C0024861:Mask [Medical Device]
   966 E C1538279:MASK [Gene or Genome]
   966 E C1845191:MASK [Gene or Genome]

Phrase: "the presence of mutations,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "exon 8 in all cases."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   760   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.83: No other mutations were found. 

Phrase: "No"

Phrase: "other mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "found."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]
Processing 00000000.tx.84: Figure 1. 

Phrase: "Figure 1."
Processing 00000000.tx.85: Restriction enzyme analyses of mutations and polymorphisms in PS-1 and PS-2. 

Phrase: "Restriction enzyme analyses of mutations"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   862   C0035269:Restriction Enzyme Analyses [Laboratory Procedure,Molecular Biology Research Technique]
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0796357:mutation analysis [Laboratory Procedure]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   726   C0002778:Analysis [Laboratory Procedure]
   726   C0936012:Analysis [Research Activity]
   726   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "polymorphisms in PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0678951:gene polymorphisms [Genetic Function]
   760   C0032529:polymorphisms [Genetic Function]
   726 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "PS-2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]
Processing 00000000.tx.86: PCR amplified exons were digested with the restriction enzymes indicated. 

Phrase: "PCR amplified exons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "digested with the restriction enzymes"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   773   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0014442:Enzymes [Enzyme,Organic Chemical]
   760   C0014445:enzymes [Functional Concept]
   760   C0443288:Restriction [Functional Concept]
   760   C0868946:digested [Physiologic Function]

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.87: (A) Missense mutations in PS-1 and PS-2. 

Phrase: "(A) Missense mutations in PS-1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0599155:Mutations, Missense [Genetic Function]
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "PS-2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]
Processing 00000000.tx.88: (B) Polymorphisms in PS-1 and PS-2. 

Phrase: "(B) Polymorphisms in PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0678951:gene polymorphisms [Genetic Function]
   753   C0032529:polymorphisms [Genetic Function]
   719 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "and"

Phrase: "PS-2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]
Processing 00000000.tx.89: In one patient a missense mutation in PS-2 was detected, resulting in an Arg -> His substitution at codon 62 in exon 4 (Table 2 and Fig. 1 A). 

Phrase: "In one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "a missense mutation in PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0599155:Missense Mutation [Genetic Function]
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "resulting in an Arg ->"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   833   C0332294:Resulting in [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "His substitution at codon 62"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1555721:Substitution [Idea or Concept]
   760   C1706204:Substitution [Activity]

Phrase: "in exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.90: Restriction digestion analysis showed that the mutation was absent in the other patients and controls. 

Phrase: "Restriction digestion analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "absent in the"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0332197:Absent [Quantitative Concept]
   790   C2699517:ABSENT [Finding]
   718 E C0424530:Absences [Finding]
   718 E C1689985:Absence [Anatomical Abnormality]

Phrase: "other patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "controls."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.91: In addition, SSCP and sequence analysis of exon 4 identified two different polymorphisms in intron 3 and at codon His87 respectively (Table 3 ). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "SSCP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243031:SSCP [Laboratory or Test Result]

Phrase: "and"

Phrase: "sequence analysis of exon 4 identified two different polymorphisms"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   745   C0796451:polymorphism analysis [Diagnostic Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0004793:Sequence [Nucleotide Sequence]
   742   C0162326:Sequence [Nucleotide Sequence]
   742   C0162327:Sequence [Nucleotide Sequence]
   742   C0936012:Analysis [Research Activity]
   742   C1519249:Sequence [Functional Concept]
   742   C1524024:analysis [Functional Concept]

Phrase: "in intron 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and at codon His87 respectively"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0009221:Codon [Nucleotide Sequence]
   760   C1095825:Codon [Plant]
   760   C1515981:And [Idea or Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.92: Also, the SSCP patterns observed for exons 3, 5, 7 and 11 were due to polymorphisms, since the nucleotide changes involved intronic variations or exonic silent mutations (Table 3 and Fig. 1 B). 

Phrase: "Also,"

Phrase: "the SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "observed for exons 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441672:Observed [Functional Concept]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "7"

Phrase: "and"

Phrase: "11"

Phrase: "were due to polymorphisms,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0032529:polymorphisms [Genetic Function]
   770   C3146286:Due [Idea or Concept]
   737 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "since"

Phrase: "the nucleotide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "involved intronic variations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0205419:variations [Qualitative Concept]

Phrase: "or"

Phrase: "exonic silent mutations"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   867   C1519323:Silent Mutation [Genetic Function]
   827   C0026882:Mutations [Genetic Function]
   827   C0443304:Silent [Qualitative Concept]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   755 E C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.93: The polymorphism in exon 5 (Thr122) was seen in only one patient and represents a very rare polymorphism. 

Phrase: "The polymorphism in exon 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Thr122"

Phrase: ")"

Phrase: "was"

Phrase: "seen in only one patient"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0030705:*^patient [Patient or Disabled Group]
   760   C0205171:Only [Quantitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0205447:One [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]

Phrase: "and"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a very rare polymorphism."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0032529:Polymorphism [Genetic Function]
   827   C1882417:Polymorphism [Qualitative Concept]
   734   C1855575:Very rare [Finding]
Processing 00000000.tx.94: Also, the polymorphism in exon 7 (Ser236) is rare, since it was seen in only two patients. 

Phrase: "Also,"

Phrase: "the polymorphism in exon 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0032529:Polymorphism [Genetic Function]
   760   C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Ser236"

Phrase: ")"

Phrase: "is"

Phrase: "rare,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "since"

Phrase: "it"

Phrase: "was"

Phrase: "seen in only two patients."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205171:Only [Quantitative Concept]
   760   C0205397:Seen [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C1720467:Only [Intellectual Product]
   726 E C0042789:see [Organism Function]
   726 E C1947903:See [Activity]
Processing 00000000.tx.95: The allele frequencies of the other more frequent polymorphisms were estimated in the 118 control individuals by restriction enzyme digestion (Table 3 ). 

Phrase: "The allele frequencies of the"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   806   C0017270:Frequencies, Allele [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "other more frequent polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0032529:polymorphisms [Genetic Function]
   793 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "estimated in the 118 control individuals"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0243148:control [Qualitative Concept]
   753   C0750572:Estimated [Quantitative Concept]
   753   C1550141:Control [Substance]
   753   C1882979:Control [Conceptual Entity]
   753   C2587213:Control [Functional Concept]
   753   C3274648:Control [Qualitative Concept]
   719   C0027361:Individual [Population Group]
   719   C0237401:Individual [Human]

Phrase: "by restriction enzyme digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0012238:Digestion [Organism Function]
   827   C2349986:Digestion [Research Activity]
   771 E C0443277:Peptic [Functional Concept]
   734   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: Comparison of the allele distribution in 15 control individuals showed that the two exon 3 polymorphisms are in linkage disequilibrium. 

Phrase: "Comparison of the allele distribution"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1707455:Comparison [Activity]

Phrase: "in 15 control individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0027361:Individual [Population Group]
   793   C0237401:Individual [Human]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the two exon 3 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are in linkage disequilibrium."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.97: Also, the two exon 4 polymorphisms are in linkage disequilibrium. 

Phrase: "Also,"

Phrase: "the two exon 4 polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0032529:polymorphisms [Genetic Function]
   779 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "are in linkage disequilibrium."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0023746:Linkage Disequilibrium [Quantitative Concept]
   770   C0023745:linkage [Molecular Function]
   770   C0281825:Disequilibrium [Finding]
   770   C0394006:Disequilibrium [Disease or Syndrome]
   770   C1551058:Are [Quantitative Concept]
Processing 00000000.tx.98: Further, we demonstrated that the PS-2 polymorphisms in exons 3 (Ala23) and 4 (His87) and intron 11 show Mendelian inheritance. 

Phrase: "Further,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1517331:Further [Spatial Concept]
   966 E C0205108:far [Spatial Concept]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the PS-2 polymorphisms in exons 3"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0678951:gene polymorphisms [Genetic Function]
   744   C0032529:polymorphisms [Genetic Function]
   711 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "(Ala23"

Phrase: ")"

Phrase: "and"

Phrase: "4"

Phrase: "(His87"

Phrase: ")"

Phrase: "and"

Phrase: "intron 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0021920:Intron [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "Mendelian inheritance."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683231:Mendelian inheritance [Genetic Function]
   861   C0242538:Inheritance [Quantitative Concept]
   861   C0728826:Inheritance [Functional Concept]
Processing 00000000.tx.99: To complete the mutation analysis of PS-1 and PS-2 we developed flanking primers for the three exons located in the 5'-untranslated region (5'-UTR) of PS-1 (numbered exons 1A, 1B and 2) and the two 5'-UTR of PS-2 (21 ,26 ). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "the mutation analysis of PS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1294200:Gene mutation analysis [Laboratory Procedure]
   778   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "we"

Phrase: "developed"

Phrase: "flanking primers for the three exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "located in the 5'-untranslated region"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0600680:Untranslated Region [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0017446:Region [Geographic Area]
   753   C0205147:Region [Spatial Concept]

Phrase: "(5'-UTR) of PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   753   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   753   C1420099:UTR [Gene or Genome]
   753   C1540171:UTR [Gene or Genome]

Phrase: "(numbered exons 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "and"

Phrase: "the two 5'-UTR of PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   744   C1420099:UTR [Gene or Genome]
   744   C1540171:UTR [Gene or Genome]

Phrase: "(21 ,"

Phrase: "26"

Phrase: ")."
Processing 00000000.tx.100: SSCP analysis followed by PCR cycle sequencing revealed two polymorphisms in the 5'-UTR of PS-1, but no mutations (Table 3 ). 

Phrase: "SSCP analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "followed by PCR cycle sequencing revealed two polymorphisms"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0332283:Followed by [Temporal Concept]
           followed
   739   C0032529:polymorphisms [Genetic Function]
   739   C0205448:Two [Quantitative Concept]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C0443289:Revealed [Qualitative Concept]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1511572:Cycle [Temporal Concept]
   739   C1524075:Chain [Idea or Concept]
   739   C1553778:Sequencing [Intellectual Product]
   739   C1561491:Sequencing [Functional Concept]
   706 E C1719822:Follow [Intellectual Product]
   706 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in the 5'-UTR"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0600493:5' UTR [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1420099:UTR [Gene or Genome]
   861   C1540171:UTR [Gene or Genome]

Phrase: "of PS-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "but"

Phrase: "no mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.101: Allele frequencies of both polymorphisms were estimated by SSCP analysis of exon 1A and restriction digestion of exon 1B (Table 3 and Fig. 1 B). 

Phrase: "Allele frequencies of both polymorphisms"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   806   C0017270:Frequencies, Allele [Quantitative Concept]
   760   C0439603:Frequencies [Temporal Concept]
   726 E C0376249:frequency [Quantitative Concept]
   726 E C0871396:Frequency [Quantitative Concept]
   726 E C1561548:Frequency [Qualitative Concept]
   726 E C1705502:Frequency [Quantitative Concept]

Phrase: "were"

Phrase: "estimated by SSCP analysis of exon 1A"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0243031:SSCP [Laboratory or Test Result]
   748   C0450344:1A [Intellectual Product]
   748   C0750572:Estimated [Quantitative Concept]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1553633:1a [Medical Device]

Phrase: "and"

Phrase: "restriction digestion of exon 1B"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0012238:Digestion [Organism Function]
   760   C2349986:Digestion [Research Activity]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "(Table 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 1 B"

Phrase: ")."
Processing 00000000.tx.102: Mendelian inheritance of both polymorphisms was demonstrated. 

Phrase: "Mendelian inheritance of both polymorphisms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0683231:Mendelian inheritance [Genetic Function]
   760   C0242538:Inheritance [Quantitative Concept]
   760   C0728826:Inheritance [Functional Concept]

Phrase: "was"

Phrase: "demonstrated."
Processing 00000000.tx.103: No mutations or polymorphisms were detected in the 5'-UTR of PS-2. 

Phrase: "No mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "or"

Phrase: "polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "were"

Phrase: "detected in the 5'-UTR of PS-2."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   764   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C1418986:PRESENILIN 2 [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0442726:Detected [Finding]
   742   C0600680:UTR [Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C1420099:UTR [Gene or Genome]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1540171:UTR [Gene or Genome]
Processing 00000000.tx.104: Although SSCP analysis of PS-1 and PS-2 was negative in eight of the 10 autosomal dominant probands included in our sample, we could not rule out that mutations may have been missed, since the sensitivity of SSCP is not 100%. 

Phrase: "Although"

Phrase: "SSCP analysis of PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "was"

Phrase: "negative in eight of the 10 autosomal dominant probands"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   762   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   742   C0205160:Negative [Qualitative Concept]
   742   C1513916:Negative [Finding]
   742   C2825415:Negative [Conceptual Entity]
   742   C2825491:Negative [Qualitative Concept]

Phrase: "included in our sample,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0370003:Sample [Substance]
   770   C2347026:Sample [Conceptual Entity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "we"

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "rule"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0805874:Rule [Idea or Concept]
  1000   C0870077:Rule [Intellectual Product]
  1000   C1446409:rule [Qualitative Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "that mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "may"

Phrase: "have"

Phrase: "been"

Phrase: "missed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1705492:Missed [Qualitative Concept]
   966 E C2349206:Miss [Conceptual Entity]

Phrase: ","

Phrase: "since"

Phrase: "the sensitivity of SSCP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "is"

Phrase: "not 100%."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]
Processing 00000000.tx.105: Therefore, we performed a mutation analysis of PS-1 and PS-2 cDNA synthesized from RNA isolated from cultured lymphoblasts of a patient and an escapee. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "a mutation analysis of PS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C1294200:Gene mutation analysis [Laboratory Procedure]
   778   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "PS-2 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "synthesized from RNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   790   C1883254:Synthesized [Activity]

Phrase: "isolated from cultured lymphoblasts of a patient"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   748   C0030705:*^patient [Patient or Disabled Group]
   748   C0205409:Isolated [Functional Concept]
   748   C0229613:Lymphoblasts [Cell]
   748   C1167770:Lymphoblasts [Laboratory Procedure]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "an escapee."
Processing 00000000.tx.106: No other than the Ala79Val and Tyr115Cys mutations in PS-1 were detected. 

Phrase: "No other than the Ala79Val"

Phrase: "and"

Phrase: "Tyr115Cys mutations in PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.107: Segregation analysis All six PS-1 mutations occurred in patients with a positive family history of presenile AD, while the PS-2 mutation was observed in a sporadic case (Table 2 ). 

Phrase: "Segregation analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "All six PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C1418985:Presenilin 1 Gene [Gene or Genome]
   840   C0596611:gene mutations [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurred in patients"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0030705:Patients [Patient or Disabled Group]
   790   C1709305:Occurred [Activity]
   756 E C2745955:OCCUR [Temporal Concept]

Phrase: "with a positive family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   901   C0241889:Family history [Finding]
   901   C1705495:Family History [Idea or Concept]
   827   C0015576:Family [Family Group]
   827   C0019664:History [Occupation or Discipline]
   827   C0019665:history [Intellectual Product]
   827   C0262512:History, NOS [Organism Attribute]
   827   C0262926:History [Finding]
   827   C1704727:Family [Conceptual Entity]
   827   C1705255:History [Conceptual Entity]
   827   C2004062:History [Finding]
   755 E C0241888:Familial [Functional Concept]
   755 E C1552658:Historical [Idea or Concept]
   755 E C1552723:Historical [Idea or Concept]

Phrase: "of presenile AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "while"

Phrase: "the PS-2 mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0596611:Gene Mutation [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed in a sporadic case"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205422:Sporadic [Temporal Concept]
   760   C0868928:Case [Functional Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1706255:CASE [Medical Device]
   760   C1706256:Case [Conceptual Entity]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.108: Two PS-1 mutations were present in autosomal dominant cases (1005 and 1066), while four PS-1 mutations were detected in familial cases (1061, 1069, 1072 and 1087) (Fig. 2 ). 

Phrase: "Two PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C1418985:Presenilin 1 Gene [Gene or Genome]
   840   C0596611:gene mutations [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "present in autosomal dominant cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(1005"

Phrase: "and"

Phrase: "1066"

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "four PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C1418985:Presenilin 1 Gene [Gene or Genome]
   840   C0596611:gene mutations [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "detected in familial cases"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]
   770   C0442726:Detected [Finding]
   770   C0868928:Cases [Functional Concept]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "(1061,"

Phrase: "1069,"

Phrase: "1072"

Phrase: "and"

Phrase: "1087"

Phrase: ")"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.109: In the latter families the inheritance pattern was consistent with autosomal dominant transmission (Fig. 2 ); 

Phrase: "In the latter families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "the inheritance pattern"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1136375:Pattern, Inheritance [Genetic Function]
   861   C0449774:Pattern [Spatial Concept]

Phrase: "was"

Phrase: "consistent with autosomal dominant transmission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.110: however, these families had not been selected for linkage studies since they did not fulfil our rigid criteria for autosomal dominant AD (1061, 1069 and 1087) or showed bilineal transmission of AD (1072) (20 ). 

Phrase: "however,"

Phrase: "these families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "selected for linkage studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0023745:linkage [Molecular Function]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737   C1707391:Select [Activity]
   737 E C2603343:Study [Research Activity]

Phrase: "since"

Phrase: "they"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "fulfil"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550543:Fulfill [Idea or Concept]

Phrase: "our rigid criteria for autosomal dominant AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "(1061,"

Phrase: "1069"

Phrase: "and"

Phrase: "1087"

Phrase: ")"

Phrase: "or"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "bilineal transmission of AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C0242781:transmission of disease [Pathologic Function]
           disease transmission
           Transmission
   760   C0040722:transmission [Idea or Concept]
   760   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "(1072"

Phrase: ")"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.111: Only in family 1072 were additional family members available and the PS-1 mutation Ala231Val was shown to be present in at-risk individuals. 

Phrase: "Only in family 1072"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015576:Family [Family Group]
   770   C0205171:Only [Quantitative Concept]
   770   C1704727:Family [Conceptual Entity]
   770   C1720467:Only [Intellectual Product]

Phrase: "were"

Phrase: "additional family members"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   901   C0086282:Family Members [Family Group]
   867 E C1611821:Family Member [Intellectual Product]
   827   C0015576:Family [Family Group]
   827   C0680022:members [Population Group]
   827   C1704727:Family [Conceptual Entity]
   793 E C2698041:Member [Professional or Occupational Group]
   755 E C0241888:Familial [Functional Concept]

Phrase: "available"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]

Phrase: "and"

Phrase: "the PS-1 mutation Ala231Val"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   717   C1418985:Presenilin 1 Gene [Gene or Genome]

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present in at-risk individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.112: Figure 2. 

Phrase: "Figure 2."
Processing 00000000.tx.113: Pedigrees of the families of the autosomal dominant AD cases and the familial cases in which a PS-1 mutation was observed. 

Phrase: "Pedigrees of the families of the autosomal dominant AD cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0030761:pedigrees [Intellectual Product]

Phrase: "and"

Phrase: "the familial cases in which"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: "a PS-1 mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:Gene Mutation [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "observed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]
Processing 00000000.tx.114: Probands were included in the mutation analysis, except for families 1005 (III-20) and 1066 (V-2). 

Phrase: "Probands"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]

Phrase: "were"

Phrase: "included in the mutation analysis,"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0796357:mutation analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0026882:Mutation [Genetic Function]
   760   C0332257:included [Functional Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]

Phrase: "except for families 1005"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "(III-20"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "1066"

Phrase: "(V-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445362:V 2 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.115: Families 1061, 1069, 1072 and 1087 had not been included in our previous linkage studies (20). 

Phrase: "Families 1061,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Families [Family Group]
   861   C1704727:Family [Conceptual Entity]
   777 E C0241888:Familial [Functional Concept]

Phrase: "1069,"

Phrase: "1072"

Phrase: "and"

Phrase: "1087"

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "included in our previous linkage studies"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0023745:linkage [Molecular Function]
   753   C0205156:Previous [Temporal Concept]
   753   C0332257:included [Functional Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1552607:previous [Temporal Concept]
   753   C3538986:INCLUDED [Gene or Genome]
   719 E C0557651:Study [Manufactured Object]
   719 E C1552866:include [Idea or Concept]
   719 E C2603343:Study [Research Activity]
   719 E C2700399:Include [Activity]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.116: Symbols: circles depict females, squares depict males; 

Phrase: "Symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0679214:symbols [Idea or Concept]
   966 E C1698987:symbol [Intellectual Product]

Phrase: ":"

Phrase: "circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: "depict"

Phrase: "females,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0015780:Females [Finding]
  1000   C0086287:Females [Population Group]
   966 E C0043210:female [Population Group]
   966 E C1705497:Female [Qualitative Concept]
   966 E C1705498:Female [Qualitative Concept]

Phrase: "squares"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205120:Square [Spatial Concept]
  1000   C1552595:Square [Intellectual Product]

Phrase: "depict"

Phrase: "males"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0024554:Males [Finding]
  1000   C0086582:Males [Population Group]
   966 E C1706180:Male [Qualitative Concept]
   966 E C1706428:Male [Qualitative Concept]
   966 E C1706429:Male [Organism Attribute]

Phrase: ";"
Processing 00000000.tx.117: open symbols: unaffected individuals; 

Phrase: "open symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ":"

Phrase: "unaffected individuals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0027361:Individual [Population Group]
   827   C0237401:Individual [Human]

Phrase: ";"
Processing 00000000.tx.118: filled symbols: AD patients; 

Phrase: "filled symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0679214:symbols [Idea or Concept]
   827 E C1698987:symbol [Intellectual Product]

Phrase: ":"

Phrase: "AD patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0030705:Patients [Patient or Disabled Group]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: ";"
Processing 00000000.tx.119: partly filled symbols: patients diagnosed with CVA. 

Phrase: "partly filled symbols"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0679214:symbols [Idea or Concept]
   793 E C1698987:symbol [Intellectual Product]

Phrase: ":"

Phrase: "patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "diagnosed with CVA."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0038454:Cerebrovascular accidents [Disease or Syndrome]
   770   C0000924:Accidents [Injury or Poisoning]
   770   C0011900:Diagnosed [Finding]
   770   C1880018:Cerebrovascular [Qualitative Concept]
   737 E C1961149:Accident [Phenomenon or Process]
Processing 00000000.tx.120: Roman numbers to the left of the pedigree denote generations. 

Phrase: "Roman numbers to the left of the pedigree"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]

Phrase: "denote"

Phrase: "generations."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0079411:Generations [Temporal Concept]
   966 E C3146294:Generation [Activity]
   900 E C1414672:Genesis [Gene or Genome]
   900 E C2984892:Genesis [Gene or Genome]
Processing 00000000.tx.121: Numbers below the patient symbols denote age at onset or age at death ([dagger]). 

Phrase: "Numbers below the patient symbols"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C1830427:Patient number [Intellectual Product]
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "denote"

Phrase: "age at onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0206132:age onset [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: "or"

Phrase: "age at death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1543138:Age at death [Clinical Attribute]
  1000   C1546180:Age at death [Clinical Attribute]
   858   C0742983:age death [Finding]
   790   C0001779:Age [Organism Attribute]

Phrase: "("

Phrase: "[dagger"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522654:Dagger [Manufactured Object]

Phrase: "]"

Phrase: ")."
Processing 00000000.tx.122: Arrows indicate the probands. 

Phrase: "Arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: "indicate"

Phrase: "the probands."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0702111:probands [Organism Attribute]
   966 E C1948021:Proband [Family Group]
   928 E C0702110:Propositus [Organism Attribute]
Processing 00000000.tx.123: Patients that had autopsy confirmation of AD are indicated by an asterisk. 

Phrase: "Patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "that"

Phrase: "had"

Phrase: "autopsy confirmation of AD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   760   C0750484:Confirmation [Idea or Concept]

Phrase: "are"

Phrase: "indicated by an asterisk."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1444656:Indicated [Finding]
   770   C2945706:asterisk [Conceptual Entity]
Processing 00000000.tx.124: In autosomal dominant families 1005 and 1066 co-segregation of the mutation with presenile AD was confirmed by restriction enzyme digestion (Table 2 and Fig. 1 A). 

Phrase: "In autosomal dominant families 1005"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0443147:Autosomal dominant [Intellectual Product]
   812   C0015576:Families [Family Group]
   812   C0596142:autosomal [Cell Component]
   812   C1527180:Dominant [Functional Concept]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "and"

Phrase: "1066 co-segregation of the mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0080141:segregation [Social Behavior]

Phrase: "with presenile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "confirmed by restriction enzyme digestion"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0012238:Digestion [Organism Function]
   760   C0014442:Enzyme [Enzyme,Organic Chemical]
   760   C0443288:Restriction [Functional Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C2349986:Digestion [Research Activity]
   726 E C1456348:Confirm [Qualitative Concept]
   704 E C0443277:Peptic [Functional Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "and"

Phrase: "Fig. 1 A"

Phrase: ")."
Processing 00000000.tx.125: Previously we had used the informative families of the 10 autosomal dominant cases included among the 101 cases in genetic linkage studies (20 ). 

Phrase: "Previously"

Phrase: "we"

Phrase: "had"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the informative families of the 10 autosomal dominant cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0015576:Families [Family Group]
   742   C1704727:Family [Conceptual Entity]

Phrase: "included among the 101 cases"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0332257:included [Functional Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C1552866:include [Idea or Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]
   726 E C2700399:Include [Activity]

Phrase: "in genetic linkage studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   896   C2827447:Genetic Study [Research Activity]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0023745:genetic linkage [Molecular Function]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.126: Family 1066 (mean onset age 42 years) was linked to D14S43 located at chromosome 14q24.3 [multipoint LOD score (Z = 3.71) at zero recombination] (20 ). 

Phrase: "Family 1066"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "(mean onset age 42 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   853   C1510829:Age-Years [Temporal Concept]
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "linked to D14S43"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C1517892:Link [Intellectual Product]
   756   C1704666:Link [Intellectual Product]

Phrase: "located at chromosome 14q24.3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1520594:14q24.3 [Cell Component]
   797   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C1520591:14q24 [Cell Component]

Phrase: "[multipoint LOD score"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0023956:Lod Score [Quantitative Concept]
   827   C0449820:Score [Quantitative Concept]
   827   C2247199:Lod [Molecular Function]

Phrase: "(Z = 3.71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "at zero recombination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034865:Recombination [Genetic Function]

Phrase: "]"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.127: Family 1005 was not informative for the chromosome 14 STR markers used. 

Phrase: "Family 1005"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "was"

Phrase: "not informative for the chromosome 14 STR markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C2986490:Informative [Qualitative Concept]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.128: DISCUSSION Mutation analysis of all 10 coding exons as well as the 5'-non-coding exons of PS-1 and PS-2 by SSCP analysis and PCR cycle sequencing identified four different missense mutations in PS-1 in six patients (Ala79Val, Tyr115Cys, Ala231Val and Glu318Gly) and one missense mutation in PS-2 in one other patient (Arg62His) among 101 unrelated presenile AD cases in our study. 

Phrase: "DISCUSSION Mutation analysis of all 10 coding exons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0796357:mutation analysis [Laboratory Procedure]
   744   C0002778:Analysis [Laboratory Procedure]
   744   C0936012:Analysis [Research Activity]
   744   C1524024:analysis [Functional Concept]

Phrase: "as well as"

Phrase: "the 5'-non-coding exons of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PS-2 by SSCP analysis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "PCR cycle sequencing identified four different missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0599155:Mutations, Missense [Genetic Function]
   790   C0026882:Mutations [Genetic Function]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in six patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:Patients [Patient or Disabled Group]

Phrase: "(Ala79Val,"

Phrase: "Tyr115Cys,"

Phrase: "Ala231Val"

Phrase: "and"

Phrase: "Glu318Gly"

Phrase: ")"

Phrase: "and"

Phrase: "one missense mutation in PS-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0599155:Missense Mutation [Genetic Function]
   774   C0596611:Gene Mutation [Genetic Function]
   748   C0026882:Mutation [Genetic Function]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "other patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]

Phrase: "(Arg62His"

Phrase: ")"

Phrase: "among 101 unrelated presenile AD cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   799   C0868928:Cases [Functional Concept]
   799   C1533148:Cases [Quantitative Concept]
   766 E C1706255:CASE [Medical Device]
   766 E C1706256:Case [Conceptual Entity]

Phrase: "in our study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.129: All but one of the mutations (7 ,27 ) are novel mutations that were absent in 118 control individuals. 

Phrase: "All"

Phrase: "but"

Phrase: "one of the mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "(7 ,"

Phrase: "27"

Phrase: ")"

Phrase: "are"

Phrase: "novel mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C2985438:Novel Mutation [Cell or Molecular Dysfunction]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "that"

Phrase: "were"

Phrase: "absent in 118 control individuals."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0332197:Absent [Quantitative Concept]
   760   C2699517:ABSENT [Finding]
Processing 00000000.tx.130: Based on our mutation data we calculated a mutation frequency of 6% for PS-1 and 1% for PS-2 in presenile AD. 

Phrase: "Based on our mutation data"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   781   C0242356:data base [Intellectual Product]
   781   C0993637:Data Base [Intellectual Product]
   760   C0026882:Mutation [Genetic Function]
   760   C1511726:Data [Idea or Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705285:Mutation [Cell or Molecular Dysfunction]
   760   C1705938:Based [Idea or Concept]
   760   C3245479:data [Medical Device]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "we"

Phrase: "calculated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444686:Calculated [Functional Concept]
  1000   C1441506:Calculated [Activity]
  1000   C1443182:Calculated [Laboratory Procedure]

Phrase: "a mutation frequency of 6%"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C3178846:Mutation Frequency [Qualitative Concept]
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "for PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "1% for PS-2"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   835   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   806   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418986:PRESENILIN 2 [Gene or Genome]
   797   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C0580272:1/2 [Intellectual Product]
   797   C1519043:1-2 [Research Activity]
   760   C0017337:Gene [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C2827734:1+ [Quantitative Concept]
   760   C2981698:1+ [Classification]

Phrase: "in presenile AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.131: Since all PS-1 mutations occurred in familial cases, i.e. cases with at least one first degree relative with AD, the mutation frequency is estimated at 9% (six out of 67 cases) in familial presenile AD cases. 

Phrase: "Since"

Phrase: "all PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "occurred in familial cases,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   770   C0015576:familial [Family Group]
   770   C0241888:Familial [Functional Concept]
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   770   C1709305:Occurred [Activity]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "i.e. cases with"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0868928:Cases [Functional Concept]
   770   C1533148:Cases [Quantitative Concept]
   737 E C1706255:CASE [Medical Device]
   737 E C1706256:Case [Conceptual Entity]

Phrase: "at least one first degree relative"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   884   C1517194:First Degree Relative [Family Group]
   840   C0444502:First degree [Qualitative Concept]
   804   C0080103:Relative [Family Group]
   804   C0205345:Relative [Qualitative Concept]
   804   C0205435:First [Quantitative Concept]
   804   C0441889:Degree [Qualitative Concept]
   804   C0449286:Degree [Quantitative Concept]
   804   C0542560:Degree [Intellectual Product]
   804   C1279901:First [Qualitative Concept]
   804   C1547039:*Relative [Quantitative Concept]
   804   C1561545:degree [Quantitative Concept]
   804   C2348088:Degree [Quantitative Concept]

Phrase: "with AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "the mutation frequency"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C3178846:Mutation Frequency [Qualitative Concept]
   861   C0376249:frequency [Quantitative Concept]
   861   C0439603:Frequency [Temporal Concept]
   861   C0871396:Frequency [Quantitative Concept]
   861   C1561548:Frequency [Qualitative Concept]
   861   C1705502:Frequency [Quantitative Concept]
   789 E C0332183:Frequent [Temporal Concept]

Phrase: "is"

Phrase: "estimated at 9%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0750572:Estimated [Quantitative Concept]

Phrase: "(six out of 67 cases"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0205452:Six [Quantitative Concept]
   760   C0439787:Out [Spatial Concept]
   760   C0849355:Out [Qualitative Concept]
   760   C0868928:Cases [Functional Concept]
   760   C1533148:Cases [Quantitative Concept]
   726 E C1706255:CASE [Medical Device]
   726 E C1706256:Case [Conceptual Entity]

Phrase: ")"

Phrase: "in familial presenile AD cases."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
   722   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   708   C0277558:Familial disease [Disease or Syndrome]
Processing 00000000.tx.132: Among the familial cases in our study there were 11 cases belonging to families fulfilling our rigid criteria for autosomal dominant AD, i.e. three patients in two generations with a clinical diagnosis of AD in at least two cases (20 ). 

Phrase: "Among the familial cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "in our study there"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "were"

Phrase: "11 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "belonging to families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0015576:Families [Family Group]
   790   C1704727:Family [Conceptual Entity]
   706 E C0241888:Familial [Functional Concept]

Phrase: "fulfilling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550543:Fulfill [Idea or Concept]

Phrase: "our rigid criteria for autosomal dominant AD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0243161:criteria [Intellectual Product]

Phrase: "i.e. three patients in two generations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0030705:Patients [Patient or Disabled Group]

Phrase: "with a clinical diagnosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332140:Diagnosis, clinical [Qualitative Concept]
   861   C0011900:Diagnosis [Finding]
   861   C0205210:Clinical [Qualitative Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "in"

Phrase: "at least two cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.133: In two autosomal dominant families a PS-1 mutation was found resulting in a mutation frequency of 18% (two out of 11 cases) in autosomal dominant presenile AD. 

Phrase: "In two autosomal dominant families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0015576:Families [Family Group]
   812   C1704727:Family [Conceptual Entity]
   729 E C0241888:Familial [Functional Concept]

Phrase: "a PS-1 mutation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:Gene Mutation [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "resulting in a mutation frequency of 18%"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   778   C0332294:Resulting in [Functional Concept]
   778   C3178846:Mutation Frequency [Qualitative Concept]
   748   C0026882:Mutation [Genetic Function]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0678226:resulting [Functional Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705285:Mutation [Cell or Molecular Dysfunction]
   748   C1705502:Frequency [Quantitative Concept]
   714 E C1274040:Result [Functional Concept]
   714 E C1546471:Result [Idea or Concept]
   714 E C2825142:Result [Finding]

Phrase: "(two out of 11 cases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205448:Two [Quantitative Concept]

Phrase: ")"

Phrase: "in autosomal dominant presenile AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.134: Since the mutation screening of PS-1 and PS-2 was performed by SSCP analysis, we cannot exclude that our estimates of mutation frequencies of PS-1 and PS-2 are underestimates, as the sensitivity of SSCP is not 100% (28 ). 

Phrase: "Since"

Phrase: "the mutation screening of PS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0220908:Screening [Health Care Activity]
   748   C0220909:screening [Functional Concept]
   748   C1698960:screening [Intellectual Product]
   748   C1710031:Screening [Diagnostic Procedure]
   748   C1710477:SCREENING [Research Activity]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "was"

Phrase: "performed by SSCP analysis,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   833   C1550369:Performed By [Qualitative Concept]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0243031:SSCP [Laboratory or Test Result]
   770   C0884358:Performed [Functional Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "we"

Phrase: "cannot"

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "that"

Phrase: "our estimates of mutation frequencies of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0750572:estimates [Quantitative Concept]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "are"

Phrase: "underestimates,"

Phrase: "as"

Phrase: "the sensitivity of SSCP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "is"

Phrase: "not 100%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "(28"

Phrase: ")."
Processing 00000000.tx.135: However, we systematically analyzed each PCR-amplified exon of PS-1 and PS-2 together with positive controls of known mutations in the presence and absence of glycerol as denaturant. 

Phrase: "However,"

Phrase: "we systematically"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "each PCR-amplified exon of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "PS-2 together with positive controls of known mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0596611:gene mutations [Genetic Function]
   739   C0017337:Gene [Gene or Genome]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "absence of glycerol"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "as denaturant."
Processing 00000000.tx.136: Mutations in PS-1 and PS-2 may also have been masked by polymorphisms in exonic and flanking intronic sequences. 

Phrase: "Mutations in PS-1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   797   C0596611:gene mutations [Genetic Function]
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "may"

Phrase: "also"

Phrase: "have"

Phrase: "been"

Phrase: "masked by polymorphisms"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   790   C0032529:polymorphisms [Genetic Function]
   790   C0150108:masked [Research Activity]
   790   C0150112:MASKED [Functional Concept]
   790   C1555580:masked [Idea or Concept]
   756 E C0024861:Mask [Medical Device]
   756 E C1538279:MASK [Gene or Genome]
   756 E C1845191:MASK [Gene or Genome]
   756 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "in exonic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "flanking intronic sequences."
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   827   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0162326:Sequences [Nucleotide Sequence]
   827   C0230171:flanking [Body Location or Region]
   793 E C0004793:Sequence [Nucleotide Sequence]
   793 E C0162327:Sequence [Nucleotide Sequence]
   793 E C1519249:Sequence [Functional Concept]
   743 E C1548958:Sequential [Idea or Concept]
   743 E C1705294:Sequential [Qualitative Concept]
Processing 00000000.tx.137: When polymorphic SSCP patterns were observed we sequenced the PCR products in five to 10 cases showing homozygous and heterozygous SSCP patterns. 

Phrase: "When"

Phrase: "polymorphic SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "we"

Phrase: "sequenced"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0004793:Sequence [Nucleotide Sequence]
   966   C0162326:Sequence [Nucleotide Sequence]
   966   C0162327:Sequence [Nucleotide Sequence]
   966   C1519249:Sequence [Functional Concept]

Phrase: "the PCR products in five"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1514468:Products [Entity]
   714 E C1704444:Product [Quantitative Concept]

Phrase: "to 10 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "homozygous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019904:Homozygous [Organism Attribute]

Phrase: "and"

Phrase: "heterozygous SSCP patterns."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]
Processing 00000000.tx.138: In each case the underlying polymorphism was detected and confirmed by restriction enzyme digestion of the amplified product. 

Phrase: "In each case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "the underlying polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "confirmed by restriction enzyme digestion of the amplified product."
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   764   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   742   C0012238:Digestion [Organism Function]
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   742   C0443288:Restriction [Functional Concept]
   742   C0750484:Confirmed [Idea or Concept]
   742   C1514468:product [Entity]
   742   C1704444:Product [Quantitative Concept]
   742   C2349986:Digestion [Research Activity]
   708 E C1456348:Confirm [Qualitative Concept]
Processing 00000000.tx.139: The efficiency of our mutation analysis strategy is demonstrated by detection of a mutation in exon 4 of PS-2 in one patient that had a unique SSCP pattern different from that of the polymorphic SSCP patterns observed for exon 4. 

Phrase: "The efficiency of our mutation analysis strategy"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0013682:Efficiency [Quantitative Concept]

Phrase: "is"

Phrase: "demonstrated by detection of a mutation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C1513778:Mutation Detection [Laboratory Procedure]
   753   C0026882:Mutation [Genetic Function]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in exon 4"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "of PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "in one patient"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "that"

Phrase: "had"

Phrase: "a unique SSCP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0243031:SSCP [Laboratory or Test Result]

Phrase: "pattern"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449774:Pattern [Spatial Concept]

Phrase: "different from that of the polymorphic SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1705242:Different [Qualitative Concept]

Phrase: "observed for exon 4."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C1441672:Observed [Functional Concept]
Processing 00000000.tx.140: Also, sequence analysis of the polymorphic PCR products of exon 8 of PS-1 identified no mutations. 

Phrase: "Also,"

Phrase: "sequence analysis of the polymorphic PCR products of exon 8"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   785   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   753   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0004793:Sequence [Nucleotide Sequence]
   736   C0162326:Sequence [Nucleotide Sequence]
   736   C0162327:Sequence [Nucleotide Sequence]
   736   C0936012:Analysis [Research Activity]
   736   C1519249:Sequence [Functional Concept]
   736   C1524024:analysis [Functional Concept]

Phrase: "of PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "no mutations."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.141: The onset age in the PS-1 mutation cases varied from 45 to 58 years, with three mutations (Ala79Val, Ala231Val and Glu318Gly) having onset ages above 55 years (Table 2 ). 

Phrase: "The onset age in the PS-1 mutation cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0206132:Onset Age [Quantitative Concept]
   739   C0001779:Age [Organism Attribute]

Phrase: "varied from 45"

Phrase: "to 58 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "with three mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(Ala79Val,"

Phrase: "Ala231Val"

Phrase: "and"

Phrase: "Glu318Gly"

Phrase: ")"

Phrase: "having"

Phrase: "onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "ages above 55 years"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1510829:Age-Years [Temporal Concept]
   770   C0001779:Age [Organism Attribute]
   770   C0439234:years [Temporal Concept]
   770   C0450382:55 [Intellectual Product]
   737 E C0439508:/year [Temporal Concept]

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.142: Most PS-1 mutations reported so far had onset ages between 35 and 55 years (29 ). 

Phrase: "Most PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "so far"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037640:SO [Geographic Area]
   861   C0205108:far [Spatial Concept]

Phrase: "had"

Phrase: "onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "ages between 35"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "55 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(29"

Phrase: ")."
Processing 00000000.tx.143: However, the majority of these mutations were located in exons 5 and 8, coding in part for TM II and the large HL after TM VI (13 ). 

Phrase: "However,"

Phrase: "the majority of these mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]

Phrase: "were"

Phrase: "located in exons 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "8,"

Phrase: "coding in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009219:Coding [Occupational Activity]
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756 E C0805701:Code [Intellectual Product]

Phrase: "for TM II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1519623:Transmembrane Domain [Amino Acid Sequence]

Phrase: "and"

Phrase: "the large HL after TM VI (13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0419518:Loop [Medical Device]
   742   C0445022:Loop [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.144: Here the mutations are predicted to interfere with the [alpha]-helical structure of TM II or the proteolytic processing of ps-1 occurring in HL VI (7 ). 

Phrase: "Here"

Phrase: "the mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "predicted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0681842:Predicted [Idea or Concept]
  1000   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "interfere with the [alpha"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439095:Alpha [Intellectual Product]
   770   C0521102:Interfere [Qualitative Concept]
   770   C2003941:Alpha [Intellectual Product]
   770   C2350010:Alpha [Qualitative Concept]

Phrase: "]-helical structure of TM II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "or"

Phrase: "the proteolytic processing of ps-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1514570:Proteolytic Processing [Molecular Function]
   753   C1709694:Processing [Activity]

Phrase: "occurring in HL VI (7"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0419518:Loop [Medical Device]
   753   C0445022:Loop [Spatial Concept]
   753   C0475370:Hydrophilic [Qualitative Concept]
   719   C1709305:Occur [Activity]
   719   C2745955:OCCUR [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.145: The ps-1 mutations identified in this study are located in the N-terminal region (Ala79Val in exon 4), in TM V (Ala231Val in exon 7) and in the middle part of HL VI (Glu318Gly in exon 9). 

Phrase: "The ps-1 mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0026882:Mutations [Genetic Function]
   793 E C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "identified in this study"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205396:Identified [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "located in the N-terminal region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205147:Region [Spatial Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "(Ala79Val in exon 4"

Phrase: ")"

Phrase: ","

Phrase: "in TM V (Ala231Val"

Phrase: "in exon 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")"

Phrase: "and in the middle part of HL VI (Glu318Gly"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C1292711:Part of [Spatial Concept]
   739   C0419518:Loop [Medical Device]
   739   C0444598:Middle [Spatial Concept]
   739   C0445022:Loop [Spatial Concept]
   739   C0449719:Part [Spatial Concept]
   739   C0475370:Hydrophilic [Qualitative Concept]
   739   C0549183:middle [Spatial Concept]
   739   C1515981:And [Idea or Concept]
   739   C1552826:middle [Idea or Concept]
   739   C1709471:Part [Quantitative Concept]
   732   C0442056:Medial part [Spatial Concept]

Phrase: "in exon 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0015295:Exon [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: ")."
Processing 00000000.tx.146: Most likely these mutations have a milder effect on ps-1 functioning, possibly because the amino acid changes are semi-conserved (Ala79Val and Ala231Val) or they are located in a functionally less important region (Glu318Gly). 

Phrase: "Most likely"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0750501:most likely [Idea or Concept]
   861   C0205393:Most [Quantitative Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "these mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "have"

Phrase: "a milder effect on ps-1 functioning,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "because"

Phrase: "the amino acid changes"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C1953353:Amino acid change [Finding]
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]
   734   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   734   C2917660:Amino Acid [Pharmacologic Substance]

Phrase: "are"

Phrase: "semi-conserved"

Phrase: "(Ala79Val"

Phrase: "and"

Phrase: "Ala231Val"

Phrase: ")"

Phrase: "or"

Phrase: "they"

Phrase: "are"

Phrase: "located in a functionally less important region"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]

Phrase: "(Glu318Gly"

Phrase: ")."
Processing 00000000.tx.147: The Glu318 mutation is located in a region of ps-1 that is less conserved in ps-2 and ps of other species (13 ). 

Phrase: "The Glu318 mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0026882:Mutation [Genetic Function]
   861   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "located in a region of ps-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0017446:Region [Geographic Area]
   748   C0205147:Region [Spatial Concept]
   748   C1418867:Ps [Gene or Genome]
   748   C1518860:PS [Geographic Area]
   748   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "that"

Phrase: "is"

Phrase: "less"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439092:less [Intellectual Product]
  1000   C0547044:Less [Qualitative Concept]

Phrase: "conserved in ps-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ps of other species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "(13"

Phrase: ")."
Processing 00000000.tx.148: Also, co-segregation of the Glu318Gly mutation with AD could not be demonstrated, since no other relatives in family 1069 were available. 

Phrase: "Also,"

Phrase: "co-segregation of the Glu318Gly mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0080141:segregation [Social Behavior]

Phrase: "with AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "demonstrated"

Phrase: ","

Phrase: "since"

Phrase: "no other relatives in family 1069"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   783   C0557086:No relatives [Finding]
   753   C0080103:Relatives [Family Group]
   719 E C0205345:Relative [Qualitative Concept]
   719 E C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "available."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0470187:Available [Functional Concept]
Processing 00000000.tx.149: High variability in onset age was observed in PS-1 family 1005 segregating the Ala79Val mutation with a mean onset age in the family of 64 years, ranging from 55 to 78 years. 

Phrase: "High variability in onset age"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2827666:Variability [Conceptual Entity]

Phrase: "was"

Phrase: "observed in PS-1 family 1005"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C1517488:Gene Family [Gene or Genome]
   748   C0015576:Family [Family Group]
   748   C0017337:Gene [Gene or Genome]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C1441672:Observed [Functional Concept]
   748   C1704727:Family [Conceptual Entity]

Phrase: "segregating"

Phrase: "the Ala79Val mutation with a mean onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0026882:Mutation [Genetic Function]
   744   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in the family"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Family [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   928 E C0241888:Familial [Functional Concept]

Phrase: "of 64 years,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "ranging from 55"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0450382:55 [Intellectual Product]
   756   C1514721:Range [Quantitative Concept]
   756   C2348147:Range [Quantitative Concept]
   756   C3542016:Range [Intellectual Product]

Phrase: "to 78 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.150: In one mutation carrier the disease was not yet fully penetrant at age 76 years. 

Phrase: "In one mutation carrier"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C2985478:Mutation Carrier [Human]
   827   C0007294:Carrier [Finding]
   827   C0560175:Carrier [Finding]
   827   C1706209:Carrier [Medical Device]
   827   C3273162:Carrier [Intellectual Product]

Phrase: "the disease"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0012634:Disease [Disease or Syndrome]
   944 E C1836721:MALS [Finding]
   944 E C3538764:MALS [Gene or Genome]
   944 E C3540595:MAL [Gene or Genome]

Phrase: "was"

Phrase: "not yet fully penetrant at age 76 years."
Processing 00000000.tx.151: Possibly, the onset age in this family is modulated by other genetic and/or environmental factors. 

Phrase: "Possibly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the onset age in this family"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0206132:Onset Age [Quantitative Concept]
   753   C0001779:Age [Organism Attribute]

Phrase: "is"

Phrase: "modulated by other genetic"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0443264:Modulated [Spatial Concept]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "and/or"

Phrase: "environmental factors."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
Processing 00000000.tx.152: In this respect it is important to note that the non-penetrant case had an APOE [epsilon]3[epsilon]3 genotype, which may have delayed his onset age (30 ). 

Phrase: "In this respect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "it"

Phrase: "is"

Phrase: "important to"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the non-penetrant case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0868928:Case [Functional Concept]
   827   C1706255:CASE [Medical Device]
   827   C1706256:Case [Conceptual Entity]

Phrase: "had"

Phrase: "an APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3 genotype,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "which"

Phrase: "may"

Phrase: "have"

Phrase: "delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "his onset age (30"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0206132:Onset Age [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]
   827   C0332162:Onset [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.153: However, APOE studies in larger samples of PS-1 cases and families are needed to conclude that the APOE genotype modulates expression of PS-1 mutations. 

Phrase: "However,"

Phrase: "APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "studies in larger samples of PS-1 cases"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   790   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   764   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   762   C1273305:Gene studies [Laboratory Procedure]
   745   C0085973:Case Studies [Intellectual Product]
   745   C1416798:LARGE gene [Gene or Genome]
   742   C0017337:Gene [Gene or Genome]
   742   C0443228:larger [Quantitative Concept]
   742   C0549177:Larger [Quantitative Concept]
   742   C0557651:Study [Manufactured Object]
   742   C0868928:Cases [Functional Concept]
   742   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   742   C0947630:studies [Laboratory Procedure]
   742   C1533148:Cases [Quantitative Concept]
   742   C1704243:Larger [Quantitative Concept]
   742   C2603343:Study [Research Activity]
   708   C0370003:Sample [Substance]
   708 E C1706255:CASE [Medical Device]
   708 E C1706256:Case [Conceptual Entity]
   708   C2347026:Sample [Conceptual Entity]

Phrase: "and"

Phrase: "families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "are"

Phrase: "needed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Needed [Qualitative Concept]
  1000   C0686904:needed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "conclude"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that"

Phrase: "the APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "expression of PS-1 mutations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0017262:Gene Expression [Genetic Function]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.154: Also, no effect of the APOE genotype on onset age was observed in chromosome 14-linked AD families with PS-1 mutations, leading to very early onset ages and severe phenotypes (31 ). 

Phrase: "Also,"

Phrase: "no effect of the APOE genotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1301751:No effect [Qualitative Concept]
   753   C1280500:Effect [Qualitative Concept]
   753   C2348382:Effect [Qualitative Concept]

Phrase: "on onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206132:Onset Age [Quantitative Concept]
   861   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "observed in chromosome 14-linked AD families"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   793   C1970144:Alzheimer Disease 14 [Disease or Syndrome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0008656:Chromosome 14 [Cell Component]
   770   C0344339:disease family [Finding]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   751   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   744   C0008633:Chromosome [Cell Component]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0015576:Families [Family Group]
   744   C1441672:Observed [Functional Concept]
   744   C1704727:Family [Conceptual Entity]
   731   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
   725 E C0277558:Familial disease [Disease or Syndrome]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "with PS-1 mutations,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "leading"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0332152:Leading [Temporal Concept]
  1000   C1522538:Leading [Functional Concept]
   966 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   966 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   966 E C2348269:Lead [Element, Ion, or Isotope]
   966 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to very early onset ages"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0206132:Onset Age [Quantitative Concept]
   804   C0001779:Age [Organism Attribute]

Phrase: "and"

Phrase: "severe phenotypes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C1836408:Severe phenotype [Finding]
   861   C0031437:Phenotypes [Organism Attribute]
   827 E C1285572:Phenotype [Laboratory Procedure]

Phrase: "(31"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.155: Another possibility is that the PS-1-linked phenotype is modulated by a polymorphism in ps-2 or that mutations in ps-1 and ps-2 act together to express the disease phenotype (digenic effect). 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that"

Phrase: "the PS-1-linked phenotype"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0031437:Phenotype [Organism Attribute]
   804   C1285572:Phenotype [Laboratory Procedure]
   717   C1418985:Presenilin 1 Gene [Gene or Genome]

Phrase: "is"

Phrase: "modulated by a polymorphism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0032529:Polymorphism [Genetic Function]
   770   C0443264:Modulated [Spatial Concept]
   770   C1882417:Polymorphism [Qualitative Concept]

Phrase: "in ps-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "that mutations in ps-1"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "ps-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "together to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883357:Together [Qualitative Concept]

Phrase: "express"

Phrase: "the disease phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]

Phrase: "(digenic effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.156: However, SSCP analysis as well as RT-PCR analysis of PS-2 cDNA did not detect sequence alterations in ps-2. 

Phrase: "However,"

Phrase: "SSCP analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "as well as"

Phrase: "RT-PCR analysis of PS-2 cDNA"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   806   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   782   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   757   C1335440:Polymerase Gene [Gene or Genome]
   739   C0002778:Analysis [Laboratory Procedure]
   739   C0337112:Chain [Manufactured Object]
   739   C0443286:Reaction [Functional Concept]
   739   C0936012:Analysis [Research Activity]
   739   C1114821:Reaction [Clinical Attribute]
   739   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C1524024:analysis [Functional Concept]
   739   C1524075:Chain [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "sequence alterations in ps-2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0596611:Sequence Alteration [Genetic Function]
   726   C1515926:Alteration [Idea or Concept]
Processing 00000000.tx.157: Family 1005 is also of particular interest since in this family several patients had been identified with cerebrovascular accidents (CVA) (Fig. 2 ). 

Phrase: "Family 1005"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "is"

Phrase: "also of particular interest since"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0543488:Interest [Mental Process]

Phrase: "in this family several patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0030705:Patients [Patient or Disabled Group]

Phrase: "had"

Phrase: "been"

Phrase: "identified with cerebrovascular accidents (CVA)"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0038454:Cerebrovascular accidents [Disease or Syndrome]
   770   C0000924:Accidents [Injury or Poisoning]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]
   770   C1880018:Cerebrovascular [Qualitative Concept]
   737 E C1961149:Accident [Phenomenon or Process]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.158: However, none of them carried the PS-1 mutation, indicating that the CVAs in this family are not related to presenile AD. 

Phrase: "However,"

Phrase: "none of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456148:None [Quantitative Concept]
   790   C0549184:None [Quantitative Concept]

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "the PS-1 mutation,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C1418985:Presenilin 1 Gene [Gene or Genome]
   861   C0596611:Gene Mutation [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutation [Genetic Function]
   812   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "indicating"

Phrase: "that"

Phrase: "the CVAs in this family"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0038454:CVA, NOS [Disease or Syndrome]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to presenile AD."
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   726 E C0163712:Relate [Organic Chemical]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.159: In contrast to the previous three PS-1 mutations, the Tyr115Cys mutation in exon 5, corresponding to HL I, was detected in chromosome 14-linked family 1066, with mean onset age of 42 years (range 39-49 years) (20 ). 

Phrase: "In contrast to the previous three PS-1 mutations,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C1418985:Presenilin 1 Gene [Gene or Genome]
   827   C0596611:gene mutations [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "the Tyr115Cys mutation in exon 5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026882:Mutation [Genetic Function]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "corresponding to HL I,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0021966:I- [Inorganic Chemical]
   760   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0419518:Loop [Medical Device]
   760   C0445022:Loop [Spatial Concept]
   760   C0475370:Hydrophilic [Qualitative Concept]

Phrase: "was"

Phrase: "detected in chromosome 14-linked family 1066,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0008656:Chromosome 14 [Cell Component]
   748   C0008633:Chromosome [Cell Component]
   748   C0015576:Family [Family Group]
   748   C0442726:Detected [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]
   748   C1704727:Family [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "with mean onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206132:Onset Age [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]

Phrase: "of 42 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 39-49 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.160: The latter provides evidence that some of the earlier mutation studies may indeed have been biased towards finding PS-1 mutations resulting in earlier onset ages and more severe phenotypes. 

Phrase: "The latter"

Phrase: "provides"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0359589:provides [Food]
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "some of the earlier mutation studies"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   753   C0026882:Mutation [Genetic Function]
   753   C0205392:Some [Quantitative Concept]
   753   C0947630:studies [Laboratory Procedure]
   753   C1705285:Mutation [Cell or Molecular Dysfunction]
   753   C3540770:Some [Intellectual Product]
   719 E C0557651:Study [Manufactured Object]
   719   C1279919:Early [Temporal Concept]
   719 E C2603343:Study [Research Activity]

Phrase: "may"

Phrase: "indeed"

Phrase: "have"

Phrase: "been"

Phrase: "biased towards finding PS-1 mutations"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   814   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   778   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0596611:gene mutations [Genetic Function]
   748   C0017337:Gene [Gene or Genome]
   748   C0026882:Mutations [Genetic Function]
   748   C0037088:Finding [Sign or Symptom]
   748   C0242568:Biased [Idea or Concept]
   748   C0243095:Finding [Finding]
   748   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   748   C2825141:Finding [Finding]
   714 E C1504315:Bias [Bird]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "resulting in earlier onset ages"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0206132:Onset Age [Quantitative Concept]
   806   C0332294:Resulting in [Functional Concept]
   790   C1833334:Early-onset [Finding]
   760   C0001779:Age [Organism Attribute]
   760   C0332162:Onset [Qualitative Concept]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726   C1279919:Early [Temporal Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "more severe phenotypes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1836408:Severe phenotype [Finding]
   827   C0031437:Phenotypes [Organism Attribute]
   793 E C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.161: Only one PS-2 mutation, Arg62His, was observed in a sporadic AD case with an onset age of 62 years. 

Phrase: "Only one PS-2 mutation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0596611:Gene Mutation [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0026882:Mutation [Genetic Function]
   799   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "Arg62His,"

Phrase: "was"

Phrase: "observed in a sporadic AD case"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205422:Sporadic [Temporal Concept]
   748   C0868928:Case [Functional Concept]
   748   C1441672:Observed [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]

Phrase: "with an onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206132:Onset Age [Quantitative Concept]
   861   C0001779:Age [Organism Attribute]

Phrase: "of 62 years."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.162: The two published PS-2 mutations had been identified in autosomal dominant families with presenile AD in TM II and TM V of ps-2 (4 ,5 ). 

Phrase: "The two published PS-2 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0596611:gene mutations [Genetic Function]
   799   C0017337:Gene [Gene or Genome]
   799   C0026882:Mutations [Genetic Function]
   766 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "had"

Phrase: "been"

Phrase: "identified in autosomal dominant families"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0443147:Autosomal dominant [Intellectual Product]
   760   C0015576:Families [Family Group]
   760   C0205396:Identified [Qualitative Concept]
   760   C0596142:autosomal [Cell Component]
   760   C1527180:Dominant [Functional Concept]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   760   C1704727:Family [Conceptual Entity]

Phrase: "with presenile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "in TM II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   701   C1519623:Transmembrane Domain [Amino Acid Sequence]

Phrase: "and"

Phrase: "TM V of ps-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0445362:V 2 [Intellectual Product]

Phrase: "(4 ,"

Phrase: "5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.163: The mutated Arg62 codon is not conserved in human ps-1 and ps of other mammalian species and is located in a region of the N-terminal domain that is generally not conserved between ps-1, ps-2 and the Caenorhabditis elegans homolog sel-12 (32 ). 

Phrase: "The mutated Arg62 codon"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0009221:Codon [Nucleotide Sequence]
   827   C1095825:Codon [Plant]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conserved in human ps-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0086418:Human [Human]
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "ps of other mammalian species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1418867:Ps [Gene or Genome]
   760   C1518860:PS [Geographic Area]
   760   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "is"

Phrase: "located in a region of the N-terminal domain"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0017446:Region [Geographic Area]
   742   C0205088:Terminal [Temporal Concept]
   742   C0205147:Region [Spatial Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
   742   C1880389:Domain [Functional Concept]
   742   C1883221:Domain [Conceptual Entity]
   742   C3541951:Domain [Intellectual Product]

Phrase: "that"

Phrase: "is"

Phrase: "generally"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "conserved between ps-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1418867:Ps [Gene or Genome]
   770   C1518860:PS [Geographic Area]
   770   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "ps-2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1418867:Ps [Gene or Genome]
   861   C1518860:PS [Geographic Area]
   861   C1552158:Ps [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "the Caenorhabditis elegans homolog sel-12"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0162610:Caenorhabditis elegans [Eukaryote]
   804   C0006638:Caenorhabditis [Eukaryote]
   804   C1334043:Homolog [Gene or Genome]
   704 E C2697616:Homology [Qualitative Concept]

Phrase: "(32"

Phrase: ")."
Processing 00000000.tx.164: Also, the mutation itself is a conserved amino acid substitution. 

Phrase: "Also,"

Phrase: "the mutation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026882:Mutation [Genetic Function]
  1000   C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "itself"

Phrase: "is"

Phrase: "a conserved amino acid substitution."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0525038:Amino Acid Substitution [Genetic Function,Molecular Biology Research Technique]
   812   C1555721:Substitution [Idea or Concept]
   812   C1706204:Substitution [Activity]
Processing 00000000.tx.165: Therefore, it cannot be excluded that this ps-2 mutation is a rare polymorphism not related to AD pathogenesis, since the patient also had an APOE [epsilon]3[epsilon]4 genotype which may have increased her risk of developing AD (30 ). 

Phrase: "Therefore,"

Phrase: "it"

Phrase: "cannot"

Phrase: "be"

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "that"

Phrase: "this ps-2 mutation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0026882:Mutation [Genetic Function]
   827   C1705285:Mutation [Cell or Molecular Dysfunction]
   734   C0528480:PS-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a rare polymorphism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032529:Polymorphism [Genetic Function]
   861   C1882417:Polymorphism [Qualitative Concept]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "related to AD pathogenesis,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0439849:Related [Qualitative Concept]
   760   C0445223:Related [Finding]
   760   C0543483:pathogenesis [Functional Concept]
   760   C0699748:Pathogenesis [Pathologic Function]
   726 E C0163712:Relate [Organic Chemical]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "since"

Phrase: "the patient also"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030705:*^patient [Patient or Disabled Group]

Phrase: "had"

Phrase: "an APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0523511:APOE [Laboratory Procedure]
  1000   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "which"

Phrase: "may"

Phrase: "have"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "her risk of developing AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1281905:disease risk [Finding]
   753   C0035647:Risk [Qualitative Concept]

Phrase: "(30"

Phrase: ")."
Processing 00000000.tx.166: In conclusion, our mutation data showed that PS-1 and PS-2 mutations are rare genetic causes of presenile AD in general. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "our mutation data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PS-2 mutations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0596611:gene mutations [Genetic Function]
   812   C0017337:Gene [Gene or Genome]
   812   C0026882:Mutations [Genetic Function]
   779 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "are"

Phrase: "rare genetic causes of presenile AD"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   757   C1314792:disease cause [Functional Concept]
           Causes
   748   C0015127:causes [Functional Concept]
   714 E C1524003:Cause [Conceptual Entity]

Phrase: "in general."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205246:General [Spatial Concept]
  1000   C1553889:General [Idea or Concept]
Processing 00000000.tx.167: Also, the frequency of PS-1 mutations in autosomal dominant AD families (18%) is less frequent than initially estimated. 

Phrase: "Also,"

Phrase: "the frequency of PS-1 mutations"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   774   C0017270:Gene Frequency [Quantitative Concept]
   757   C3178846:Mutation Frequency [Qualitative Concept]
   748   C0376249:frequency [Quantitative Concept]
   748   C0439603:Frequency [Temporal Concept]
   748   C0871396:Frequency [Quantitative Concept]
   748   C1561548:Frequency [Qualitative Concept]
   748   C1705502:Frequency [Quantitative Concept]

Phrase: "in autosomal dominant AD families"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   721 E C0241888:Familial [Functional Concept]

Phrase: "(18%"

Phrase: ")"

Phrase: "is"

Phrase: "less frequent than initially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332183:Frequent [Temporal Concept]

Phrase: "estimated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750572:Estimated [Quantitative Concept]
Processing 00000000.tx.168: No mutations were identified in exons 16 and 17 of APP of any of the cases (33 ), suggesting that other AD genes must exist. 

Phrase: "No mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0026882:Mutations [Genetic Function]
   966 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "were"

Phrase: "identified in exons 16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0205396:Identified [Qualitative Concept]
   770   C1550043:Identified [Finding]
   770   C1551388:Identified [Functional Concept]

Phrase: "and"

Phrase: "17 of APP of any of the cases"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   744   C0868928:Cases [Functional Concept]
   744   C1533148:Cases [Quantitative Concept]
   744   C3538722:APP [Laboratory Procedure]
   711 E C1706255:CASE [Medical Device]
   711 E C1706256:Case [Conceptual Entity]

Phrase: "(33"

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other AD genes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   856   C1416989:MAL gene [Gene or Genome]
   827   C0017337:Genes [Gene or Genome]
   734   C0002395:Alzheimer's Disease [Disease or Syndrome]
   734   C1521724:Alzheimer's Disease [Pathologic Function]

Phrase: "must"

Phrase: "exist."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2987476:Exist [Conceptual Entity]
Processing 00000000.tx.169: It is possible that a fraction of the cases may be attributed to the presence of an APOE [epsilon]4 allele. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "a fraction of the cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1264633:Fraction of [Quantitative Concept]
           Fraction
   760   C1554103:Fraction [Idea or Concept]

Phrase: "may"

Phrase: "be"

Phrase: "attributed to the presence of an APOE"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C0523511:APOE [Laboratory Procedure]
   748   C1412481:APOE [Gene or Genome]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 allele."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0002085:Allele [Gene or Genome]
Processing 00000000.tx.170: In a previous study of this population-based sample we demonstrated that the risk for developing presenile AD is significantly increased in APOE [epsilon]4 homozygotes independent of family history and in APOE [epsilon]4 heterozygotes in which the family history is positive (33 ). 

Phrase: "In a previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "of this population-based sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "we"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the risk for developing presenile AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1281905:disease risk [Finding]
   748   C0035647:Risk [Qualitative Concept]

Phrase: "is"

Phrase: "significantly"

Phrase: "increased in APOE"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0205217:Increased [Quantitative Concept]
   790   C0442805:Increased [Functional Concept]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 homozygotes independent of family history"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0019904:Homozygotes [Organism Attribute]

Phrase: "and in APOE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0523511:APOE [Laboratory Procedure]
   790   C1412481:APOE [Gene or Genome]
   790   C1515981:And [Idea or Concept]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 heterozygotes in which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0019425:Heterozygotes [Organism Attribute]

Phrase: "the family history"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
  1000   C0241889:Family history [Finding]
  1000   C1705495:Family History [Idea or Concept]
   861   C0015576:Family [Family Group]
   861   C0019664:History [Occupation or Discipline]
   861   C0019665:history [Intellectual Product]
   861   C0262512:History, NOS [Organism Attribute]
   861   C0262926:History [Finding]
   861   C1704727:Family [Conceptual Entity]
   861   C1705255:History [Conceptual Entity]
   861   C2004062:History [Finding]
   789 E C0241888:Familial [Functional Concept]
   789 E C1552658:Historical [Idea or Concept]
   789 E C1552723:Historical [Idea or Concept]

Phrase: "is"

Phrase: "positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0439178:% Positive [Quantitative Concept]
  1000   C1446409:Positive [Qualitative Concept]
  1000   C1514241:Positive [Finding]
  1000   C2825490:Positive [Qualitative Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.171: In the sample of 101 cases there were 19 APOE [epsilon]4 homozygotes and 31 familial APOE [epsilon]4 heterozygotes. 

Phrase: "In the sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "of 101 cases there"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0868928:Cases [Functional Concept]
   827   C1533148:Cases [Quantitative Concept]
   793 E C1706255:CASE [Medical Device]
   793 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "19 APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0523511:APOE [Laboratory Procedure]
   861   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 homozygotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019904:Homozygotes [Organism Attribute]

Phrase: "and"

Phrase: "31 familial APOE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0003595:Apo-E [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0523511:APOE [Laboratory Procedure]
   827   C1412481:APOE [Gene or Genome]

Phrase: "[epsilon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439098:Epsilon [Intellectual Product]

Phrase: "]4 heterozygotes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019425:Heterozygotes [Organism Attribute]
Processing 00000000.tx.172: In contrast to previous reports (29 ), we observed several PS-1 mutations leading to AD with onset ages above 55 years. 

Phrase: "In contrast to previous reports"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0684224:Reports [Intellectual Product]
   861   C0700287:reports [Health Care Activity]
   827 E C3273238:Report [Intellectual Product]

Phrase: "(29"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "several PS-1 mutations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   884   C1418985:Presenilin 1 Gene [Gene or Genome]
   840   C0596611:gene mutations [Genetic Function]
   804   C0017337:Gene [Gene or Genome]
   804   C0026882:Mutations [Genetic Function]
   771 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "leading to AD"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0012634:Disease [Disease or Syndrome]
   770   C0332152:Leading [Temporal Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "with onset"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332162:Onset [Qualitative Concept]

Phrase: "ages above 55 years."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   819   C1510829:Age-Years [Temporal Concept]
   770   C0001779:Age [Organism Attribute]
   770   C0439234:years [Temporal Concept]
   770   C0450382:55 [Intellectual Product]
   737 E C0439508:/year [Temporal Concept]
Processing 00000000.tx.173: Also, one of these PS-1 mutations was identified in an autosomal dominant family with a mean onset age of 64 years (range 55-78 years). 

Phrase: "Also,"

Phrase: "one of these PS-1 mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "identified in an autosomal dominant family"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0443147:Autosomal dominant [Intellectual Product]
   753   C0015576:Family [Family Group]
   753   C0205396:Identified [Qualitative Concept]
   753   C0596142:autosomal [Cell Component]
   753   C1527180:Dominant [Functional Concept]
   753   C1550043:Identified [Finding]
   753   C1551388:Identified [Functional Concept]
   753   C1704727:Family [Conceptual Entity]

Phrase: "with a mean onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0206132:Onset Age [Quantitative Concept]
   827   C0001779:Age [Organism Attribute]

Phrase: "of 64 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "(range 55-78 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0439234:years [Temporal Concept]
   779 E C0439508:/year [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.174: The identification of these PS-1 mutations predicts that PS-1 mutations with even milder effects on ps-1 functioning may be present in senile AD. 

Phrase: "The identification of these PS-1 mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "predicts"

Phrase: "that PS-1 mutations with even milder effects"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C1418985:Presenilin 1 Gene [Gene or Genome]
   764   C0596611:gene mutations [Genetic Function]
   742   C0017337:Gene [Gene or Genome]
   742   C0026882:Mutations [Genetic Function]
   708 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "on ps-1 functioning"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0542341:functioning [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   734   C0299212:PS-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "be"

Phrase: "present in senile AD."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
Processing 00000000.tx.175: This is of particular importance since a genetic association between an intronic PS-1 polymorphism and senile AD has been reported (25 ), although this association could not be replicated in all studies. 

Phrase: "This"

Phrase: "is of particular importance"

Phrase: "since"

Phrase: "a genetic association between an intronic PS-1 polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1328885:genetic association [Occupation or Discipline]
   739   C0004083:Association [Mental Process]
   739   C0439849:Association [Qualitative Concept]
   739   C0596306:Association [Phenomenon or Process]
   739   C0699792:association [Social Behavior]

Phrase: "and"

Phrase: "senile AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(25"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "this association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "could"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "replicated in all studies."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   770   C0205173:replicated [Functional Concept]
   770   C0947630:studies [Laboratory Procedure]
   737 E C0205341:Replicate [Functional Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1883725:Replicate [Qualitative Concept]
   737 E C2603343:Study [Research Activity]
Processing 00000000.tx.176: Possibly, the association is the result of a functionally more relevant sequence variation elsewhere in the PS-1 gene. 

Phrase: "Possibly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "the association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0004083:Association [Mental Process]
  1000   C0439849:Association [Qualitative Concept]
  1000   C0596306:Association [Phenomenon or Process]
  1000   C0699792:association [Social Behavior]

Phrase: "is"

Phrase: "the result of a functionally more relevant sequence variation elsewhere"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "in the PS-1 gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1418985:Presenilin 1 Gene [Gene or Genome]
Processing 00000000.tx.177: Preliminary data obtained by sequence analysis failed to demonstrate sequence variations in the coding region of PS-1 (25 ). 

Phrase: "Preliminary data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "obtained by sequence analysis"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   833   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0004793:Sequence [Nucleotide Sequence]
   770   C0162326:Sequence [Nucleotide Sequence]
   770   C0162327:Sequence [Nucleotide Sequence]
   770   C0936012:Analysis [Research Activity]
   770   C1301820:Obtained [Functional Concept]
   770   C1519249:Sequence [Functional Concept]
   770   C1524024:analysis [Functional Concept]
   737 E C1706701:Obtain [Activity]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "demonstrate"

Phrase: "sequence variations in the coding region of PS-1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0079941:Coding Sequence [Gene or Genome]
   739   C0004793:Sequence [Nucleotide Sequence]
   739   C0162326:Sequence [Nucleotide Sequence]
   739   C0162327:Sequence [Nucleotide Sequence]
   739   C0205419:variations [Qualitative Concept]
   739   C1519249:Sequence [Functional Concept]
   726   C0042333:Sequence Variation [Natural Phenomenon or Process]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.178: However, the promoter and 5'-non-coding region of PS-1 had not been examined, since these sequences became available only recently. 

Phrase: "However,"

Phrase: "the promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "5'-non-coding region of PS-1"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0079941:Coding Region [Gene or Genome]
   767   C1883644:5' Region [Nucleotide Sequence]
   744   C0009219:Coding [Occupational Activity]
   744   C0017446:Region [Geographic Area]
   744   C0205147:Region [Spatial Concept]
   744   C1518422:Non [Functional Concept]
   711 E C0805701:Code [Intellectual Product]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "since"

Phrase: "these sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "became"

Phrase: "available only recently."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205171:Only [Quantitative Concept]
   827   C0332185:Recently [Temporal Concept]
   827   C0470187:Available [Functional Concept]
   827   C1720467:Only [Intellectual Product]
Processing 00000000.tx.179: In this respect the identification by us of two polymorphisms in the 5'-non-coding region of PS-1 is of interest, since these polymorphisms may be used in genetic association studies to test whether PS-1 is also a susceptibility gene for senile and/or presenile AD. 

Phrase: "In this"

Phrase: "respect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679133:respect [Social Behavior]

Phrase: "the identification by us of two polymorphisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0020792:Identification [Mental Process]
   748   C0205396:Identification [Qualitative Concept]

Phrase: "in the 5'-non-coding region"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   902   C1883644:5' Region [Nucleotide Sequence]
   861   C0079941:Coding Region [Gene or Genome]
   812   C0009219:Coding [Occupational Activity]
   812   C0017446:Region [Geographic Area]
   812   C0205147:Region [Spatial Concept]
   812   C1518422:Non [Functional Concept]
   779 E C0805701:Code [Intellectual Product]
   741 E C0205276:Regional [Spatial Concept]
   741 E C1947913:Regional [Spatial Concept]

Phrase: "of PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is of interest,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0543488:Interest [Mental Process]

Phrase: "since"

Phrase: "these polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0032529:polymorphisms [Genetic Function]
   966 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "used in genetic association"
Meta Candidates (Total=18; Excluded=10; Pruned=0; Remaining=8)
   833   C1328885:genetic association [Occupation or Discipline]
   770   C0004083:Association [Mental Process]
   770   C0017296:GENETIC [Therapeutic or Preventive Procedure]
   770   C0314603:Genetic [Functional Concept]
   770   C0439849:Association [Qualitative Concept]
   770   C0596306:Association [Phenomenon or Process]
   770   C0699792:association [Social Behavior]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
   715 E C0005615:Birth [Organism Function]
   715 E C0035150:Reproduction [Organism Function]
   715 E C0079946:origin [Classification]
   715 E C0439659:Origin [Temporal Concept]
   715 E C1550512:origin [Intellectual Product]
   715 E C1550722:birth [Idea or Concept]
   715 E C3245487:birth [Intellectual Product]

Phrase: "studies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557651:Study [Manufactured Object]
  1000   C0947630:studies [Laboratory Procedure]
  1000   C2603343:Study [Research Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "whether"

Phrase: "PS-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "also"

Phrase: "a susceptibility gene for senile"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0919453:Susceptibility Gene [Gene or Genome]
   797   C0079429:A Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]

Phrase: "and/or"

Phrase: "presenile AD."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   827   C0012634:Disease [Disease or Syndrome]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.180: Also, the intronic and exonic polymorphisms identified in PS-2 are useful to test the role of this gene in AD, an analysis that has not yet been performed. 

Phrase: "Also,"

Phrase: "the intronic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "exonic polymorphisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0032529:polymorphisms [Genetic Function]
   827 E C1882417:Polymorphism [Qualitative Concept]

Phrase: "identified in PS-2"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1418986:PRESENILIN 2 [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0205396:Identified [Qualitative Concept]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]

Phrase: "are"

Phrase: "useful to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   789   C0042153:use [Functional Concept]
   789   C0457083:Use [Functional Concept]
   789   C1947944:Use [Intellectual Product]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the role of this gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in AD,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "an analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "that"

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "performed."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.181: MATERIALS AND METHODS Subjects All patients with a clinical diagnosis of AD and onset at or before age 65 years, made in the period January 1980 and July 1987, living in metropolitan Rotterdam and the four northern provinces were ascertained (18 ). 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "Subjects"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0681850:Subject [Group]
  1000   C1550501:{Subject} [Idea or Concept]
  1000   C1706203:Subject [Idea or Concept]
  1000   C2349001:Subject [Human]
  1000   C2697811:Subject [Functional Concept]

Phrase: "All patients with a clinical diagnosis of AD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030705:Patients [Patient or Disabled Group]

Phrase: "and"

Phrase: "onset at"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0332162:Onset [Qualitative Concept]

Phrase: "or before age 65 years,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   797   C1510829:Age-Years [Temporal Concept]
   760   C0001779:Age [Organism Attribute]
   760   C0439234:years [Temporal Concept]
   760   C0450385:65 [Intellectual Product]
   726 E C0439508:/year [Temporal Concept]

Phrase: "made in the period January 1980"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439531:/period [Temporal Concept]
   753   C1948053:Period [Temporal Concept]
   719   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "July 1987,"

Phrase: "living in metropolitan Rotterdam"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0376558:Living [Idea or Concept]
   770   C0599587:metropolitan [Spatial Concept]
   737 E C1548795:Live [Qualitative Concept]
   737 E C1634625:% live [Qualitative Concept]
   737 E C2982691:Live [Activity]

Phrase: "and"

Phrase: "the four northern provinces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1514578:Province [Geographic Area]

Phrase: "were"

Phrase: "ascertained"

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.182: The clinical diagnosis of AD was independently confirmed by two neurologists using a standardized protocol according to NINCDS-ADRDA criteria for AD (34 ). 

Phrase: "The clinical diagnosis of AD"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0332140:Diagnosis, clinical [Qualitative Concept]
   753   C0011900:Diagnosis [Finding]
   753   C0205210:Clinical [Qualitative Concept]
   753   C1704338:diagnosis [Qualitative Concept]
   753   C1704656:DIAGNOSIS [Research Activity]

Phrase: "was"

Phrase: "independently"

Phrase: "confirmed by two neurologists"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   770   C0205448:Two [Quantitative Concept]
   770   C0237426:Neurologists [Professional or Occupational Group]
   770   C0750484:Confirmed [Idea or Concept]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standardized protocol according to NINCDS-ADRDA criteria"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0442711:Protocol [Intellectual Product]
   744   C1507394:Protocol [Intellectual Product]
   744   C1522729:Protocol [Intellectual Product]
   744   C2348563:Protocol [Intellectual Product]

Phrase: "for AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(34"

Phrase: ")."
Processing 00000000.tx.183: A total of 198 patients participated in the study (18 ). 

Phrase: "A total of 198 patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]

Phrase: "participated in the study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.184: Onset age was defined as the age at which memory problems or behavior changes were first noted. 

Phrase: "Onset age"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206132:Onset Age [Quantitative Concept]
   861   C0001779:Age [Organism Attribute]

Phrase: "was"

Phrase: "defined as the age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0001779:Age [Organism Attribute]
   770   C1704788:Defined [Conceptual Entity]
   770   C3539106:Defined [Intellectual Product]

Phrase: "at which memory problems"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0233794:memory problems [Mental or Behavioral Dysfunction]
   861   C1546466:Problems [Idea or Concept]
   827 E C0033213:Problem [Finding]

Phrase: "or"

Phrase: "behavior changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0542299:behavior changes [Individual Behavior]
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.185: Cases were considered familial when at least one first degree relative suffered from dementia. 

Phrase: "Cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "were"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "familial"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:familial [Family Group]
  1000   C0241888:Familial [Functional Concept]
   928 E C1704727:Family [Conceptual Entity]

Phrase: "when at least one first degree relative"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   814   C1517194:First Degree Relative [Family Group]
   778   C0444502:First degree [Qualitative Concept]
   748   C0080103:Relative [Family Group]
   748   C0205345:Relative [Qualitative Concept]
   748   C0205435:First [Quantitative Concept]
   748   C0205447:One [Quantitative Concept]
   748   C0441889:Degree [Qualitative Concept]
   748   C0449286:Degree [Quantitative Concept]
   748   C0542560:Degree [Intellectual Product]
   748   C1279901:First [Qualitative Concept]
   748   C1547039:*Relative [Quantitative Concept]
   748   C1561545:degree [Quantitative Concept]
   748   C1720477:When [Qualitative Concept]
   748   C1948054:When [Temporal Concept]
   748   C2348088:Degree [Quantitative Concept]

Phrase: "suffered from dementia."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011265:dementia [Mental or Behavioral Dysfunction]
   790   C0497327:Dementia [Mental or Behavioral Dysfunction]
   790   C0683278:suffered [Mental or Behavioral Dysfunction]
Processing 00000000.tx.186: The percentage of familial cases in the total sample of presenile AD patients was 48% (18 ,33 ). 

Phrase: "The percentage of familial cases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439165:Percentage [Quantitative Concept]
   760   C1549488:Percentage [Idea or Concept]
   760   C1561533:Percentage [Idea or Concept]

Phrase: "in the total sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "of presenile AD patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:Patients [Patient or Disabled Group]

Phrase: "was"

Phrase: "48%"

Phrase: "(18 ,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.187: Of familial cases the pedigree was considered to segregate with autosomal dominant AD if at least three patients with dementia were reported in two generations and if there were at least two patients with detailed medical records on the clinical diagnosis of AD (18 ,33 ). 

Phrase: "Of familial cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "the pedigree"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030761:Pedigree [Intellectual Product]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "segregate with autosomal dominant AD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0443147:Autosomal dominant [Intellectual Product]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0596142:autosomal [Cell Component]
   753   C1527180:Dominant [Functional Concept]

Phrase: "if at least three patients"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205449:Three [Quantitative Concept]
   760   C0750557:If [Qualitative Concept]

Phrase: "with dementia"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0011265:dementia [Mental or Behavioral Dysfunction]
  1000   C0497327:Dementia [Mental or Behavioral Dysfunction]
   900 E C0860630:dement [Mental or Behavioral Dysfunction]

Phrase: "were"

Phrase: "reported in two generations"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0079411:Generations [Temporal Concept]
   770   C0205448:Two [Quantitative Concept]
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3146294:Generation [Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "and"

Phrase: "if"

Phrase: "there"

Phrase: "were at least two patients"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0030705:Patients [Patient or Disabled Group]
   760   C0205448:Two [Quantitative Concept]

Phrase: "with detailed medical records"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   901   C0025102:Medical Records [Intellectual Product]
   901   C0551625:Medical records [Clinical Attribute]
   901   C1554096:Medical records [Intellectual Product]
   827   C0034869:Records [Intellectual Product]
   827   C0205476:Medical [Functional Concept]
   827   C1548330:Records [Idea or Concept]
   827   C1553414:Records [Qualitative Concept]

Phrase: "on the clinical diagnosis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0332140:Diagnosis, clinical [Qualitative Concept]
   861   C0011900:Diagnosis [Finding]
   861   C0205210:Clinical [Qualitative Concept]
   861   C1704338:diagnosis [Qualitative Concept]
   861   C1704656:DIAGNOSIS [Research Activity]

Phrase: "of AD"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "(18 ,"

Phrase: "33"

Phrase: ")."
Processing 00000000.tx.188: Blood samples were drawn from 100 randomly selected AD patients (33 ) and detailed data on family history of disease were collected (18 ). 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "drawn from 100 randomly selected AD patients"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0030705:Patients [Patient or Disabled Group]
   711   C0013113:Draw [Intellectual Product]
   711   C1707391:Select [Activity]

Phrase: "(33"

Phrase: ")"

Phrase: "and"

Phrase: "detailed data on family history of disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1511726:Data [Idea or Concept]
   748   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "(18"

Phrase: ")."
Processing 00000000.tx.189: Affected and unaffected relatives of 17 families were visited at home, where blood was drawn. 

Phrase: "Affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "and"

Phrase: "unaffected relatives of 17 families"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   760   C0080103:Relatives [Family Group]
   726 E C0205345:Relative [Qualitative Concept]
   726 E C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "visited at home,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   841   C0020043:Home visit [Health Care Activity]
   841   C0199358:home visit [Health Care Activity]
   841   C0695714:home visit [Therapeutic or Preventive Procedure]
   790   C0442519:Home [Conceptual Entity]
   756   C0545082:Visit [Behavior]
   756   C1512346:visit [Health Care Activity]
   756   C2826704:VISIT [Intellectual Product]

Phrase: "where blood"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   861   C0005767:Blood [Tissue]
   861   C0005768:blood [Body Substance]
   861   C0229664:Blood [Body Substance]
   789 E C0333275:Bloody [Qualitative Concept]
   777 E C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
   777 E C0392895:Bloods [Population Group]
   777 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   777 E C1511228:VESSEL, BLOOD [Tissue]
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]

Phrase: "was"

Phrase: "drawn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013113:Draw [Intellectual Product]
Processing 00000000.tx.190: All relatives were assessed for family history of disease, risk factors for AD and memory performance (20 ). 

Phrase: "All relatives"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0080103:Relatives [Family Group]
   966 E C0205345:Relative [Qualitative Concept]
   966 E C1547039:*Relative [Quantitative Concept]

Phrase: "were"

Phrase: "assessed for family history of disease,"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   882   C0850707:family history of disease [Finding]
           disease family history
   805   C0683519:History of diseases [Finding]
           disease history
   790   C0241889:Family history [Finding]
   790   C1705495:Family History [Idea or Concept]
   783   C0344339:disease family [Finding]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0015576:Family [Family Group]
   753   C0019664:History [Occupation or Discipline]
   753   C0019665:history [Intellectual Product]
   753   C0262512:History, NOS [Organism Attribute]
   753   C0262926:History [Finding]
   753   C1516048:Assessed [Activity]
   753   C1704727:Family [Conceptual Entity]
   753   C1705255:History [Conceptual Entity]
   753   C2004062:History [Finding]
   748 E C0277558:Familial disease [Disease or Syndrome]

Phrase: "risk factors for AD"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   835   C0850664:disease factors risk [Finding]
   806   C0035648:risk factors [Quantitative Concept]
   806   C1553898:risk factors [Idea or Concept]
   797   C0679238:disease factors [Functional Concept]
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]
   726   C1521761:Factor [Functional Concept]
   726   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "memory performance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1285654:Memory performance [Mental Process]
   861   C0597198:Performance [Individual Behavior]
   861   C1882330:Performance [Activity]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.191: Blood samples were obtained from 118 control individuals matched for age within 5 years and place of residence. 

Phrase: "Blood samples"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178913:blood samples [Body Substance]
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "obtained from 118 control individuals"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   760   C0243148:control [Qualitative Concept]
   760   C1301820:Obtained [Functional Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]
   726   C0027361:Individual [Population Group]
   726   C0237401:Individual [Human]
   726 E C1706701:Obtain [Activity]

Phrase: "matched for age"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0001779:Age [Organism Attribute]
   790   C0150103:matched [Research Activity]
   790   C1708943:Matched [Qualitative Concept]

Phrase: "within 5 years"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0439234:years [Temporal Concept]
   827 E C0439508:/year [Temporal Concept]

Phrase: "and"

Phrase: "place of residence."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0682130:place of residence [Finding]
   790   C0442504:Place [Spatial Concept]
   790   C1704765:Place [Functional Concept]
   790   C1882509:Place [Activity]
   790   C3496241:place [Disease or Syndrome]
Processing 00000000.tx.192: The controls were drawn randomly from the population register of the municipality of the patient (33 ). 

Phrase: "The controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0243148:control [Qualitative Concept]
   966   C1550141:Control [Substance]
   966   C1882979:Control [Conceptual Entity]
   966   C2587213:Control [Functional Concept]
   966   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "drawn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013113:Draw [Intellectual Product]

Phrase: "randomly from the population register of the municipality of the patient"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   756   C0032681:Population Register [Intellectual Product,Quantitative Concept]
   754   C0585825:patient register [Functional Concept]
   738   C0030705:*^patient [Patient or Disabled Group]
   738   C0032659:Population [Quantitative Concept]
   738   C0600182:municipality [Geographic Area]
   738   C1257890:Population [Population Group]
   738   C1550712:municipality [Idea or Concept]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.193: Cognitive status of the control individuals was tested and none of them showed symptoms of dementia at the time of the study. 

Phrase: "Cognitive status of the control individuals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449438:Status [Qualitative Concept]

Phrase: "was"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "and"

Phrase: "none of them"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456148:None [Quantitative Concept]
   790   C0549184:None [Quantitative Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "symptoms of dementia"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0683368:symptoms [Functional Concept]
   790   C1457887:Symptoms [Sign or Symptom]

Phrase: "at the time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0040223:Time [Temporal Concept]
  1000   C3541383:Time [Temporal Concept]
   944 E C0442043:Temporal [Spatial Concept]
   944 E C2362314:Temporal [Temporal Concept]
   916 E C1632851:Times [Quantitative Concept]

Phrase: "of the study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.194: Leukocytes were collected from total blood of the patients and relatives and permanent lymphoblast cell lines were obtained by transformation using Ebstein-Barr virus. 

Phrase: "Leukocytes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023516:Leukocytes [Cell]

Phrase: "were"

Phrase: "collected from total blood of the patients"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0005767:Blood [Tissue]
   748   C0005768:blood [Body Substance]
   748   C0030705:Patients [Patient or Disabled Group]
   748   C0229664:Blood [Body Substance]
   748   C0439175:% total [Quantitative Concept]
   748   C0439810:Total [Qualitative Concept]
   748   C1516695:Collected [Idea or Concept]
   748   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "relatives"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0080103:Relatives [Family Group]
   966 E C0205345:Relative [Qualitative Concept]
   966 E C1547039:*Relative [Quantitative Concept]

Phrase: "and"

Phrase: "permanent lymphoblast cell lines"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   906   C0598090:permanent cell line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0007634:Cell [Cell]
   812   C0205132:lines [Spatial Concept]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]

Phrase: "were"

Phrase: "obtained by transformation"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   790   C0040682:Transformation [Cell Function]
   790   C1301820:Obtained [Functional Concept]
   790   C1510411:Transformation [Pathologic Function]
   790   C1705163:Transformation [Research Activity]
   756 E C1706701:Obtain [Activity]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Ebstein-Barr virus."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0042776:Virus [Virus]
   827   C0319157:virus [Virus]
Processing 00000000.tx.195: DNA was extracted from total blood or cultured lymphoblasts using a standard phenol/chloroform DNA extraction procedure. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "extracted from total blood"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0005767:Blood [Tissue]
   770   C0005768:blood [Body Substance]
   770   C0185115:Extracted [Therapeutic or Preventive Procedure]
   770   C0229664:Blood [Body Substance]
   770   C0439175:% total [Quantitative Concept]
   770   C0439810:Total [Qualitative Concept]
   770   C3541890:EXTRACTED [Finding]
   737 E C2828366:Extract [Substance]

Phrase: "or"

Phrase: "cultured lymphoblasts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0229613:Lymphoblasts [Cell]
   861   C1167770:Lymphoblasts [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a standard phenol/chloroform DNA extraction procedure."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0185115:extraction procedure [Therapeutic or Preventive Procedure]
   799   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   799   C1948041:Procedure [Therapeutic or Preventive Procedure]
   799   C2700391:Procedure [Activity]
   799   C3274430:PROCEDURE [Health Care Activity]
   799   C3538935:Procedure [Idea or Concept]
   799   C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.196: In our initial genetic analyses of the 100 cases we had included nine autosomal dominant cases. 

Phrase: "In our initial genetic analyses"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0679560:genetic analysis [Laboratory Procedure]
   884   C0796344:Genetic Analysis [Laboratory Procedure]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "of the 100 cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0868928:Cases [Functional Concept]
   861   C1533148:Cases [Quantitative Concept]
   827 E C1706255:CASE [Medical Device]
   827 E C1706256:Case [Conceptual Entity]

Phrase: "we"

Phrase: "had"

Phrase: "included nine autosomal dominant cases."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   804   C0868928:Cases [Functional Concept]
   804   C1533148:Cases [Quantitative Concept]
   771 E C1706255:CASE [Medical Device]
   771 E C1706256:Case [Conceptual Entity]
Processing 00000000.tx.197: However, recently an at-risk individual in 1066 (V-2, Fig. 2 ) was diagnosed with probable AD and included in this study, bringing the total number of cases to 101. 

Phrase: "However,"

Phrase: "recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "an at-risk individual in 1066"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0027361:Individual [Population Group]
   753   C0237401:Individual [Human]

Phrase: "(V-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0445362:V 2 [Intellectual Product]

Phrase: "Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "was"

Phrase: "diagnosed with probable AD"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0011900:Diagnosed [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0033204:Probable [Quantitative Concept]
   760   C0332148:Probable [Qualitative Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "included in this study,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   770   C0332257:included [Functional Concept]
   770   C0557651:Study [Manufactured Object]
   770   C2603343:Study [Research Activity]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "bringing"

Phrase: "the total number of cases"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0237753:*Number [Quantitative Concept]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "to 101."
Processing 00000000.tx.198: Mutation analysis of exons 16 and 17 of APP excluded the presence of APP mutations in all cases (33 ). 

Phrase: "Mutation analysis of exons 16"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0796357:mutation analysis [Laboratory Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "17 of APP"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538722:APP [Laboratory Procedure]

Phrase: "excluded"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]

Phrase: "the presence of APP mutations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in all cases"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0868928:Cases [Functional Concept]
  1000   C1533148:Cases [Quantitative Concept]
   966 E C1706255:CASE [Medical Device]
   966 E C1706256:Case [Conceptual Entity]

Phrase: "(33"

Phrase: ")."
Processing 00000000.tx.199: The informative families of 10 autosomal dominant cases were used in linkage analysis studies with chromosome 14, 19 and 21 markers (20 ). 

Phrase: "The informative families of 10 autosomal dominant cases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0015576:Families [Family Group]
   744   C1704727:Family [Conceptual Entity]

Phrase: "were"

Phrase: "used in linkage analysis"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   833   C0796345:linkage analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0023745:linkage [Molecular Function]
   770   C0936012:Analysis [Research Activity]
   770   C1273517:used [Finding]
   770   C1524024:analysis [Functional Concept]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "studies with chromosome 14,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0008656:Chromosome 14 [Cell Component]
   819   C1273411:Chromosome studies [Laboratory Procedure]
   770   C0008633:Chromosome [Cell Component]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]

Phrase: "19"

Phrase: "and"

Phrase: "21 markers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005516:Marker [Clinical Attribute]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.200: Family 1066 (mean onset age 42 years) was conclusively linked to chromosome 14, while two others were excluded. 

Phrase: "Family 1066"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0015576:Family [Family Group]
   861   C1704727:Family [Conceptual Entity]
   789 E C0241888:Familial [Functional Concept]

Phrase: "(mean onset age 42 years"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   853   C1510829:Age-Years [Temporal Concept]
   804   C0439234:years [Temporal Concept]
   771 E C0439508:/year [Temporal Concept]

Phrase: ")"

Phrase: "was"

Phrase: "conclusively"

Phrase: "linked to chromosome 14,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0008656:Chromosome 14 [Cell Component]
   770   C0008633:Chromosome [Cell Component]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "while"

Phrase: "two others"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1955473:Others [Finding]

Phrase: "were"

Phrase: "excluded."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1554077:Excluded [Idea or Concept]
  1000   C2828389:Excluded [Activity]
   966 E C0332196:Exclude [Functional Concept]
Processing 00000000.tx.201: The other results were not informative. 

Phrase: "The"

Phrase: "other results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "were"

Phrase: "not informative."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986490:Informative [Qualitative Concept]
Processing 00000000.tx.202: Since the linkage analysis studies were performed before the presenile AD locus on chromosome 1 was identified, the families had not been analyzed for linkage with chromosome 1 markers. 

Phrase: "Since"

Phrase: "the linkage analysis studies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0796345:linkage analysis [Laboratory Procedure]

Phrase: "were"

Phrase: "performed before the presenile AD locus"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0884358:Performed [Functional Concept]
   748   C1708726:Locus [Gene or Genome]
   714 E C2947996:Perform [Pharmacologic Substance]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "was"

Phrase: "identified"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: ","

Phrase: "the families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "had"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "analyzed for linkage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0023745:linkage [Molecular Function]
   790   C0936012:Analyzed [Research Activity]

Phrase: "with chromosome 1 markers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0008631:Chromosome Markers [Cell or Molecular Dysfunction]
   793   C0005516:Marker [Clinical Attribute]
   734   C0008651:Chromosome 1 [Cell Component]
Processing 00000000.tx.203: Polymerase chain reaction (PCR) analyses About 200 ng DNA were amplified in a 25 l reaction mixture containing 20 pmol each primer, 0.2 mM dNTPs, 0.2 U Taq DNA polymerase (Gibco-BRL, Gaithersburg, MD), 1.0 mM MgCl2, 75 mM Tris-HCl, pH 9.0, 20 mM (NH4)2SO4 and 0.01% Tween-20. 

Phrase: "Polymerase chain reaction (PCR) analyses About 200 ng DNA"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   799   C0200931:Polymerase chain reaction analysis [Laboratory Procedure]
   767   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   750   C0200898:DNA analysis [Laboratory Procedure]
   744   C0337112:Chain [Manufactured Object]
   744   C0443286:Reaction [Functional Concept]
   744   C1114821:Reaction [Clinical Attribute]
   744   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C1524075:Chain [Idea or Concept]
   711   C0002778:Analysis [Laboratory Procedure]
   711   C0936012:Analysis [Research Activity]
   711   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "amplified in a 25 l reaction mixture"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0439962:Mixture [Substance]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "20 pmol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439192:pmol [Quantitative Concept]

Phrase: "each primer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "0.2 mM dNTPs,"

Phrase: "0.2 U Taq DNA polymerase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0075813:Taq DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
           Taq Polymerase
   861   C2257065:Taq DNA polymerase [Genetic Function]
   827   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   799   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Gibco-BRL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: "Gaithersburg,"

Phrase: "MD),"

Phrase: "1.0 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "75 mM Tris-HCl,"

Phrase: "pH 9.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "20 mM (NH4"

Phrase: ")"

Phrase: "2SO4"

Phrase: "and"

Phrase: "0.01% Tween-20."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0041415:Tween 20 [Organic Chemical,Pharmacologic Substance]
   833 E C0032600:Polysorbate 20 [Organic Chemical,Pharmacologic Substance]
   812   C0041420:tween [Organic Chemical,Pharmacologic Substance]
   756 E C0032602:Polysorbate [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.204: The PCR amplification consisted of 30 cycles of 90 s at 94C, 90 s at the empirically defined optimal annealing temperature and 90 s at 72C. 

Phrase: "The PCR amplification"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1524075:Chain [Idea or Concept]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "consisted of 30 cycles of 90 s"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439083:>90 [Quantitative Concept]
   748   C0439087:<90 [Quantitative Concept]
   714   C0332529:CONSIST [Qualitative Concept]
   714   C1511572:Cycle [Temporal Concept]

Phrase: "at 94C,"

Phrase: "90 s at the empirically"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "optimal annealing temperature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]

Phrase: "and"

Phrase: "90 s at 72C."
Processing 00000000.tx.205: In the PCR-SSCP analyses intronic PCR primers were used to amplify the exons and flanking intronic sequences of PS-1 and PS-2 (Table 1 ). 

Phrase: "In the PCR-SSCP analyses intronic PCR primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "amplify"

Phrase: "the exons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "flanking intronic sequences of PS-1"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0021920:Intronic [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0162326:Sequences [Nucleotide Sequence]
   748   C0230171:flanking [Body Location or Region]
   714 E C0004793:Sequence [Nucleotide Sequence]
   714 E C0162327:Sequence [Nucleotide Sequence]
   714 E C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.206: The PCR amplification products were heat denatured, cooled on ice and separated using two different electrophoresis systems. 

Phrase: "The PCR amplification products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "heat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "denatured"

Phrase: ","

Phrase: "cooled on ice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020746:Ice [Inorganic Chemical]
   756   C1548792:Cool [Qualitative Concept]

Phrase: "and"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two different electrophoresis systems."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   779   C0449913:System [Functional Concept]
   779   C1553451:System [Manufactured Object]
   779   C1704459:System [Medical Device]
   729 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.207: The coding exons of PS-1 were analyzed on a 1 HydroLink MDE gel (J.T.Baker, Phillipsburg) with and without 10% glycerol. 

Phrase: "The coding exons of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "analyzed on a 1 HydroLink MDE gel"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0063092:HydroLink [Organic Chemical]
   748   C0936012:Analyzed [Research Activity]
   748   C1382104:Gel [Substance]

Phrase: "(J.T.Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0238749:Baker [Professional or Occupational Group]

Phrase: "Phillipsburg"

Phrase: ")"

Phrase: "with"

Phrase: "and without 10% glycerol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C1515981:And [Idea or Concept]
Processing 00000000.tx.208: Electrophoresis was for 20 h at 800 V and at 4C (with glycerol) or room temperature (without glycerol). 

Phrase: "Electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "was for 20 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1421478:WAS [Gene or Genome]

Phrase: "at 800 V"

Phrase: "and at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1515981:And [Idea or Concept]

Phrase: "("

Phrase: "with glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "or"

Phrase: "room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "("

Phrase: "without glycerol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.209: The SSCP/heteroduplex patterns were visualized using silver staining. 

Phrase: "The SSCP/heteroduplex patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "silver staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.210: Alternatively, the non-coding exons of PS-1 and all exons of PS-2 were analyzed on a MultiPhorII electrophoresis system (Pharmacia Biotech, Uppsala, Sweden) using ExcellGel precast polyacrylamide gels and 1 HydroLink MDE gels containing 5% glycerol. 

Phrase: "Alternatively,"

Phrase: "the non-coding exons of PS-1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "and"

Phrase: "all exons of PS-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0015295:Exons [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "analyzed on a MultiPhorII electrophoresis system"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0013855:Electrophoresis [Laboratory Procedure]
   753   C0449913:System [Functional Concept]
   753   C0936012:Analyzed [Research Activity]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]

Phrase: "(Pharmacia Biotech,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Uppsala,"

Phrase: "Sweden"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0038995:Sweden [Geographic Area]

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "ExcellGel precast polyacrylamide gels"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   812   C0017243:Gels [Biomedical or Dental Material]
   812   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   779 E C1382104:Gel [Substance]

Phrase: "and"

Phrase: "1 HydroLink MDE gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "5% glycerol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.211: Electrophoresis was at 600 V for 2-5 h, depending on the product sizes, and SSCP patterns were visualized using silver staining. 

Phrase: "Electrophoresis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013855:Electrophoresis [Laboratory Procedure]

Phrase: "was at 600 V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "for 2-5 h,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C0011744:2 H [Element, Ion, or Isotope]
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]
   734   C0450346:2 5 [Quantitative Concept]

Phrase: "depending on the product sizes,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0456389:SIZES [Spatial Concept]
   760   C1514468:product [Entity]
   760   C1704444:Product [Quantitative Concept]
   726   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "silver staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.212: SSCP analyses of exons 5-8, and 11 of PS-1 were performed in the presence of positive control samples of the Ile143Thr, Met146Leu, His163Arg, Ala246Glu, Leu286Val, Gly384Ala and Cys410Tyr mutations (3 ,23 ). 

Phrase: "SSCP analyses of exons 5-8,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   773   C1519159:SSCP Analysis [Molecular Biology Research Technique]
   719   C0002778:Analysis [Laboratory Procedure]
   719   C0936012:Analysis [Research Activity]
   719   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "11 of PS-1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   806   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0017337:Gene [Gene or Genome]
   760   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "performed in the presence of positive control samples of the Ile143Thr,"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   756   C1883676:Positive Control [Conceptual Entity]
   738   C0243148:control [Qualitative Concept]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0439178:% Positive [Quantitative Concept]
   738   C0884358:Performed [Functional Concept]
   738   C1446409:Positive [Qualitative Concept]
   738   C1514241:Positive [Finding]
   738   C1550141:Control [Substance]
   738   C1882979:Control [Conceptual Entity]
   738   C2587213:Control [Functional Concept]
   738   C2825490:Positive [Qualitative Concept]
   738   C3274648:Control [Qualitative Concept]
   704   C0370003:Sample [Substance]
   704   C2347026:Sample [Conceptual Entity]
   704 E C2947996:Perform [Pharmacologic Substance]

Phrase: "Met146Leu,"

Phrase: "His163Arg,"

Phrase: "Ala246Glu,"

Phrase: "Leu286Val,"

Phrase: "Gly384Ala"

Phrase: "and"

Phrase: "Cys410Tyr mutations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "(3 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.213: When aberrant SSCP patterns were observed the sequences of the fragments were determined using cycle sequencing. 

Phrase: "When"

Phrase: "aberrant SSCP patterns"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449774:Patterns [Spatial Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "the sequences of the fragments"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0162326:Sequences [Nucleotide Sequence]
   726 E C0004793:Sequence [Nucleotide Sequence]
   726 E C0162327:Sequence [Nucleotide Sequence]
   726 E C1519249:Sequence [Functional Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cycle sequencing."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]
Processing 00000000.tx.214: The PCR amplification products were pretreated with 10 U exonuclease I and 2 U shrimp alkaline phosphatase to remove excess PCR primers and nucleotides. 

Phrase: "The PCR amplification products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C1514468:Products [Entity]
   771 E C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "were"

Phrase: "pretreated with 10 U exonuclease I"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0059944:exonuclease I [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0015296:Exonuclease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0021966:I- [Inorganic Chemical]
   753   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "2 U shrimp alkaline phosphatase to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002059:Alkaline Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1318717:Alkaline phosphatase [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   799   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C1149880:phosphatase [Molecular Function]
   799   C1979842:Alkaline [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "excess PCR primers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "and"

Phrase: "nucleotides."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.215: PCR amplification product (5 l) was used as template in the cycle sequencing reaction using the ABI PRISM Dye Terminator Cycle Sequencing Core Kit (Applied Biosystems, Foster City, CA) according to the supplier's protocol, using the same primers as in the PCR amplification. 

Phrase: "PCR amplification product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1514468:product [Entity]
   804   C1704444:Product [Quantitative Concept]
   717   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]

Phrase: "(5 l)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348935:.5 L [Quantitative Concept]

Phrase: "was"

Phrase: "used as template"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   790   C0728990:TEMPLATE [Medical Device]
   790   C1273517:used [Finding]
   790   C1514575:Template [Conceptual Entity]
   790   C1705542:Template [Idea or Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in the cycle sequencing reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the ABI PRISM Dye Terminator Cycle Sequencing Core Kit (Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA) according to the supplier's protocol,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0050385:CA protocol [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "as in the PCR amplification."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1524075:Chain [Idea or Concept]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.216: The sequences were analyzed on an ABI 373A automated DNA sequencer. 

Phrase: "The sequences"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0162326:Sequences [Nucleotide Sequence]
   966 E C0004793:Sequence [Nucleotide Sequence]
   966 E C0162327:Sequence [Nucleotide Sequence]
   966 E C1519249:Sequence [Functional Concept]
   916 E C1548958:Sequential [Idea or Concept]
   916 E C1705294:Sequential [Qualitative Concept]

Phrase: "were"

Phrase: "analyzed on an ABI 373A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0936012:Analyzed [Research Activity]
   760   C1328319:ABI [Clinical Attribute]

Phrase: "automated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205554:Automated [Functional Concept]
   966 E C1072074:Automate [Eukaryote]

Phrase: "DNA sequencer."
Processing 00000000.tx.217: Sequence variations in PS-1 and PS-2 were analyzed by restriction enzyme digestion of amplified products when they involved the creation or abolition of a restriction enzyme recognition site. 

Phrase: "Sequence variations in PS-1"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0042333:Sequence Variation [Natural Phenomenon or Process]
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C0205419:variations [Qualitative Concept]
   753   C1519249:Sequence [Functional Concept]

Phrase: "and"

Phrase: "PS-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0017337:Gene [Gene or Genome]
   734   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1418986:PRESENILIN 2 [Gene or Genome]

Phrase: "were"

Phrase: "analyzed by restriction enzyme digestion of amplified products"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0012906:Restriction Enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0012238:Digestion [Organism Function]
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0443288:Restriction [Functional Concept]
   744   C0936012:Analyzed [Research Activity]
   744   C1514468:Products [Entity]
   744   C2349986:Digestion [Research Activity]
   711 E C1704444:Product [Quantitative Concept]

Phrase: "when"

Phrase: "they"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: "the creation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0441513:Creation [Therapeutic or Preventive Procedure]
  1000   C1706214:Creation [Activity]

Phrase: "or"

Phrase: "abolition of a restriction enzyme recognition site."
Processing 00000000.tx.218: Also, the intron 8 polymorphism in PS-1 was analyzed by BamHI digestion as described (25 ). 

Phrase: "Also,"

Phrase: "the intron 8 polymorphism in PS-1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0678951:gene polymorphism [Genetic Function]
   744   C0032529:Polymorphism [Genetic Function]
   744   C1882417:Polymorphism [Qualitative Concept]

Phrase: "was"

Phrase: "analyzed by BamHI digestion"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0012238:Digestion [Organism Function]
   770   C0936012:Analyzed [Research Activity]
   770   C2349986:Digestion [Research Activity]
   715 E C0443277:Peptic [Functional Concept]

Phrase: "as described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(25"

Phrase: ")."
Processing 00000000.tx.219: Genomic PCR amplification products were digested for 3 h using 5 U of the corresponding restriction enzyme (Tables 2 and 3 ) at the appropriate reaction temperature. 

Phrase: "Genomic PCR amplification products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C1514468:Products [Entity]
   766 E C1704444:Product [Quantitative Concept]

Phrase: "were"

Phrase: "digested for 3 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   819   C0041119:h 3 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0868946:digested [Physiologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "5 U of the corresponding restriction enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   774   C1880519:{Enzyme}U [Quantitative Concept]

Phrase: "(Tables 2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0039224:tables [Manufactured Object]
   861   C1706074:Tables [Intellectual Product]
   827 E C1706073:Table [Medical Device]

Phrase: "and"

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "at the appropriate reaction temperature."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0005903:temperature [Organism Attribute]
   827   C0039476:*Temperature [Quantitative Concept]
Processing 00000000.tx.220: The restriction fragments were separated on a 1.5-3% agarose gel, depending on the allele sizes, and visualized on an UV transilluminator after EtBr staining. 

Phrase: "The restriction fragments"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0332255:fragments [Functional Concept]
   861   C0443288:Restriction [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "separated on a 1.5-3% agarose gel,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C1706746:Agarose Gel [Research Device]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C0036681:Agarose [Carbohydrate]
   744   C0086972:Separated [Finding]
   744   C0443299:separated [Spatial Concept]
   744   C0687118:Separated [Functional Concept]
   744   C1382104:Gel [Substance]

Phrase: "depending on the allele sizes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0002085:Allele [Gene or Genome]
   760   C0456389:SIZES [Spatial Concept]
   726   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "visualized on an UV transilluminator"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0184035:Transilluminator [Medical Device]
   760   C0234621:Visualized [Functional Concept]
   760   C1961129:uV [Quantitative Concept]

Phrase: "after EtBr staining."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.221: The APOE genotype was scored by PCR amplification of genomic DNA using published primers (35 ) in a standard PCR of 35 cycles. 

Phrase: "The APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "was"

Phrase: "scored by PCR amplification of genomic DNA"
Meta Candidates (Total=16; Excluded=0; Pruned=0; Remaining=16)
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   764   C3272453:Genomic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   762   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0683230:DNA amplification [Genetic Function]
   742   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   742   C0017428:Genomic [Gene or Genome]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C0449820:scored [Quantitative Concept]
   742   C0887950:genomic [Biomedical Occupation or Discipline]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1524075:Chain [Idea or Concept]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "published primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(35"

Phrase: ")"

Phrase: "in a standard PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   812   C0337112:Chain [Manufactured Object]
   812   C0443286:Reaction [Functional Concept]
   812   C1114821:Reaction [Clinical Attribute]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C1524075:Chain [Idea or Concept]

Phrase: "of 35 cycles."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1511572:Cycle [Temporal Concept]
Processing 00000000.tx.222: After digestion with 5 U HhaI for 3 h at 37C the alleles were separated on ExcellGel precast polyacrylamide gels as described above and visualized using silver staining. 

Phrase: "After digestion"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0012238:Digestion [Organism Function]
  1000   C2349986:Digestion [Research Activity]
   944 E C0443277:Peptic [Functional Concept]

Phrase: "with 5 U HhaI"

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37C"

Phrase: "the alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "separated on ExcellGel precast polyacrylamide gels"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0071500:polyacrylamide gels [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gels [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   719 E C1382104:Gel [Substance]

Phrase: "as"

Phrase: "described above"

Phrase: "and"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "silver staining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1293950:Silver Staining [Laboratory Procedure]
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]
Processing 00000000.tx.223: The STRs D14S1028, D14S77 and D14S1008 were amplified in a standard PCR using published primer sets, one of which was fluorescently labeled. 

Phrase: "The STRs D14S1028,"

Phrase: "D14S77"

Phrase: "and"

Phrase: "D14S1008"

Phrase: "were"

Phrase: "amplified in a standard PCR"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0337112:Chain [Manufactured Object]
   748   C0443286:Reaction [Functional Concept]
   748   C1114821:Reaction [Clinical Attribute]
   748   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C1442989:Standard [Qualitative Concept]
   748   C1524075:Chain [Idea or Concept]
   748   C2828392:Standard [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "published primer sets,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0036849:Set [Mental Process]
   827   C1442518:Set [Functional Concept]
   827   C1705195:Set [Conceptual Entity]

Phrase: "one of which"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "fluorescently"

Phrase: "labeled."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.224: The alleles were separated on a 6% polyacrylamide gel containing 8 M urea and analyzed on an ABI 373A automated DNA sequencer using GENESCAN 672 software (Applied Biosystems). 

Phrase: "The alleles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0002085:Alleles [Gene or Genome]

Phrase: "were"

Phrase: "separated on a 6% polyacrylamide gel"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0071500:Polyacrylamide Gel [Biomedical or Dental Material,Pharmacologic Substance]
   753   C0017243:Gel [Biomedical or Dental Material]
   753   C0071499:polyacrylamide [Biomedical or Dental Material,Organic Chemical]
   753   C0086972:Separated [Finding]
   753   C0443299:separated [Spatial Concept]
   753   C0687118:Separated [Functional Concept]
   753   C1382104:Gel [Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "8 M urea"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "analyzed on an ABI 373A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0936012:Analyzed [Research Activity]
   760   C1328319:ABI [Clinical Attribute]

Phrase: "automated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205554:Automated [Functional Concept]
   966 E C1072074:Automate [Eukaryote]

Phrase: "DNA sequencer"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "GENESCAN 672 software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Applied Biosystems"

Phrase: ")."
Processing 00000000.tx.225: cDNA sequence analysis Approximately 107 lymphoblast cells were homogenized in the presence of 1 ml TRIzol (Gibco-BRL). 

Phrase: "cDNA sequence analysis Approximately 107 lymphoblast cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   795   C0007634:Cells [Cell]
   795   C3282337:Cells [Cell]
   762 E C1269647:Cell [Cell]
   762 E C1704653:Cell [Medical Device]
   762 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "homogenized in the presence of 1 ml TRIzol"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0439526:/mL [Quantitative Concept]
   744   C0916178:trizol [Organic Chemical]

Phrase: "(Gibco-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1412820:BRL [Gene or Genome]

Phrase: ")."
Processing 00000000.tx.226: RNA was isolated by chloroform extraction and precipitated with isopropanol. 

Phrase: "RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "isolated by chloroform extraction"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0008238:Chloroform [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0185115:Extraction [Therapeutic or Preventive Procedure]
   770   C0205409:Isolated [Functional Concept]
   770   C0684295:extraction [Laboratory Procedure]
   770   C1548221:Isolated [Idea or Concept]
   737 E C0370215:Isolate [Substance]
   737 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "and"

Phrase: "precipitated with isopropanol."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022237:Isopropanol [Organic Chemical,Pharmacologic Substance]
   756   C1882443:PRECIPITATE [Phenomenon or Process]
Processing 00000000.tx.227: After centrifugation for 10 min in a microfuge, the pellet was washed with 75% EtOH and dissolved in 20 l DEPC-treated H2O. 

Phrase: "After centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "in a microfuge,"

Phrase: "the pellet"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441436:Pellet [Manufactured Object]
  1000   C0993610:Pellet [Biomedical or Dental Material]
  1000   C1998480:Pellet [Quantitative Concept]

Phrase: "was"

Phrase: "washed with 75% EtOH"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0001962:ETOH [Organic Chemical]
   770   C1548982:Washed [Idea or Concept]
   737 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "dissolved in 20 l DEPC-treated H2O."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0332293:treated [Therapeutic or Preventive Procedure]
   748   C1522326:Treated [Functional Concept]
   714 E C1292734:TREAT [Functional Concept]
   714   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.228: First strand cDNA synthesis was performed with random primers using the SuperScript pre-amplification kit (Gibco-BRL) as described in the protocol supplied with the kit. 

Phrase: "First"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cDNA synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "performed with random primers"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0034656:RANDOM [Research Activity]
   770   C0439605:Random [Qualitative Concept]
   770   C0884358:Performed [Functional Concept]
   737   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the SuperScript pre-amplification kit (Gibco-BRL"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C1412820:BRL [Gene or Genome]

Phrase: ")"

Phrase: "as"

Phrase: "described in the protocol"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0442711:Protocol [Intellectual Product]
   770   C1507394:Protocol [Intellectual Product]
   770   C1522729:Protocol [Intellectual Product]
   770   C1552738:described [Idea or Concept]
   770   C2348563:Protocol [Intellectual Product]

Phrase: "supplied with the kit."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0812225:KIT [Medical Device]
   770   C1150635:KIT [Molecular Function]
   770   C1705212:Kit [Medical Device]
   770   C1705213:KIT [Medical Device]
   770   C1999230:Supplied [Activity]
   770   C3273202:Kit [Manufactured Object]
   737 E C0243163:supply [Idea or Concept]
   737 E C0699914:supply [Quantitative Concept]
   737 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   737 E C1561604:supply [Functional Concept]
   737 E C1875802:SUPPLY [Medical Device]
Processing 00000000.tx.229: The RNA was removed by adding 2 U RNase H and incubating for 20 min at 37C. 

Phrase: "The RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "removed by adding 2 U RNase H"
Meta Candidates (Total=17; Excluded=2; Pruned=0; Remaining=15)
   778   C0085431:RNAase H [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0011744:h 2 [Element, Ion, or Isotope]
   774   C0073250:RNase U [Amino Acid, Peptide, or Protein,Enzyme]
   774   C0456685:U/h [Quantitative Concept]
   774   C0525614:RNase 2 [Amino Acid, Peptide, or Protein,Enzyme]
   762   C0947272:Add 2 [Quantitative Concept]
   748   C0014241:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0033727:H+ [Element, Ion, or Isotope]
   748   C0035541:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0035542:RNase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441932:H+ [Classification]
   748   C0564385:/h [Quantitative Concept]
   748   C0849355:Removed [Qualitative Concept]
   714   C1883712:Add [Functional Concept]
   714 E C1883720:Remove [Activity]
   714 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "incubating for 20 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:incubating [Laboratory Procedure]

Phrase: "at 37C."
Processing 00000000.tx.230: A standard PCR amplification of 30 cycles was performed using 100 ng first strand cDNA as template. 

Phrase: "A standard PCR amplification of 30 cycles"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   742   C0337112:Chain [Manufactured Object]
   742   C0443286:Reaction [Functional Concept]
   742   C1114821:Reaction [Clinical Attribute]
   742   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C1517480:Amplification [Molecular Biology Research Technique]
   742   C1521871:Amplification [Phenomenon or Process]
   742   C1524075:Chain [Idea or Concept]
   742   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "100 ng"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "strand"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704972:Strand [Spatial Concept]
  1000   C1704973:Strand [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "cDNA as template."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.231: Then PS-1 cDNA was PCR amplified using primer pairs 917/892, 901/111R and 1017/852 (3 ). 

Phrase: "Then PS-1 cDNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   717   C1418985:Presenilin 1 Gene [Gene or Genome]

Phrase: "was"

Phrase: "PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "917/892,"

Phrase: "901/111R"

Phrase: "and"

Phrase: "1017/852"

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.232: The sequence of the amplification products was determined by cycle sequencing as described above. 

Phrase: "The sequence of the amplification products"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0004793:Sequence [Nucleotide Sequence]
   753   C0162326:Sequence [Nucleotide Sequence]
   753   C0162327:Sequence [Nucleotide Sequence]
   753   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "determined by cycle sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511572:Cycle [Temporal Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]

Phrase: "as described above."
Processing 00000000.tx.233: Sequencing primers were as published (3 ,23 ). 

Phrase: "Sequencing primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "were"

Phrase: "as"

Phrase: "published"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034037:Published [Occupational Activity]
  1000   C1704324:Published [Intellectual Product]

Phrase: "(3 ,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.234: PS-2 cDNA was PCR amplified using primer pairs STM2-6/7 (5'-AACCAGCGCTGCCCTCTTTGAA-3' and 5'-AGGATGACCCACGCGGACCACTC-3') and STM2-8/9 (5'-CTACCCCACCCTCTTGCTGACTGT-3' and 5'-CTCCCCGCCCTAATCTGACCTTCT-3'). 

Phrase: "PS-2 cDNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "PCR"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
   827   C0337112:Chain [Manufactured Object]
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]
   827   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1524075:Chain [Idea or Concept]

Phrase: "amplified"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "primer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "pairs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709450:Pair [Qualitative Concept]

Phrase: "STM2-6/7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418986:STM2 [Gene or Genome]
   827   C2986919:STM2 [Gene or Genome]

Phrase: "(5'-AACCAGCGCTGCCCTCTTTGAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-AGGATGACCCACGCGGACCACTC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "STM2-8/9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1418986:STM2 [Gene or Genome]
   827   C2986919:STM2 [Gene or Genome]

Phrase: "(5'-CTACCCCACCCTCTTGCTGACTGT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: "and"

Phrase: "5'-CTCCCCGCCCTAATCTGACCTTCT-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.235: Cycle sequencing was performed using the same primers, primer 1021 (5 ) (5'-CAGAGGATGGAGAGAACAC-3'), STM2-6 (5'-AACCAGCGCTGCCCTCTTTGAA-3'), STM2-1 (5'-ATCGTGGTGGTAGCC-3'), STM2-2 (5'-GTTATGACCATCTTCTTGG-3'), STM2-4 (5'-TGTGCTGTGTCCCAAAGG-3') and PS2-1742AS (5'-TCCAATGAAAATTCCCTGC-3'). 

Phrase: "Cycle sequencing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1553778:Sequencing [Intellectual Product]
   861   C1561491:Sequencing [Functional Concept]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the same primers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "primer 1021"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "(5'-CAGAGGATGGAGAGAACAC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "STM2-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418986:STM2 [Gene or Genome]
   861   C2986919:STM2 [Gene or Genome]

Phrase: "(5'-AACCAGCGCTGCCCTCTTTGAA-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "STM2-1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418986:STM2 [Gene or Genome]
   861   C2986919:STM2 [Gene or Genome]

Phrase: "(5'-ATCGTGGTGGTAGCC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "STM2-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418986:STM2 [Gene or Genome]
   861   C2986919:STM2 [Gene or Genome]

Phrase: "(5'-GTTATGACCATCTTCTTGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "STM2-4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1418986:STM2 [Gene or Genome]
   861   C2986919:STM2 [Gene or Genome]

Phrase: "(5'-TGTGCTGTGTCCCAAAGG-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "PS2-1742AS"

Phrase: "(5'-TCCAATGAAAATTCCCTGC-3'"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439084:>5 [Quantitative Concept]
   827   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.236: The sequence of the PS-2 cDNA was determined by cycle sequencing as described above. 

Phrase: "The sequence of the PS-2 cDNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0004793:Sequence [Nucleotide Sequence]
   744   C0162326:Sequence [Nucleotide Sequence]
   744   C0162327:Sequence [Nucleotide Sequence]
   744   C1519249:Sequence [Functional Concept]

Phrase: "was"

Phrase: "determined by cycle sequencing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511572:Cycle [Temporal Concept]
   770   C1553778:Sequencing [Intellectual Product]
   770   C1561491:Sequencing [Functional Concept]

Phrase: "as described above."
Processing 00000000.tx.237: ACKNOWLEDGEMENTS The work described in this study was financed in part by the Fund for Scientific Research-Flanders (Belgium) (FWO), the Flemish Biotechnology Programme, the DWTC Interuniversity Attractionpoles, European BIOTECH grant CT96-0743, the American Health Assistance Foundation and grants of the Netherlands Organization of Scientific Research (NWO). 

Phrase: "ACKNOWLEDGEMENTS"

Phrase: "The work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "described in this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0557651:Study [Manufactured Object]
   770   C1552738:described [Idea or Concept]
   770   C2603343:Study [Research Activity]

Phrase: "was"

Phrase: "financed in part"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]
   756   C0149692:Finance [Occupational Activity]

Phrase: "by the Fund"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016820:Fund [Quantitative Concept]

Phrase: "for Scientific Research-Flanders"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1875156:Flanders [Inorganic Chemical,Pharmacologic Substance]
   734   C0683933:scientific research [Research Activity]

Phrase: "(Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "(FWO"

Phrase: ")"

Phrase: ","

Phrase: "the Flemish Biotechnology Programme,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1709697:Program [Conceptual Entity]
   827   C2728259:Program [Pharmacologic Substance]
   827   C3484370:Program [Functional Concept]

Phrase: "the DWTC Interuniversity Attractionpoles,"

Phrase: "European BIOTECH grant CT96-0743,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   804   C0018173:Grant [Quantitative Concept]
   804   C0239307:European [Population Group]
   804   C1336688:CT96 [Gene or Genome]
   804   C1535514:European [Population Group]
   804   C1548284:Grant [Idea or Concept]

Phrase: "the American Health Assistance Foundation"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   812   C0016617:Foundation [Organization]
   729 E C0002055:base [Inorganic Chemical]
   729 E C0178499:Base [Chemical Viewed Functionally]
   729 E C1626935:Bases [Quantitative Concept]
   729 E C1880279:Base [Biomedical or Dental Material]
   706 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "grants of the Netherlands Organization of Scientific Research"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   767   C0260206:Research Grants [Research Activity]
   744   C0018173:Grants [Quantitative Concept]
   711 E C1548284:Grant [Idea or Concept]

Phrase: "(NWO"

Phrase: ")."
Processing 00000000.tx.238: We thank Drs Wim Schulte, Teun Tanja, Rob Haaxma, Arie Lameris and Rolf Saan for assisting with the case diagnoses and Helen de Bruijn, Micheline de Haes, Jeanette Kammen, Hilda Kornman, Hanneke van Meurs and Caroline Valkenburg for genealogy studies. 

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Drs Wim Schulte,"

Phrase: "Teun Tanja,"

Phrase: "Rob Haaxma,"

Phrase: "Arie Lameris"

Phrase: "and"

Phrase: "Rolf Saan for assisting"

Phrase: "with the case diagnoses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0011900:Diagnoses [Finding]
   827 E C1704338:diagnosis [Qualitative Concept]
   827 E C1704656:DIAGNOSIS [Research Activity]

Phrase: "and"

Phrase: "Helen de Bruijn,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0011198:DE [Geographic Area]
   827   C0017480:DE [Geographic Area]
   827   C3541240:DE [Idea or Concept]

Phrase: "Micheline de Haes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0019243:HAE [Disease or Syndrome]

Phrase: "Jeanette Kammen,"

Phrase: "Hilda Kornman,"

Phrase: "Hanneke van Meurs"

Phrase: "and"

Phrase: "Caroline Valkenburg for genealogy studies."
Processing 00000000.tx.239: Marc Cruts is a post-doctoral fellow of the FWO. 

Phrase: "Marc Cruts"

Phrase: "is"

Phrase: "a post-doctoral fellow of the FWO."
Processing 00000000.tx.240: REFERENCES 1 Van Broeckhoven,C. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "1 Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.241: (1995) Molecular genetics of Alzheimer disease: identification of genes and gene mutations. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Molecular genetics of Alzheimer disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0086345:Genetics, Molecular [Biomedical Occupation or Discipline]
   797   C0019247:Molecular Disease [Disease or Syndrome]
           genetics disease
   760   C0017398:Genetics [Biomedical Occupation or Discipline]
   760   C0017399:genetics [Biologic Function]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: ":"

Phrase: "identification of genes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "gene mutations."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0596611:gene mutations [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.242: Eur. 

Phrase: "Eur."
Processing 00000000.tx.243: Neurol., 35, 8-19. 

Phrase: "Neurol.,"

Phrase: "35,"

Phrase: "8-19."
Processing 00000000.tx.244: MEDLINE Abstract 2 Goate,A., Chartier-Harlin,M., Mullan,M., Brown,J., Crawford,F., Fidani,L., Giuffra,L., Haynes,A., Irving,N., James,L., Mant,R., Newton,P., Rooke,K., Roques,P., Talbot,C., Pericak-Vance,M., Roses,A., Williamson,R., Rossor,M., Owen,M. and Hardy,J. 

Phrase: "MEDLINE Abstract 2 Goate,"

Phrase: "A.,"

Phrase: "Chartier-Harlin,"

Phrase: "M."

Phrase: ","

Phrase: "Mullan,"

Phrase: "M."

Phrase: ","

Phrase: "Brown,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678579:Brown [Natural Phenomenon or Process]

Phrase: "J.,"

Phrase: "Crawford,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Fidani,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Giuffra,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Haynes,"

Phrase: "A.,"

Phrase: "Irving,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "James,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mant,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Newton,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0542569:newton [Quantitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Rooke,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pericak-Vance,"

Phrase: "M."

Phrase: ","

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Williamson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Owen,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.245: (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Segregation of a missense mutation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0080141:segregation [Social Behavior]

Phrase: "in the amyloid precursor protein gene"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0017337:Gene [Gene or Genome]
   756   C0085151:amyloid precursor protein [Amino Acid, Peptide, or Protein]
   756   C3538722:Amyloid Precursor Protein [Laboratory Procedure]
   708   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "with familial Alzheimer's disease."
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.246: Nature, 349, 704-706. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "349,"

Phrase: "704-706."
Processing 00000000.tx.247: MEDLINE Abstract 3 Sherrington,R., Rogaev,E.I., Liang,Y., Rogaeva,E.A., Levasque,G., Ikeda,M., Chi,H., Lin,C., Li,G., Holman,K., Tsuda,T., Mar,L., Foncin,J.F., Bruni,A.C., Montesi,M.P., Sorbi,S., Rainero,I., Pinessi,L., Nee,L., Chumakov,I., Pollen,D., Brookes,A., Sansosu,P., Polinsky,R.J., Wasco,W., Da Silva,H.A.R., Haines,J.L., Pericak-Vance,M.A., Tanzi,R.E., Roses,A.D., Fraser,P.E., Rommens,J.M. and St George-Hyslop,P. 

Phrase: "MEDLINE Abstract 3 Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Levasque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Chi,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lin,C., Li,G.,"

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Foncin,"

Phrase: "J.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Bruni,"

Phrase: "A.C.,"

Phrase: "Montesi,"

Phrase: "M."

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Rainero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pinessi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nee,L., Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Pollen,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0032385:Pollen [Plant]
  1000   C0795585:POLLEN [Organic Chemical,Pharmacologic Substance]
  1000   C1320238:Pollen [Immunologic Factor]

Phrase: "D."

Phrase: ","

Phrase: "Brookes,"

Phrase: "A.,"

Phrase: "Sansosu,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Polinsky,"

Phrase: "R.J.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Da Silva,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   789   C0144237:Silvan [Organic Chemical]
   768 E C0043217:Wood [Substance]
   768 E C0442548:Woods [Geographic Area]

Phrase: "H.A.R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "Haines,"

Phrase: "J.L., Pericak-Vance,"

Phrase: "M.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Tanzi,"

Phrase: "R.E.,"

Phrase: "Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0035853:Roses [Plant]
   966 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Fraser,"

Phrase: "P.E.,"

Phrase: "Rommens,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.248: (1995) Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Cloning of a gene bearing mis-sense mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0598888:Gene Cloning [Laboratory Procedure,Molecular Biology Research Technique]
   744   C0009015:Cloning [Research Activity]

Phrase: "in early-onset familial Alzheimer's disease."
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   924   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   897   C0679245:early disease [Temporal Concept]
   884   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   853   C0277558:Familial disease [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   817 E C0344339:family disease [Finding]
   804   C0012634:Disease [Disease or Syndrome]
   804   C0015576:familial [Family Group]
   804   C0241888:Familial [Functional Concept]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
   733 E C1704727:Family [Conceptual Entity]
Processing 00000000.tx.249: Nature, 375, 754-760. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "375,"

Phrase: "754-760."
Processing 00000000.tx.250: MEDLINE Abstract 4 Levy-Lahad,E., Wasco,W., Poorkaj,P., Romano,D.M., Oshima,J., Pettingell,W.H., Yu,C., Jondro,P.D., Schmidt,S.D., Wang,K., Crowley,A.C., Fu,Y., Guenette,S.Y., Galas,D., Nemens,E., Wijsman,E.M., Bird,T.D., Schellenberg,G.D. and Tanzi,R.E. 

Phrase: "MEDLINE Abstract 4 Levy-Lahad,"

Phrase: "E.,"

Phrase: "Wasco,"

Phrase: "W.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Romano,"

Phrase: "D."

Phrase: "M."

Phrase: ","

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Pettingell,"

Phrase: "W.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Yu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1006780:yu [Plant]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Jondro,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Schmidt,"

Phrase: "S.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crowley,"

Phrase: "A.C.,"

Phrase: "Fu,Y.,"

Phrase: "Guenette,"

Phrase: "S."

Phrase: "Y.,"

Phrase: "Galas,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0082651:gala [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966   C1439334:GALA [Gene or Genome]

Phrase: "D."

Phrase: ","

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "Wijsman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]

Phrase: "and"

Phrase: "Tanzi,"

Phrase: "R.E."
Processing 00000000.tx.251: (1995) Candidate gene for the chromosome 1 familial Alzheimer's disease locus. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Candidate gene for the chromosome 1 familial Alzheimer's disease locus."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   775   C1332838:Candidate Disease Gene [Gene or Genome]
           Candidate Gene
   757   C1708726:Gene Locus [Gene or Genome]
   739   C0017337:Gene [Gene or Genome]
   730   C1416989:MAL gene [Gene or Genome]
   722   C1517488:Gene Family [Gene or Genome]
Processing 00000000.tx.252: Science, 269, 973-977. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "269,"

Phrase: "973-977."
Processing 00000000.tx.253: MEDLINE Abstract 5 Rogaev,E.I., Sherrington,R., Rogeava,E.A., Levesque,G., Ikeda,M., Liang,Y., Chi,H., Lin,C., Holman,K., Tsuda,T., Mar,L., Sorbi,S., Nacmias,B., Piancentini,S., Amaducci,L., Chumakov,I., Cohen,D., Lannfelt,L., Fraser,P.E., Rommens,J.M. and St George-Hyslop,P.H. 

Phrase: "MEDLINE Abstract 5 Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Rogeava,"

Phrase: "E.A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Chi,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lin,C., Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Piancentini,"

Phrase: "S."

Phrase: ","

Phrase: "Amaducci,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Chumakov,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Cohen,"

Phrase: "D."

Phrase: ","

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fraser,"

Phrase: "P.E.,"

Phrase: "Rommens,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.254: (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Familial Alzheimer's disease in kindreds"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   862   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   797   C0277558:Familial disease [Disease or Syndrome]
   762 E C0344339:disease family [Finding]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0015576:familial [Family Group]
   760   C0241888:Familial [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "with missense mutations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0599155:Mutations, Missense [Genetic Function]
   861   C0026882:Mutations [Genetic Function]
   827 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in a gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "on chromosome 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008651:Chromosome 1 [Cell Component]
   861   C0008633:Chromosome [Cell Component]

Phrase: "related to the Alzheimer's disease type 3 gene."
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C1843013:Alzheimer disease type 3 [Disease or Syndrome]
           Alzheimer disease 3
   819   C2986918:Alzheimer Disease 3 Gene [Gene or Genome]
   770   C0002395:Alzheimer's Disease [Disease or Syndrome]
   770   C0441731:Type 3 [Classification]
   770   C0457464:disease type [Intellectual Product]
   770   C1521724:Alzheimer's Disease [Pathologic Function]
   767   C0314611:Gene type [Genetic Function]
   744   C0012634:Disease [Disease or Syndrome]
   744   C0017337:Gene [Gene or Genome]
   744   C0332307:Type [Qualitative Concept]
   744   C0439849:Related [Qualitative Concept]
   744   C0445223:Related [Finding]
   744   C1547052:*Type [Quantitative Concept]
   739   C0067430:MAL-3 [Organic Chemical]
   739   C1416989:MAL gene [Gene or Genome]
   739   C1425077:MALS-3 [Gene or Genome]
   711 E C0163712:Relate [Organic Chemical]
Processing 00000000.tx.255: Nature, 376, 775-778. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "376,"

Phrase: "775-778."
Processing 00000000.tx.256: MEDLINE Abstract 6 Hardy,J. 

Phrase: "MEDLINE Abstract 6 Hardy,"

Phrase: "J."
Processing 00000000.tx.257: (1997) Amyloid, the presenilins and Alzheimer disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "the presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.258: Trends Neurosci., 20, 154-159. 

Phrase: "Trends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0040833:trends [Temporal Concept]
  1000   C1521798:Trends [Temporal Concept]

Phrase: "Neurosci.,"

Phrase: "20,"

Phrase: "154-159."
Processing 00000000.tx.259: MEDLINE Abstract 7 Cruts,M., Hendriks,L. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 7 Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Hendriks,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.260: (1996) The presenilin genes: a new gene family involved in Alzheimer disease pathology. 

Phrase: "(1996"

Phrase: ")"

Phrase: "The presenilin genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: ":"

Phrase: "a new gene family"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C1517488:Gene Family [Gene or Genome]
   827   C0015576:Family [Family Group]
   827   C1704727:Family [Conceptual Entity]
   755 E C0241888:Familial [Functional Concept]

Phrase: "involved in Alzheimer disease pathology."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0030664:Pathology [Biomedical Occupation or Discipline]
   760   C0205469:pathology [Functional Concept]
   760   C0677042:pathology [Pathologic Function]
   760   C1314939:Involved [Functional Concept]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.261: Hum. 

Phrase: "Hum."
Processing 00000000.tx.262: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.263: Genet., 5, 1449-1455. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "1449-1455."
Processing 00000000.tx.264: MEDLINE Abstract 8 Doan,A., Thinakaran,G., Borchelt,D.R., Slunt,H.H., Ratovitsky,T., Podlisny,M., Selkoe,D.J., Seeger,M., Gandy,S.E., Price,D.L. and Sisodia,S.S. 

Phrase: "MEDLINE Abstract 8 Doan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0591397:Doan's [Organic Chemical,Pharmacologic Substance]

Phrase: "A.,"

Phrase: "Thinakaran,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Borchelt,"

Phrase: "D.R.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Slunt,"

Phrase: "H.H.,"

Phrase: "Ratovitsky,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Podlisny,"

Phrase: "M."

Phrase: ","

Phrase: "Selkoe,"

Phrase: "D.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Seeger,"

Phrase: "M."

Phrase: ","

Phrase: "Gandy,S.E.,"

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Sisodia,"

Phrase: "S.S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.265: (1996) Protein topology of presenilin 1. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Protein topology of presenilin 1."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0002812:Topology [Biomedical Occupation or Discipline]
Processing 00000000.tx.266: Neuron, 17, 1023-1030. 

Phrase: "Neuron,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "17,"

Phrase: "1023-1030."
Processing 00000000.tx.267: MEDLINE Abstract 9 Lehman,S., Chiesa,R. and Harris,D.A. 

Phrase: "MEDLINE Abstract 9 Lehman,"

Phrase: "S."

Phrase: ","

Phrase: "Chiesa,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Harris,"

Phrase: "D.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0718133:d a [Organic Chemical,Pharmacologic Substance,Vitamin]
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.268: (1997) Evidence for a six-transmembrane domain structure of presenilin 1. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Evidence for a six-transmembrane domain structure of presenilin 1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
Processing 00000000.tx.269: J. 

Phrase: "J."
Processing 00000000.tx.270: Biol. 

Phrase: "Biol."
Processing 00000000.tx.271: Chem., 272, 12047-12051. 

Phrase: "Chem.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]

Phrase: "272,"

Phrase: "12047-12051."
Processing 00000000.tx.272: 10 Schellenberg,G.D., Bird,T.D., Wijsman,E.M., Orr,H.T., Anderson,L., Nemens,E., White,J.A., Bonnycastle,L., Weber,J.L., Alonso,M.E., Potter,H., Heston,L.L. and Martin,G.M. 

Phrase: "10 Schellenberg,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "D."

Phrase: ","

Phrase: "Bird,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0005595:Bird [Bird]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "D."

Phrase: ","

Phrase: "Wijsman,"

Phrase: "E.M.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Orr,H.T.,"

Phrase: "Anderson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Nemens,"

Phrase: "E.,"

Phrase: "White,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007457:White [Population Group]
  1000   C0043157:White [Population Group]
  1000   C0220938:White [Qualitative Concept]

Phrase: "J."

Phrase: "A.,"

Phrase: "Bonnycastle,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Weber,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0582525:weber [Quantitative Concept]

Phrase: "J.L., Alonso,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Heston,"

Phrase: "L.L."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3539687:L/L [Quantitative Concept]

Phrase: "and"

Phrase: "Martin,"

Phrase: "G.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456715:g m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.273: (1992) Genetic linkage evidence for a familial Alzheimer's disease locus on chromosome 14. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Genetic linkage evidence for a familial Alzheimer's disease locus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0332120:Evidence [Functional Concept]

Phrase: "on chromosome 14."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008656:Chromosome 14 [Cell Component]
   861   C0008633:Chromosome [Cell Component]
Processing 00000000.tx.274: Science, 258, 668-671. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "258,"

Phrase: "668-671."
Processing 00000000.tx.275: MEDLINE Abstract 11 Alzheimer's Disease Collaborative Group: Clark,R.F., Hutton,M., Fuldner,R.A., Froelich,S., Karran,E., Talbot,C., Crook,R., Lendon,C., Prihar,G., He,C., Korenblat,K., Martinez,A., Wragg,M., Busfield,F., Behrens,M.I., Myers,A., Norton,J., Morris,J., Mehta,N., Pearson,C., Lincoln,C., Baker,M., Duff,K., Zehr,C., Perez-Tur,J., Houlden,H., Ruiz,A., Ossa,J., Lopera,F., Arcos,M., Madrigal,L., Collinge,J., Humphreys,C., Ashworth,A., Sarner,S., Fox,N., Harvey,R., Kennedy,A., Roques,P., Cline,R.T., Philips,C.A., Venter,J.C., Forsell,L., Axelman,K., Lilius,L., Johnston,J., Cowburn,R., Viitanen,M., Windblad,B., Kosik,K., Haltia,M., Poyhonen,M., Dickson,D., Mann,D., Neary,D., Snowdon,J., Lantos,P., Lannfelt,L., Rossor,M., Roberts,G.W., Adams,M.D., Hardy,J. and Goate,A. 

Phrase: "MEDLINE Abstract 11 Alzheimer's Disease Collaborative Group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   795   C0441833:Group [Idea or Concept]
   795   C0687744:group [Population Group]
   795   C1257890:Group [Population Group]
   795   C1552516:Group [Health Care Related Organization]
   795   C1705428:Group [Conceptual Entity]
   795   C1705429:Group [Population Group]

Phrase: ":"

Phrase: "Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Fuldner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Karran,"

Phrase: "E.,"

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "He,C., Korenblat,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "A.,"

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Behrens,"

Phrase: "M.I.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Myers,"

Phrase: "A.,"

Phrase: "Norton,"

Phrase: "J.,"

Phrase: "Morris,"

Phrase: "J.,"

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Pearson,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lincoln,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Zehr,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Ruiz,"

Phrase: "A.,"

Phrase: "Ossa,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0262950:Ossa [Body Part, Organ, or Organ Component]
  1000   C1825255:OSSA [Gene or Genome]

Phrase: "J.,"

Phrase: "Lopera,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Arcos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1206428:Arcos [Fish]

Phrase: "M."

Phrase: ","

Phrase: "Madrigal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Collinge,"

Phrase: "J.,"

Phrase: "Humphreys,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Ashworth,"

Phrase: "A.,"

Phrase: "Sarner,"

Phrase: "S."

Phrase: ","

Phrase: "Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Harvey,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kennedy,"

Phrase: "A.,"

Phrase: "Roques,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cline,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Philips,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Venter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0224086:Venter [Body Part, Organ, or Organ Component]

Phrase: "J.C., Forsell,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Axelman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lilius,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Johnston,"

Phrase: "J.,"

Phrase: "Cowburn,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Viitanen,"

Phrase: "M."

Phrase: ","

Phrase: "Windblad,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kosik,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Haltia,"

Phrase: "M."

Phrase: ","

Phrase: "Poyhonen,"

Phrase: "M."

Phrase: ","

Phrase: "Dickson,"

Phrase: "D."

Phrase: ","

Phrase: "Mann,"

Phrase: "D."

Phrase: ","

Phrase: "Neary,"

Phrase: "D."

Phrase: ","

Phrase: "Snowdon,"

Phrase: "J.,"

Phrase: "Lantos,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G.W., Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331762:Adams [Health Care Related Organization]

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.276: (1995) The structure of the Presenilin 1 (S182) gene and identification of six novel mutations in early onset AD families. 

Phrase: "(1995"

Phrase: ")"

Phrase: "The structure of the Presenilin 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0678594:Structure [Spatial Concept]

Phrase: "(S182"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418985:S182 [Gene or Genome]
  1000   C2986918:S182 [Gene or Genome]

Phrase: ")"

Phrase: "gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "identification of six novel mutations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "in early onset AD families."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   840   C0344339:disease family [Finding]
   804   C0015576:Families [Family Group]
   804   C1704727:Family [Conceptual Entity]
   771   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   721 E C0241888:Familial [Functional Concept]
   708   C0679245:early disease [Temporal Concept]
Processing 00000000.tx.277: Nature Genet., 11, 219-222. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "219-222."
Processing 00000000.tx.278: 12 Cruts,M., Backhovens,H., Wang,S.-Y., Van Gassen,G., Theuns,J., De Longhe,C., Wehnert,A., De Voecht,J., De Winter,G., Cras,P., Bruyland,M., Datson,N., Weissenbach,J., den Dunnen,J.T., Martin, J.-J., Hendriks, L. and Van Broeckhoven,C. 

Phrase: "12 Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "S.-"

Phrase: "Y.,"

Phrase: "Van Gassen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Theuns,"

Phrase: "J.,"

Phrase: "De Longhe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "De Voecht,"

Phrase: "J.,"

Phrase: "De Winter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241737:Winter [Temporal Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bruyland,"

Phrase: "M."

Phrase: ","

Phrase: "Datson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Weissenbach,"

Phrase: "J.,"

Phrase: "den Dunnen,"

Phrase: "J.T.,"

Phrase: "Martin,"

Phrase: "J.-J.,"

Phrase: "Hendriks,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.279: (1995) Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Molecular genetic analysis of familial early-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   764   C0679560:genetic analysis [Laboratory Procedure]
   764   C0796344:Genetic Analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "linked to chromosome 14q24.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1520594:14q24.3 [Cell Component]
   797   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C1520591:14q24 [Cell Component]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.280: Hum. 

Phrase: "Hum."
Processing 00000000.tx.281: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.282: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.283: 4, 2363-2372. 

Phrase: "4,"

Phrase: "2363-2372."
Processing 00000000.tx.284: MEDLINE Abstract 13 Cruts,M. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 13 Cruts,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.285: (1997) Presenilin mutations in Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Presenilin mutations in Alzheimer's disease."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0026882:Mutations [Genetic Function]
   726 E C1705285:Mutation [Cell or Molecular Dysfunction]
Processing 00000000.tx.286: Hum. 

Phrase: "Hum."
Processing 00000000.tx.287: Mutat., in press. 

Phrase: "Mutat.,"

Phrase: "in press."
Processing 00000000.tx.288: 14 Campion,D., Flaman,J.-M., Brice,A., Hannequin,D., Dubois,B., Martin,C., Moreau,V., Charbonnier,F., Didierjean,O., Tardieu,S., Penet,C., Puel,M., Pasquier,F., Bellis,G., Calenda,A., Heilig,R., Martinez,M., Mallet,J., Bellis,M., Clerget-Darpoux,F., Agid,Y. and Frebourg,T. 

Phrase: "14 Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Flaman,"

Phrase: "J.-"

Phrase: "M."

Phrase: ","

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Hannequin,"

Phrase: "D."

Phrase: ","

Phrase: "Dubois,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Martin,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Moreau,"

Phrase: "V.,"

Phrase: "Charbonnier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Didierjean,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Tardieu,"

Phrase: "S."

Phrase: ","

Phrase: "Penet,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Puel,"

Phrase: "M."

Phrase: ","

Phrase: "Pasquier,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Bellis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1009534:Bellis [Plant]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Calenda,"

Phrase: "A.,"

Phrase: "Heilig,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Martinez,"

Phrase: "M."

Phrase: ","

Phrase: "Mallet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0181716:MALLET [Medical Device]

Phrase: "J.,"

Phrase: "Bellis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1009534:Bellis [Plant]

Phrase: "M."

Phrase: ","

Phrase: "Clerget-Darpoux,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Agid,Y."

Phrase: "and"

Phrase: "Frebourg,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.289: (1995) Mutations of the Presenilin-1 gene in families with early-onset Alzheimer's disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Mutations of the Presenilin-1 gene"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   783   C0596611:gene mutations [Genetic Function]
   753   C0026882:Mutations [Genetic Function]
   719 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.290: Hum. 

Phrase: "Hum."
Processing 00000000.tx.291: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.292: Genet., 4, 2373-2377. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "2373-2377."
Processing 00000000.tx.293: MEDLINE Abstract 15 Hutton,M., Busfield,F., Wragg,M., Crook,R., Perez-Tur,J., Clark,R.F., Prihar,G., Talbot,C., Phillips,H., Wright,K., Baker,M., Lendon,C., Duff,K., Martinez,A., Houlden,H., Nichols,A., Karran,E., Roberts,G., Venter,J.C., Adams,M.D., Cline,R.T., Phillips,C.A., Fuldner,R.A., Hardy,J. and Goate,A. 

Phrase: "MEDLINE Abstract 15 Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Phillips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wright,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1261259:Wright [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Martinez,"

Phrase: "A.,"

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Nichols,"

Phrase: "A.,"

Phrase: "Karran,"

Phrase: "E.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Venter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0224086:Venter [Body Part, Organ, or Organ Component]

Phrase: "J.C., Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0331762:Adams [Health Care Related Organization]

Phrase: "M.D.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Cline,"

Phrase: "R.T.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0232024:R T [Clinical Attribute]
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Phillips,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Fuldner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Hardy,"

Phrase: "J."

Phrase: "and"

Phrase: "Goate,"

Phrase: "A."
Processing 00000000.tx.294: (1996) Complete analysis of the presenilin 1 gene in families with early onset Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "analysis of the presenilin 1 gene"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with early onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.295: Neuroreport, 7, 801-805. 

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "801-805."
Processing 00000000.tx.296: MEDLINE Abstract 16 Tanahashi,H., Kawakatsu,S., Kaneko,M., Yamanaka,H., Takahashi,K. and Tabira,T. 

Phrase: "MEDLINE Abstract 16 Tanahashi,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Kawakatsu,"

Phrase: "S."

Phrase: ","

Phrase: "Kaneko,"

Phrase: "M."

Phrase: ","

Phrase: "Yamanaka,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Takahashi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Tabira,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.297: (1996) Sequence analysis of presenilin-1 gene mutation in Japanese Alzheimer's disease patient. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Sequence analysis of presenilin-1 gene mutation"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   804   C1294200:Gene mutation analysis [Laboratory Procedure]
   778   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   774   C0796357:mutation analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0004793:Sequence [Nucleotide Sequence]
   748   C0162326:Sequence [Nucleotide Sequence]
   748   C0162327:Sequence [Nucleotide Sequence]
   748   C0936012:Analysis [Research Activity]
   748   C1519249:Sequence [Functional Concept]
   748   C1524024:analysis [Functional Concept]

Phrase: "in Japanese Alzheimer's disease patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.298: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.299: Lett., 218, 139-141. 

Phrase: "Lett.,"

Phrase: "218,"

Phrase: "139-141."
Processing 00000000.tx.300: MEDLINE Abstract 17 Sherrington,R., Froelich,S., Sorbi,S., Campion,D., Chi,H., Rogaeva,E.A., Levesque,G., Rogaev,E.I., Lin,C., Liang,Y., Ikeda,M., Mar,L., Brice,A., Agid,Y., Percy,M.E., Clerget-Darpoux,F., Piacentini,S., Marcon,G., Nacmias,B., Amaducci,L., Frebourg,T., Lannfelt,L., Rommens,J.M. and St George-Hyslop,P.H. 

Phrase: "MEDLINE Abstract 17 Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Froelich,"

Phrase: "S."

Phrase: ","

Phrase: "Sorbi,"

Phrase: "S."

Phrase: ","

Phrase: "Campion,"

Phrase: "D."

Phrase: ","

Phrase: "Chi,H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Lin,C., Liang,"

Phrase: "Y.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Mar"

Phrase: ","

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Brice,"

Phrase: "A.,"

Phrase: "Agid,Y.,"

Phrase: "Percy,"

Phrase: "M."

Phrase: "E.,"

Phrase: "Clerget-Darpoux,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Piacentini,"

Phrase: "S."

Phrase: ","

Phrase: "Marcon,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Nacmias,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Amaducci,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Frebourg,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Lannfelt,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Rommens,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.301: (1996) Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrant. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "associated with mutations"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0026882:Mutations [Genetic Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1705285:Mutation [Cell or Molecular Dysfunction]
   756 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in presenilin 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0528480:Presenilin-2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1418986:PRESENILIN 2 [Gene or Genome]
   861   C0872078:Presenilin [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "is"

Phrase: "rare"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521114:Rare [Temporal Concept]
  1000   C0522498:Rare [Qualitative Concept]
  1000   C1514917:RARE [Gene or Genome]

Phrase: "and"

Phrase: "variably penetrant."
Processing 00000000.tx.302: Hum. 

Phrase: "Hum."
Processing 00000000.tx.303: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.304: Genet., 5, 985-988. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "985-988."
Processing 00000000.tx.305: MEDLINE Abstract 18 Hofman,A., Schulte,W., Tanja,T.A., van Duijn,C.M., Haaxma,R., Lameris,A.J., Otten,V.M. and Saan,R.J. 

Phrase: "MEDLINE Abstract 18 Hofman,"

Phrase: "A.,"

Phrase: "Schulte,"

Phrase: "W.,"

Phrase: "Tanja,"

Phrase: "T.A.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0193959:t a [Therapeutic or Preventive Procedure]
   861   C2603360:T' [Clinical Attribute]

Phrase: "van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Haaxma,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lameris,"

Phrase: "A.J.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1510707:A/J [Mammal]

Phrase: "Otten,"

Phrase: "V.M."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2349138:V/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Saan,"

Phrase: "R.J."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.306: (1989) History of dementia and Parkinson's disease in 1st-degree relatives of patients with Alzheimer's disease. 

Phrase: "(1989"

Phrase: ")"

Phrase: "History of dementia"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0455499:History of - dementia [Finding]
   790   C0019664:History [Occupation or Discipline]
   790   C0019665:history [Intellectual Product]
   790   C0262512:History, NOS [Organism Attribute]
   790   C0262926:History [Finding]
   790   C1705255:History [Conceptual Entity]
   790   C2004062:History [Finding]
   718 E C1552658:Historical [Idea or Concept]
   718 E C1552723:Historical [Idea or Concept]

Phrase: "and"

Phrase: "Parkinson's disease in 1st-degree relatives of patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030567:Parkinson Disease [Disease or Syndrome]
   770   C1521736:Parkinson's Disease [Functional Concept]
   770   C2681933:PARKINSON DISEASE [Gene or Genome]
   744   C0012634:Disease [Disease or Syndrome]

Phrase: "with Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.307: Neurology, 39, 1589-1592. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "39,"

Phrase: "1589-1592."
Processing 00000000.tx.308: MEDLINE Abstract 19 van Duijn,C.M., Hendriks,L., Cruts,M., Hardy,J.A., Hofman,A. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 19 van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Hendriks,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J."

Phrase: "A.,"

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.309: (1991) Amyloid precursor protein gene mutation in early-onset Alzheimer's disease. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Amyloid precursor protein gene mutation in early-onset Alzheimer's disease."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0596611:Gene Mutation [Genetic Function]
   760   C0751455:protein gene [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0017337:Gene [Gene or Genome]
   739   C0026882:Mutation [Genetic Function]
   739   C1705285:Mutation [Cell or Molecular Dysfunction]
   730   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.310: Lancet, 337, 978. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "337,"

Phrase: "978."
Processing 00000000.tx.311: MEDLINE Abstract 20 van Duijn,C.M., Farrer,L.A., Backhovens,H., Cruts,M., Wehnert,A., Hofman,A. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 20 van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Farrer,"

Phrase: "L.A.,"

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.312: (1994) A population-based study of familial Alzheimer's disease: linkage to chromosome 14, 19 and 21. 

Phrase: "(1994"

Phrase: ")"

Phrase: "A population-based study of familial Alzheimer's disease"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C1709599:Population Based Study [Research Activity]
   767   C0199236:Familial Study [Diagnostic Procedure]
   767   C0681876:Population Study [Research Activity]
   767   C2348561:Study Population [Population Group]
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]

Phrase: ":"

Phrase: "linkage to chromosome 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0023745:linkage [Molecular Function]

Phrase: "19"

Phrase: "and"

Phrase: "21."
Processing 00000000.tx.313: Am. 

Phrase: "Am."
Processing 00000000.tx.314: J. 

Phrase: "J."
Processing 00000000.tx.315: Hum. 

Phrase: "Hum."
Processing 00000000.tx.316: Genet., 55, 714-727. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "714-727."
Processing 00000000.tx.317: MEDLINE Abstract 21 Rogaev,E.I., Sherrington,R., Wu,C., Levesque,G., Liang,Y., Rogaeva,E.A., Ikeda,M., Holman,K., Lin,C., Lukiw,W.J., de Jong,P.J., Fraser,P.E., Rommens,J.M. and St George-Hyslop,P.H. 

Phrase: "MEDLINE Abstract 21 Rogaev,"

Phrase: "E.I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Sherrington,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Wu,C., Levesque,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Liang,"

Phrase: "Y.,"

Phrase: "Rogaeva,"

Phrase: "E.A.,"

Phrase: "Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3613423:Ikeda [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "Holman,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lin,C., Lukiw,"

Phrase: "W.J.,"

Phrase: "de Jong,"

Phrase: "P.J.,"

Phrase: "Fraser,"

Phrase: "P.E.,"

Phrase: "Rommens,"

Phrase: "J.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "St George-Hyslop,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1553316:St. George [Population Group]

Phrase: "P.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.318: (1997) Analysis of the 5' sequence, genomic structure, and alternative splicing of the presenilin-1 gene (PSEN1) associated with early onset Alzheimer's disease. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Analysis of the 5' sequence,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0162801:Sequence Analysis [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "genomic structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "alternative splicing of the presenilin-1 gene (PSEN1)"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002345:Alternative Splicing [Genetic Function]
   774   C0017365:gene splicing [Gene or Genome]
   774   C0017387:Gene Splicing [Molecular Biology Research Technique]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]

Phrase: "associated with early onset Alzheimer's disease."
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
   901   C0750901:Alzheimer's disease with early onset [Disease or Syndrome]
           Alzheimer Disease, Early Onset
   814   C0814120:early disease onset [Disease or Syndrome]
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   790   C1833334:Early-onset [Finding]
   783   C0243083:associated disease [Pathologic Function]
   783   C0277793:disease onset [Temporal Concept]
   783   C0679245:early disease [Temporal Concept]
   753   C0012634:Disease [Disease or Syndrome]
   753   C0332162:Onset [Qualitative Concept]
   753   C1279919:Early [Temporal Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.319: Genomics, 40, 415-424. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "415-424."
Processing 00000000.tx.320: MEDLINE Abstract 22 Prihar,G., Fuldner,R.A., Perez-Tur,J., Lincoln,S., Duff,K., Crook,R., Hardy,J., Phillips,C.A., Venter,C., Talbot,C., Clark,R.F., Goate,A., Li,J., Potter,H., Karran,E., Roberts,G.W., Hutton,M. and Adams,M.D. 

Phrase: "MEDLINE Abstract 22 Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Fuldner,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "A.,"

Phrase: "Perez-Tur,"

Phrase: "J.,"

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Duff,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Phillips,"

Phrase: "C."

Phrase: "A.,"

Phrase: "Venter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0224086:Venter [Body Part, Organ, or Organ Component]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Li,J.,"

Phrase: "Potter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336168:potter [Professional or Occupational Group]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Karran,"

Phrase: "E.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G.W., Hutton,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]

Phrase: "and"

Phrase: "Adams,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331762:Adams [Health Care Related Organization]

Phrase: "M.D."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1512018:M.D. [Intellectual Product]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.321: (1996) Structure and alternative splicing of the presenilin-2 gene. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "alternative splicing of the presenilin-2 gene."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002345:Alternative Splicing [Genetic Function]
   774   C0017365:gene splicing [Gene or Genome]
   774   C0017387:Gene Splicing [Molecular Biology Research Technique]
   748   C0035687:Splicing [Genetic Function]
   748   C2610186:splicing [Genetic Function]
Processing 00000000.tx.322: Neuroreport, 7, 1680-1684. 

Phrase: "Neuroreport,"

Phrase: "7,"

Phrase: "1680-1684."
Processing 00000000.tx.323: MEDLINE Abstract 23 Cruts,M., Backhovens,H., Wang,S.-Y., Van Gassen,G., Theuns,J., De Jonghe,C., Wehnert,A., De Voecht,J., De Winter,G., Cras,P., Bruyland,M., Datson,N., Weissenbach,J., den Dunnen,J.T., Martin,J.-J., Hendriks,L. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 23 Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wang,"

Phrase: "S.-"

Phrase: "Y.,"

Phrase: "Van Gassen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Theuns,"

Phrase: "J.,"

Phrase: "De Jonghe,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "De Voecht,"

Phrase: "J.,"

Phrase: "De Winter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0241737:Winter [Temporal Concept]

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Cras,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Bruyland,"

Phrase: "M."

Phrase: ","

Phrase: "Datson,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Weissenbach,"

Phrase: "J.,"

Phrase: "den Dunnen,"

Phrase: "J.T.,"

Phrase: "Martin,"

Phrase: "J.-J.,"

Phrase: "Hendriks,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.324: (1995) Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Molecular genetic analysis of familial early-onset Alzheimer's disease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C1513380:Molecular Genetic Analysis [Molecular Biology Research Technique]
           Molecular Analysis
   764   C0679560:genetic analysis [Laboratory Procedure]
   764   C0796344:Genetic Analysis [Laboratory Procedure]
   742   C0002778:Analysis [Laboratory Procedure]
   742   C0936012:Analysis [Research Activity]
   742   C1524024:analysis [Functional Concept]

Phrase: "linked to chromosome 14q24.3."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C1520594:14q24.3 [Cell Component]
   797   C0008666:Chromosome 3 [Cell Component]
   760   C0008633:Chromosome [Cell Component]
   760   C1520591:14q24 [Cell Component]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
Processing 00000000.tx.325: Hum. 

Phrase: "Hum."
Processing 00000000.tx.326: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.327: Genet., 4, 2363-2372. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "4,"

Phrase: "2363-2372."
Processing 00000000.tx.328: MEDLINE Abstract 24 van Duijn,C.M., Cruts,M., Backhovens,H., Wehnert,A., Theuns,J., Van Gassen,G., Hofman,A. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 24 van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Theuns,"

Phrase: "J.,"

Phrase: "Van Gassen,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.329: (1996) A genetic association study of presenilin 1 in early-onset Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "A genetic association study of presenilin 1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   814   C2717878:Study, Genetic Association [Molecular Biology Research Technique]
   774   C2827447:Genetic Study [Research Activity]
   748   C0557651:Study [Manufactured Object]
   748   C2603343:Study [Research Activity]

Phrase: "in early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.330: Am. 

Phrase: "Am."
Processing 00000000.tx.331: J. 

Phrase: "J."
Processing 00000000.tx.332: Hum. 

Phrase: "Hum."
Processing 00000000.tx.333: Genet., 59 (suppl.), A192. 

Phrase: "Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]

Phrase: "59"

Phrase: "(suppl."

Phrase: ")"

Phrase: ","

Phrase: "A192."
Processing 00000000.tx.334: 25 Wragg,M., Hutton,M., Talbot,C., Busfield,F., Han,S.W., Lendon,C., Clark,R.F., Morris,J.C., Edwards,D., Goate,A., Pfeiffer,E., Crook,R., Prihar,G., Philips,H., Baker,M., Hardy,J., Rossor,M., Houlden,H., Karran,E., Roberts,G. and Craddock,N. 

Phrase: "25 Wragg,"

Phrase: "M."

Phrase: ","

Phrase: "Hutton,"

Phrase: "M."

Phrase: ","

Phrase: "Talbot,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Busfield,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Han,S.W., Lendon,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Clark,"

Phrase: "R.F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Morris,"

Phrase: "J.C., Edwards,"

Phrase: "D."

Phrase: ","

Phrase: "Goate,"

Phrase: "A.,"

Phrase: "Pfeiffer,"

Phrase: "E.,"

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Prihar,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Philips,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baker,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0238749:Baker [Professional or Occupational Group]

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Rossor,"

Phrase: "M."

Phrase: ","

Phrase: "Houlden,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Karran,"

Phrase: "E.,"

Phrase: "Roberts,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331964:Roberts [Health Care Related Organization]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Craddock,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.335: (1996) Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genetic association between intronic polymorphism"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1328885:genetic association [Occupation or Discipline]
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "in presenilin-1 gene"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1418985:Presenilin 1 Gene [Gene or Genome]
           PRESENILIN 1
   827   C0017337:Gene [Gene or Genome]
   734   C0299212:Presenilin-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "late-onset Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0494463:Alzheimer Disease, Late Onset [Mental or Behavioral Dysfunction]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   812   C0012634:Disease [Disease or Syndrome]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.336: Lancet, 347, 509-512. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "347,"

Phrase: "509-512."
Processing 00000000.tx.337: MEDLINE Abstract 26 Levy-Lahad,E., Poorkaj,P., Wang,K., Hui Fu,Y., Oshima,J., Mulligan,J. and Schellenberg,G.D. 

Phrase: "MEDLINE Abstract 26 Levy-Lahad,"

Phrase: "E.,"

Phrase: "Poorkaj,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wang,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Hui Fu,Y.,"

Phrase: "Oshima,"

Phrase: "J.,"

Phrase: "Mulligan,"

Phrase: "J."

Phrase: "and"

Phrase: "Schellenberg,"

Phrase: "G.D."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439417:g d [Quantitative Concept]
Processing 00000000.tx.338: (1996) Genomic structure and expression of STM2, the chromosome 1 familial Alzheimer's disease gene. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Genomic structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "expression of STM2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "the chromosome 1 familial Alzheimer's disease gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017337:Gene [Gene or Genome]
   799   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.339: Genomics, 34, 198-204. 

Phrase: "Genomics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0887950:Genomics [Biomedical Occupation or Discipline]

Phrase: "34,"

Phrase: "198-204."
Processing 00000000.tx.340: MEDLINE Abstract 27 Sandbrink,R., Zhang,D., Schaeffer,S., Masters,C.L., Bauer,J., Frstl,H. and Beyreuther,K. 

Phrase: "MEDLINE Abstract 27 Sandbrink,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Zhang,"

Phrase: "D."

Phrase: ","

Phrase: "Schaeffer,"

Phrase: "S."

Phrase: ","

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C.L.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553033:[c] [Quantitative Concept]

Phrase: "Bauer,"

Phrase: "J.,"

Phrase: "Frstl,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Beyreuther,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.341: (1996) Missense mutations of the S182/PS1 gene in German early-onset Alzheimer's disease patients. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Missense mutations of the S182/PS1 gene"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   778   C0599155:Mutations, Missense [Genetic Function]
   774   C0596611:gene mutations [Genetic Function]
   748   C0026882:Mutations [Genetic Function]
   714 E C1705285:Mutation [Cell or Molecular Dysfunction]

Phrase: "in German early-onset Alzheimer's disease patients."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0030705:Patients [Patient or Disabled Group]
   734   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
Processing 00000000.tx.342: Annls Neurol., 40, 265-266. 

Phrase: "Annls Neurol.,"

Phrase: "40,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439509:/40 [Temporal Concept]

Phrase: "265-266."
Processing 00000000.tx.343: 28 Hayashi,K. and Yandell,D.W. 

Phrase: "28 Hayashi,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Yandell,"

Phrase: "D.W."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.344: (1993) How sensitive is PCR-SSCP? 

Phrase: "(1993"

Phrase: ")"

Phrase: "How sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332324:Sensitive [Functional Concept]
   861   C1550474:sensitive [Idea or Concept]

Phrase: "is"

Phrase: "PCR-SSCP?"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0243031:SSCP [Laboratory or Test Result]
   756   C0032520:Polymerase Chain Reaction [Laboratory Procedure,Molecular Biology Research Technique]
Processing 00000000.tx.345: Hum. 

Phrase: "Hum."
Processing 00000000.tx.346: Mutat., 2, 338-346. 

Phrase: "Mutat.,"

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "338-346."
Processing 00000000.tx.347: MEDLINE Abstract 29 Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 29 Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.348: (1995) Presenilins and Alzheimer disease. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Presenilins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0872078:Presenilins [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "Alzheimer disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.349: Nature Genet., 11, 230-232. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "11,"

Phrase: "230-232."
Processing 00000000.tx.350: MEDLINE Abstract 30 Corder,E.H., Saunders,A.M., Strittmatter,W.J., Schmechel,D.E., Gaskell,P.C., Small,G.W., Roses,A.D., Haines,J.L. and Pericak-Vance,M.A. 

Phrase: "MEDLINE Abstract 30 Corder,"

Phrase: "E.H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Saunders,"

Phrase: "A.M.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2346751:A/m [Quantitative Concept]
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Strittmatter,"

Phrase: "W.J.,"

Phrase: "Schmechel,"

Phrase: "D."

Phrase: "E.,"

Phrase: "Gaskell,"

Phrase: "P.C.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "G.W., Roses,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0035853:Roses [Plant]
   793 E C0995005:ROSE [Pharmacologic Substance]

Phrase: "A.D.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0718133:a & d [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "Haines,"

Phrase: "J.L."

Phrase: "and"

Phrase: "Pericak-Vance,"

Phrase: "M.A."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.351: (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Gene dose of apolipoprotein E type 4 allele"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0178602:Dose [Quantitative Concept]
   744   C0869039:Dose [Quantitative Concept]
   744   C1114758:Dose # [Clinical Attribute]

Phrase: "and"

Phrase: "the risk of Alzheimer's disease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1281905:disease risk [Finding]
   760   C0035647:Risk [Qualitative Concept]

Phrase: "in late onset families."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0015576:Families [Family Group]
   827   C1704727:Family [Conceptual Entity]
   743 E C0241888:Familial [Functional Concept]
Processing 00000000.tx.352: Science, 261, 921-923. 

Phrase: "Science,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "261,"

Phrase: "921-923."
Processing 00000000.tx.353: MEDLINE Abstract 31 Van Broeckhoven,C., Backhovens,H., Cruts,M., Martin,J., Crook,R., Houlden,H. and Hardy,J. 

Phrase: "MEDLINE Abstract 31 Van Broeckhoven,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Backhovens,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Martin,"

Phrase: "J.,"

Phrase: "Crook,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Houlden,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Hardy,"

Phrase: "J."
Processing 00000000.tx.354: (1994) APOE genotype does not modulate age of onset in families with chromosome 14 encoded Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "APOE genotype"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017431:Genotype [Organism Attribute]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "age of onset"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0206132:Age of Onset [Quantitative Concept]
           Onset Age
   790   C0001779:Age [Organism Attribute]

Phrase: "in families"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0015576:Families [Family Group]
  1000   C1704727:Family [Conceptual Entity]
   916 E C0241888:Familial [Functional Concept]

Phrase: "with chromosome 14 encoded Alzheimer's disease."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   862   C0008626:Chromosomal disease, NOS [Disease or Syndrome]
   840   C0002395:Alzheimer's Disease [Disease or Syndrome]
   840   C1521724:Alzheimer's Disease [Pathologic Function]
   804   C0012634:Disease [Disease or Syndrome]
   748 E C1836721:MALS [Finding]
   748 E C3538764:MALS [Gene or Genome]
   748 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.355: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.356: Lett., 169, 179-180. 

Phrase: "Lett.,"

Phrase: "169,"

Phrase: "179-180."
Processing 00000000.tx.357: MEDLINE Abstract 32 Levitan,D. and Greenwald,I. 

Phrase: "MEDLINE Abstract 32 Levitan,"

Phrase: "D."

Phrase: "and"

Phrase: "Greenwald,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.358: (1995) Facilitation of lin-12-mediated signalling by sel-12, a Caenorhabditis elegans S182 Alzheimer's disease gene. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Facilitation of lin-12-mediated signalling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0234112:Facilitation [Organ or Tissue Function]

Phrase: "by sel-12,"

Phrase: "a Caenorhabditis elegans S182 Alzheimer's disease gene."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0017337:Gene [Gene or Genome]
   799   C1416989:MAL gene [Gene or Genome]
Processing 00000000.tx.359: Nature, 377, 351-354. 

Phrase: "Nature,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0349590:Nature [Idea or Concept]
  1000   C1262865:Nature [Functional Concept]
   928 E C0205296:Natural [Functional Concept]

Phrase: "377,"

Phrase: "351-354."
Processing 00000000.tx.360: MEDLINE Abstract 33 van Duijn,C.M., de Knijff,P., Cruts,M., Wehnert,A., Havekes,L.M., Hofman,A. and Van Broeckhoven,C. 

Phrase: "MEDLINE Abstract 33 van Duijn,"

Phrase: "C."

Phrase: "M."

Phrase: ","

Phrase: "de Knijff,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cruts,"

Phrase: "M."

Phrase: ","

Phrase: "Wehnert,"

Phrase: "A.,"

Phrase: "Havekes,"

Phrase: "L.M.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0439394:l's [Quantitative Concept]
   861   C0441923:M+ [Intellectual Product]
   861   C1706495:L- [Intellectual Product]
   861   C3642217:/L [Quantitative Concept]

Phrase: "Hofman,"

Phrase: "A."

Phrase: "and"

Phrase: "Van Broeckhoven,"

Phrase: "C."
Processing 00000000.tx.361: (1994) Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Apolipoprotein E4 allele in a population-based study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   800   C3642141:Apolipoprotein E*4 Allele [Gene or Genome]
   744   C0002085:Allele [Gene or Genome]

Phrase: "of early-onset Alzheimer's disease."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
  1000   C0750901:Alzheimer Disease, Early Onset [Disease or Syndrome]
   902   C0679245:early disease [Temporal Concept]
   861   C0002395:Alzheimer's Disease [Disease or Syndrome]
   861   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C1833334:Early-onset [Finding]
   812   C0012634:Disease [Disease or Syndrome]
   812   C0332162:Onset [Qualitative Concept]
   812   C1279919:Early [Temporal Concept]
   756 E C1836721:MALS [Finding]
   756 E C3538764:MALS [Gene or Genome]
   756 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.362: Nature Genet., 7, 74-78. 

Phrase: "Nature Genet.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0325074:Genet [Mammal]

Phrase: "7,"

Phrase: "74-78."
Processing 00000000.tx.363: MEDLINE Abstract 34 McKhann,G., Drachman,D., Folstein,M., Katzman,R., Price,D. and Stadlan,E.M. 

Phrase: "MEDLINE Abstract 34 McKhann,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Drachman,"

Phrase: "D."

Phrase: ","

Phrase: "Folstein,"

Phrase: "M."

Phrase: ","

Phrase: "Katzman,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "D."

Phrase: "and"

Phrase: "Stadlan,"

Phrase: "E.M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.364: (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. 

Phrase: "(1984"

Phrase: ")"

Phrase: "Clinical diagnosis of Alzheimer's disease"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0332140:Diagnosis, clinical [Qualitative Concept]
   760   C0011900:Diagnosis [Finding]
   760   C0205210:Clinical [Qualitative Concept]
   760   C1704338:diagnosis [Qualitative Concept]
   760   C1704656:DIAGNOSIS [Research Activity]

Phrase: ":"

Phrase: "report of the NINCDS-ADRDA Work Group"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0684224:Report [Intellectual Product]
   748   C0700287:Report [Health Care Activity]
   748   C3273238:Report [Intellectual Product]

Phrase: "under the auspices"

Phrase: "of Department of Health and Human Services Task Force"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   812   C0162458:Task Force [Governmental or Regulatory Activity]
   793   C0441722:Force [Phenomenon or Process]
   793   C0563538:Force [Phenomenon or Process]
   793   C3540678:Task [Occupational Activity]
   756   C0041711:Department of Health and Human Services [Health Care Related Organization]
           department health human services
   737 E C0729333:Dynamic [Functional Concept]

Phrase: "on Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.365: Neurology, 34, 939-944. 

Phrase: "Neurology,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0027855:Neurology [Biomedical Occupation or Discipline]
   928 E C0205494:Neurologic [Qualitative Concept]
   928 E C2707261:Neurological [Clinical Attribute]
   907 E C0027763:Nervous System [Body System]
   907 E C0422837:NERVOUS SYSTEM [Finding]
   907 E C1269560:Nervous system [Body System]

Phrase: "34,"

Phrase: "939-944."
Processing 00000000.tx.366: MEDLINE Abstract 35 Wenhan,P.R., Price,W.H. and Blundell,G. 

Phrase: "MEDLINE Abstract 35 Wenhan,"

Phrase: "P.R.,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205090:R- [Spatial Concept]
   861   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]
   861   C2603361:P' [Clinical Attribute]

Phrase: "Price,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0080045:Price [Quantitative Concept]

Phrase: "W.H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Blundell,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.367: (1991) Apolipoprotein E genotyping by one-stage PCR. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Apolipoprotein E genotyping by one-stage PCR."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1285573:Genotyping [Laboratory Procedure]
Processing 00000000.tx.368: Lancet, 337, 1158-1159. 

Phrase: "Lancet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0777169:Lancet [Medical Device]

Phrase: "337,"

Phrase: "1158-1159."
Processing 00000000.tx.369: *To whom correspondence should be addressed. 

Phrase: "*"

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]
Processing 00000000.tx.370: Tel: +32 3 8202601; 

Phrase: "Tel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"

Phrase: "+32 3 8202601"

Phrase: ";"
Processing 00000000.tx.371: Fax: +32 3 8202541; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "+32 3 8202541"

Phrase: ";"
Processing 00000000.tx.372: Email: cvbroeck@uia.ac.be

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "cvbroeck@uia.ac."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1412573:AC [Gene or Genome]
   827   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   827   C3539770:AC [Gene or Genome]

Phrase: "be"

